UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment (Amendment No.     )

 

 

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

 Preliminary Proxy Statement

���
 Confidential, for Use of the Commission Only (as permitted byRule 14a-6(e)(2))

 Definitive Proxy Statement

 Definitive Additional Materials

 Soliciting Material Pursuant to§240.14a-12 §240.14a-12

Teleflex Incorporated

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

 

Fee computed on table below per Exchange ActRules 14a-6(i)(1) and0-11.

 

(1)

 

Title of each class of securities to which transaction applies:

 

     

 

(2)

 

Aggregate number of securities to which transaction applies:

 

     

 

(3)

 

Per unit or other underlying value of transaction computed pursuant to Exchange ActRule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

 

(4)

 

Proposed maximum aggregate value of transaction:

 

     

 

(5)

 

Total fee paid:

 

     

 Fee paid previously with preliminary materials.

 Check box if any part of the fee is offset as provided by Exchange ActRule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 (1) 

Amount Previously Paid:

 

     

 (2) 

Form, Schedule or Registration Statement No.:

 

     

 (3) 

Filing Party:

 

     

 (4) 

Date Filed:

 

     

 

 

 


LOGO

550 East Swedesford Road, Suite 400

Wayne, Pennsylvania 19087

 

 

Notice of Annual Meeting of Stockholders

To Be Held on May 3, 2019April 30, 2021

 

 

March 29, 201926, 2021

TO THE STOCKHOLDERS OF TELEFLEX INCORPORATED:

The annual meeting of stockholders (the “Annual Meeting”) of Teleflex Incorporated will be held on Friday, May 3, 2019April 30, 2021 at 11:00 a.m., local time, at the Company’s headquarters, located at 550 East Swedesford Road, Wayne, Pennsylvania 19087, for the following purposes:

1. To elect three directors to serve on our Board of Directors for a term of three years orand until their successors have been duly elected and qualified;

2. To vote upon a proposal to approve, on an advisory basis, the compensation of our named executive officers;

3. To vote upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2019;2021;

4. To vote upon a stockholder proposal to declassify our Board of Directors, if properly presented at the Annual Meeting; and

4.5. To transact such other business as may properly come before the meeting.

Our Board of Directors has fixed Monday,Friday, March 4, 20195, 2021 as the record date for the Annual Meeting. This means that owners of our common stock at the close of business on that date are entitled to receive notice of, and to vote at, the Annual Meeting.

We intend to hold the Annual Meeting in person. However, as part of our precautions regarding the ongoing COVID-19 pandemic, we are sensitive to the public health and travel concerns that our stockholders may have, as well as any protocols that federal, state and local governments may impose. In the event it is not possible or advisable for stockholders to attend the Annual Meeting in person, we will announce in advance via press release alternative arrangements for the meeting, which may include providing a webcast of the Annual Meeting. The press release, which will include details on how to access the meeting, will be posted on our website and filed with the SEC as additional proxy materials. If you are planning to participate in the Annual Meeting, please check our website prior to the meeting date. As always, you are encouraged to vote your shares prior to the Annual Meeting.

Stockholders are requested to date, sign and return the enclosed proxy card in the enclosed envelope. No postage is necessary if mailed in the United States or Canada. You may also vote by telephone by calling toll free1-800-PROXIES(776-9437), or via the internet at www.voteproxy.com.

 

By Order of the Board of Directors,
James J. Leyden,

Daniel V. Logue

Corporate Vice President,

General Counsel and Secretary

PLEASE VOTE — YOUR VOTE IS IMPORTANT


TABLE OF CONTENTS

 

   Page 

GENERAL INFORMATION

   1 

QUESTIONS AND ANSWERS

   2 

PROPOSAL 1: ELECTION OF DIRECTORS

   45 

CORPORATE GOVERNANCE

   10 

Corporate Governance Principles and Other Corporate Governance Documents

   10 

Board Independence

   10 

Lead Director

   11 

Positions of Chairman and Chief Executive OfficerBoard Leadership Structure

   1112 

Executive Sessions ofNon-Management Directors

   12 

The Board and Board Committees

   1213 

Risk Oversight and Management

   15 

Director Compensation – 20182020

   1516 

Director Stock Ownership Guidelines

   18 

AUDIT COMMITTEE REPORT

   19 

COMPENSATION DISCUSSION AND ANALYSIS

   20 

Introduction

   20 

Executive Compensation Overview

   20 

20182020 Compensation

   23 

Ongoing and Post-Employment Arrangements

   39 

Tax Considerations

   4241 

Clawback Policy

   4342 

Stock Ownership Guidelines

   42

Pledging and Hedging Policies

43 

20182020 Stockholder Advisory Vote on Executive Compensation

   4443 

COMPENSATION COMMITTEE REPORT

   44 

CEO PAY RATIO

   45 

SUMMARY COMPENSATION TABLE – 20182020

   47 

GRANTS OF PLAN-BASED AWARDS – 20182020

   49 

OUTSTANDING EQUITY AWARDS AT FISCALYEAR-END  – 20182020

   50 

OPTION EXERCISES AND STOCK VESTED – 20182020

   52 

PENSION BENEFITS – 20182020

   53 

NONQUALIFIED DEFERRED COMPENSATION – 20182020

   54 

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL

   56 

Employment and Severance Arrangements

   56 

Change-of-ControlArrangements

   5857 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

   61 

CERTAIN TRANSACTIONS

   63 

Related Person Transactions Policy

63

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

   63 

PROPOSAL 2: ADVISORY VOTE ON COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS

   64 

PROPOSAL 3: RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

   65 

Audit andNon-Audit Fees

   65 

Audit CommitteePre-Approval Procedures

   65 

PROPOSAL 4: STOCKHOLDER PROPOSAL – BOARD DECLASSIFICATION

66

STOCKHOLDER PROPOSALS

   6668 

OTHER MATTERS

   6668 


TELEFLEX INCORPORATED

550 East Swedesford Road, Suite 400

Wayne, Pennsylvania 19087

PROXY STATEMENT

GENERAL INFORMATION

This proxy statement is furnished to stockholders in connection with the solicitation of proxies by the Board of Directors of Teleflex Incorporated (the “Company” or “Teleflex”) for use at the Company’s annual meeting of stockholders (the “Annual Meeting”) to be held on Friday, May 3, 2019April 30, 2021 at 11:00 a.m., local time, atthe Company’s headquarters, located at 550 East Swedesford Road, Wayne, Pennsylvania 19087. The proxies may also be voted at any adjournment or postponement of the Annual Meeting. Only stockholders of record at the close of business on March 4, 2019,5, 2021, the record date for the meeting, are entitled to vote. Each stockholder of record on the record date is entitled to one vote for each share of common stock held. On the record date, the Company had 46,071,32146,747,758 shares of common stock outstanding.

This proxy statement and the enclosed form of proxy are being mailed to stockholders on or about March 29, 2019.26, 2021. A copy of the Company’s 20182020 Annual Report is provided with this proxy statement.

The Company will pay the cost of solicitation of proxies. In addition to this mailing, proxies may be solicited, without extra compensation, by our officers and employees, by mail, telephone, facsimile, electronic mail and other methods of communication. The Company reimburses banks, brokerage houses and other custodians, nominees and fiduciaries for their reasonableout-of-pocket expenses in forwarding solicitation materials to the beneficial owners of the Company’s common stock.

Important Notice Regarding the Availability of Proxy Materials

for the Stockholder Meeting to be Held on May 3, 2019April 30, 2021

This proxy statement, the accompanying Notice of Annual Meeting, proxy card and

our 20182020 Annual Report are available at http://www.teleflex.com/ProxyMaterials.

QUESTIONS AND ANSWERS

 

1.

What is a “proxy”?

It is your way of legally designating another person to vote for you. That other person is called a “proxy.” If you designate another person as your proxy in writing, the written document is called a “proxy” or “proxy card.”

 

2.

What is a “proxy statement”?

It is a document required by the Securities and Exchange Commission (the “SEC”) that contains information about the matters that stockholders will vote upon at the Annual Meeting. The proxy statement also includes other information required by SEC regulations.

 

3.

What is a “quorum”?

A quorum is the minimum number of stockholders who must be present at the Annual Meeting or voting by proxy to conduct business at the meeting. A majority of the outstanding shares of our common stock, whether present in person or represented by proxy, will constitute a quorum at the Annual Meeting.

 

4.

How many votes are required to elect director nominees and approve the proposals?

To be elected at the meeting, a director nominee must receive the affirmative vote of a majority of the votes cast. For this purpose, a majority of the votes cast means that the number of votes cast in favor of a director nominee must exceed the number of votes cast against that director nominee. Abstentions and “brokernon-votes” will have no effect on the vote.

Approval of each of the other proposals requires the affirmative vote of a majority of the shares present in person or represented by proxy at the meeting and entitled to vote on the proposal. Accordingly, abstentions have the same effect as votes against a proposal, while brokernon-votes will not be included in the vote count and will have no effect on the vote.

 

5.

What is a “brokernon-vote”?

A broker“non-vote” occurs when a broker holding shares for a beneficial owner does not vote on a particular proposal because the broker does not have discretionary voting power with respect to that proposal and has not received voting instructions from the beneficial owner. Under New York Stock Exchange rules, brokers are not permitted to vote on the election of directors, or the advisory vote on executive compensation;compensation or the stockholder proposal to declassify our Board of Directors; therefore, if your shares are held by a broker, you must provide voting instructions if you want your broker to vote on these matters. Your broker or its designee should provide you with a voting instruction form for this purpose.

 

6.

What is the difference between holding shares as a stockholder of record and as a beneficial owner?

If your shares are registered directly in your name with our transfer agent, American Stock Transfer and& Trust Company, LLC, you are considered the stockholder of record, or a “record holder,” with respect to those shares, and you may submit a proxy card and vote those shares in the manner described in this proxy statement.

Most of our stockholders hold their shares as a beneficial owner through a broker, bank or other nominee rather than directly in their own name. If your shares are held through a broker, bank or other nominee, you are considered the “beneficial owner” of the shares. As the beneficial owner, you

generally have the right to direct your broker, bank or other nominee on how to vote your shares. Your broker, bank or other nominee should provide you with a voting instruction form that you use to give instructions as to how your shares are to be voted.

7.

How do I vote?

If you were a record holder on the record date, you may vote through any of the following methods:

 

attend the Annual Meeting in person and submit a ballot,

sign and date each proxy card you receive and return it in the prepaid envelope included in your proxy package,

vote by telephone by calling1-800-PROXIES(776-9437) or

  

vote via the internet atwww.voteproxy.com.

The shares represented by a proxy will be voted in accordance with the instructions you provide on the proxy card or that you submit via telephone or the internet, unless the proxy is revoked before it is exercised. Any proxy card which is signed and returned but does not indicate voting instructions will be treated as authorizing a vote FOR the election of the director nominees described in this proxy statement, FOR the approval, on an advisory basis, of the compensation of our named executive officers, and FOR the ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2019.2021 and ABSTAIN as to the stockholder proposal regarding board declassification.

If you were a beneficial owner of shares at the close of business on the record date, you may vote your shares by providing instructions to your broker, bank or other nominee. Your broker, bank or other nominee should provide a voting instruction form that you can use to give instructions as to how your shares are to be voted; please refer to the instructions it provides for voting your shares. If you want to vote those shares in person at the Annual Meeting, you must bring a signed proxy from the broker, bank or other holder of record giving you the right to vote the shares.

 

8.

What should I do if I receive more than one proxy card?

If you hold shares registered in more than one account, you may receive more than one copy of the proxy materials, including multiple paper copies of this proxy statement and multiple proxy cards. To vote all of your shares by proxy, you must complete, sign, date and return each proxy card that you receive or, if you submit a proxy by telephone or the internet, submit one proxy for each proxy card you receive.

 

9.

How can I revoke my proxy?

You may revoke your proxy at any time before the proxy is exercised by delivering a signed statement indicating your revocation to our Corporate Secretary at our principal executive offices at 550 East Swedesford Road, Suite 400, Wayne, Pennsylvania 19087 at or prior to the Annual Meeting. Alternatively, you may revoke your proxy by timely executing and delivering, by internet, telephone, mail, or in person at the Annual Meeting, another proxy dated as of a later date. You also may revoke your proxy by attending the Annual Meeting in person and voting by ballot. Attendance at the Annual Meeting will not by itself revoke a previously granted proxy.

If your shares are held by a broker, bank or other nominee, contact that institution for instructions.

10.

Who can attend the Annual Meeting?

Any Company stockholder as of the close of business on March 5, 2021 may attend the Annual Meeting. You will need proof of ownership to enter the meeting. If your shares are held in street name (beneficially held in the name of a broker, bank or other holder of record), you must present proof of your ownership, such as a bank or brokerage account statement, to be admitted to the meeting. Please note that if you are a beneficial holder and would like to vote at the meeting in person, you will need to bring a legal proxy from your broker, bank or other holder of record. Stockholders must also present a valid form of photo identification, such as a driver’s license, in order to be admitted to the meeting.

In light of the ongoing COVID-19 pandemic, the Annual Meeting will be conducted in compliance with limitations on public gatherings mandated by federal, state and local authorities and other preventive measures recommended by public health experts. These measures are expected to include conducting health screenings for all attendees prior to admission to the meeting, enforcing optimal social distancing guidelines for all attendees and requiring all attendees to wear masks. Health screening prior to admission to the Annual Meeting are expected to include a temperature scan and completion of a questionnaire concerning potential exposure to COVID-19 and the presence, or absence, of symptoms associated with COVID-19. Any individual who refuses to complete a questionnaire, wear a mask or submit to screening or who answers a screening question affirmatively or displays any symptoms that could be related to COVID-19 will not be permitted to attend the Annual Meeting in person.

Even if you plan to attend the meeting in person, you are strongly encouraged to vote your shares by submitting a proxy.

11.

What happens if a change to the Annual Meeting is necessary due to exigent circumstances?

As part of our precautions regarding the ongoing COVID-19 pandemic, we are sensitive to the public health and travel concerns that our stockholders may have, as well as any protocols that federal, state and local governments may impose. In the event it is not possible or advisable for stockholders to attend our annual meeting in person, we will announce in advance via press release alternative arrangements for the meeting, which may include providing a webcast of the annual meeting. The press release, which will include details on how to access the meeting, will be posted on our website and filed with the SEC as additional proxy materials. If you are planning to participate in the Annual Meeting, please check our website prior to the meeting date. As always, you are encouraged to vote your shares prior to the Annual Meeting.

PROPOSAL 1:

ELECTION OF DIRECTORS

Our Board of Directors (the “Board”) currently consists of tennine members divided into three classes, with one class being elected each year for a three-year term. At the Annual Meeting, three directors will be elected for terms expiring at our annual meeting of stockholders in 2022 or until2024 and upon their successors arebeing duly elected and qualified. The Board, upon the recommendation of the Nominating and Governance Committee, has nominated John C. Heinmiller, AndrewCandace H. Duncan, Stephen K. Klasko, M.D. and Stuart A. Krakauer and Richard A. PackerRandle for election to the Board for three-year terms. Messrs. KrakauerMs. Duncan, Dr. Klasko and PackerMr. Randle are continuing directors who previously were elected by our stockholders. Mr. Heinmiller was appointed as a director by our Board in December 2018 to fill a vacancy created as a result of the retirement of W. Kim Foster, one of our former Board members.

Our bylaws generally require that, in order to be elected in an uncontested election of directors, a director nominee must receive a majority of the votes cast with respect to that director nominee’s election (for this purpose, a majority of the votes cast means that the number of votes cast “for” a director nominee must exceed the number of votes cast “against” that nominee). If a nominee who is currently serving as a director is notre-elected, Delaware law provides that the director will continue to serve on the board of directors. However, under our Corporate Governance Principles, the Board will not nominate for election as a director any incumbent director unless the director has submitted in writing his or her irrevocable resignation, which would be effective if the director does not receive the required majority vote and the Board accepts the resignation. Generally, if an incumbent director does not receive the required majority vote, our Nominating and Governance Committee will make a recommendation to the Board on whether to accept or reject the resignation, or whether to take other action. The Board would act on the resignation, generally within 90 days from the date that the election results are certified. The Board’s decision and an explanation of any determination with respect to the director’s resignation will be disclosed promptly in a current report on Form8-K filed with the SEC.

We seek to assemble a Board that operates cohesively and works with management in a constructive way so as to deliver long term stockholder value. In addition, the Board believes it operates best when its membership reflects a diverse range of experiences, and areas of expertise.expertise and backgrounds. To this end, the Board seeks to identify candidates whose respective experience expands or complements the Board’s existing expertise in overseeing our company. Our Corporate Governance Principles provide that directors are expected to possess the highest character and integrity and to have business, professional, academic, government or other experience which is relevant to our business and operations. In evaluating nominees for election to the Board, our Board and Nominating and Governance Committee consider diversity principally from the standpoint of differences in occupational experience, education, skills, race, gender and national origin. However, there is no set list of qualities or areas of expertise used by the Board in its analysis because it assesses the attributes each particular candidate could bring to the Board in light of the then-current composition of the Board. In evaluating nominees for election to the Board, consistent with our Corporate Governance Principles, our Nominating and Governance Committee considers, among other factors, the candidate’s potential to contribute to the diversity of the Board, including with respect to gender, race, ethnicity, national origin and other differentiating characteristics. Currently, 22% of the directors on our Board are women. While we currently do not have any directors who self-identify as racially or ethnically diverse, in connection with its succession planning efforts and in addition to certain specified criteria related to business experience and areas of expertise, our Board has determined to prioritize the inclusion of racially and ethnically diverse candidates as part of the pool of potential director nominees to be considered with respect to the next director to be added to our Board.

We believe our current directors possess valuable experience in a variety of areas, which enables them to guide Teleflex in the best interests of the stockholders. Information regarding each of our nominees and continuing directors is set forth below.

Nominees for election to the Board of Directors – Terms Expiring in 2024

Candace H. Duncan-

Ms. Duncan, 67, has been a director of Teleflex since 2015 and currently serves as chair of the Audit Committee. Ms. Duncan retired in November 2013 after a 35-year career with KPMG LLP, a public accounting firm. From 2009 until her retirement, she was the managing partner of KPMG’s Washington, D.C. office and served on KPMG’s board of directors. Earlier, Ms. Duncan served in various capacities at KPMG, including managing partner for audit for the Mid-Atlantic area and audit partner in charge of KPMG’s Virginia business unit. Ms. Duncan is currently a director of Discover Financial Services.

Ms. Duncan’s extensive experience in public accounting enables her to provide helpful insights to the Board on financial matters. Her background renders her especially well-qualified to assist the Board in addressing a variety of financial and budgeting matters and in its oversight of the integrity of our financial statements and our internal controls.

Stephen K. Klasko, M.D.-

Dr. Klasko, 67, has been a director of Teleflex since 2008 and currently serves as a member of the Nominating and Governance Committee. Since June 2013, he has been the President and Chief Executive Officer of Thomas Jefferson University and Jefferson Health. From September 2004 to June 2013, Dr. Klasko served as Dean of the College of Medicine of the University of South Florida. From 2009 to June 2013, Dr. Klasko also served as the Chief Executive Officer of USF Health, which encompasses the University of South Florida’s colleges of medicine, nursing and public health. He was a Vice President of USF Health from 2004 to 2009. Dr. Klasko served as Dean of the College of Medicine of Drexel University from 2000 to 2004.

Dr. Klasko’s background in medicine and business enables him to provide valuable insights with regard to our strategic and growth initiatives. His background in medicine enables him to provide a unique and practical perspective regarding the application and marketing of our medical device products, as well as trends in global healthcare markets.

Stuart A. Randle-Mr. Randle, 61, has been a director of Teleflex since 2009 and currently serves as chair of the Nominating and Governance Committee and as a member of the Compensation Committee. Mr. Randle retired in December 2018 after serving for three years as the Chief Executive Officer of Ivenix, Inc., a medical device company that provides infusion delivery systems. Previously, Mr. Randle had been retired since September 2014 after serving for 10 years as President and Chief Executive Officer of GI Dynamics, Inc., a medical device company. From 2003 to 2004, he served as Interim Chief Executive Officer of Optobionics Corporation, a medical device company. From 2002 to 2003, Mr. Randle held the position of Entrepreneur in Residence of Advanced Technology Ventures, a healthcare and information technology venture capital firm. From 1998 to 2001, he was President and Chief Executive Officer of Act Medical, Inc. Prior to 1998, Mr. Randle held various senior management positions with Allegiance Healthcare Corporation and Baxter

International Inc. Mr. Randle currently serves as a director of Beacon Roofing Supply, Inc.

Mr. Randle’s medical device company experience, coupled with past senior management positions at medical device companies, enables him to provide valuable insights regarding a variety of business, management and technical issues.

In the unlikely event that any nominee becomes unable or unwilling to stand for election, the proxies may be voted for one or more substitute nominees designated by the Board, or the Board may decide to reduce the number of directors.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE ELECTION OF ALL NOMINEES.

The following individuals currently serve as directors in the two other classes. Their terms will end at the Annual Meetings in 2022 and 2023, respectively.

Terms Expiring in 2022

 

John C. Heinmiller  -  

Mr. Heinmiller, 64,66, has been a director of Teleflex since January 2019 and currently serves as a member of the Audit Committee. Prior to his retirement in January 2017, Mr. Heinmiller was Executive Vice President of St. Jude Medical, Inc. (“St. Jude Medical”), a global medical device company. During his19-year career with St. Jude Medical, Mr. Heinmiller served in various executive and senior level positions, including Executive Vice President from August 2012 to January 2017; Executive Vice President and Chief Financial Officer from May 2004 to August 2012; Vice President, Finance and Chief Financial Officer from September 1998 to May 2004; and Vice President of Corporate Business Development from May 1998 to September 1998. Prior to joining St. Jude Medical, Mr. Heinmiller held senior management positions with and was a member of the board of directors of Daig Corporation, a medical device company, and LifeCore Biomedical, a medical technology company.

 

Mr. Heinmiller’s executive and senior management experience in the medical device industry will enable him to provide a wide range of perspectives on financial and business initiatives. In addition, his extensive experience as a financial executive renders him especially well qualified to assist the Board in addressing a variety of financial and budgeting matters and in its oversight of the integrity of our financial statements and our internal controls.

 

Andrew A. Krakauer  - 

Mr. Krakauer, 64,66, has been a director of Teleflex since 2018 and currently serves as a member of the Compensation Committee. Prior to his retirement in October 2016, Mr. Krakauer was Chief Executive Officer of Cantel Medical Corp. (“Cantel”), a provider of infection control products and services. During his 12 years at Cantel, Mr. Krakauer served in various executive and senior level positions, including Chief Executive Officer from November 2014 to July 2016; President and Chief Executive Officer from March 2009 to November 2014; President from April 2008 to March 2009; and Executive Vice President and Chief

Operating Officer from August 2004 through April 2008. Mr. Krakauer also served as a member of Cantel’s board of directors from 2009 to 2016. Prior to joining Cantel, Mr. Krakauer was President of the Ohmeda Medical Division of Instrumentarium Corp. (which was acquired by General Electric Company in 2003), a provider of medical devices, from 1998 to 2004. Mr. Krakauer currently serves as a director of KL Acquisition Corp.

 

Mr. Krakauer’s executive and senior management experience in the medical device industry enables him to provide valuable insights regarding a wide range of business matters, including strategy, acquisitions, management, operations and growth initiatives.

 

Richard A. Packer  - 

Mr. Packer, 61,63, has been a director of Teleflex since 2017 and currently serves as a member of the Nominating and Governance Committee. Since April 2016, Mr. Packer has served as a Primary Executive Officer of Asahi Kasei Corporation, a diversified manufacturing company,co-leader of Asahi Kasei’s healthcare business unit andnon-executive Chairman of ZOLL Medical Corporation, a subsidiary of Asahi Kasei. (Prior to its acquisition by

Asahi Kasei in April 2012, ZOLL was a public company.) Mr. Packer previously served in a number of capacities for ZOLL, including Chief Executive Officer from November 1999 to April 2016, Chairman from 1999 until November 2010 (as noted above, he again became Chairman in April 2016), President from 1996 until 1999, Vice President of Operations from 1992 to 1996, and Chief Financial Officer and Head of North American Sales from 1995 to 1996. He has been a director of ZOLL since 1996. Prior to joining ZOLL, Mr. Packer held various positions with Whistler Corporation, a consumer electronics company, and PRTM/KPMG LLP, a consulting firm. Mr. Packer currently serves as a director of Bruker Corporation.

 

Mr. Packer’s executive and senior management experience in the medical device industryand pharmaceutical industries enables him to provide valuable insights regarding a wide range of business, management, operations and strategic planning matters.

In the unlikely event that any nominee becomes unable or unwilling to stand for election, the proxies may be voted for one or more substitute nominees designated by the Board, or the Board may decide to reduce the number of directors.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE ELECTION OF ALL NOMINEES.

The following individuals currently serve as directors in the two classes having terms that will end at the Annual Meetings in 2020 and 2021, respectively.

Terms Expiring in 20202023

 

George Babich, Jr.  - 

Mr. Babich, 67,69, has been a director of Teleflex since 2005 and currently serves as Lead Director and as chair of the Compensation Committee. Mr. Babich retired in May 2016 after serving for three years as the President and Chief Executive Officer of Checkpoint Systems, Inc., a provider of retail security, labeling and merchandising systems and products. He served as interim President and Chief Executive Officer of Checkpoint from May 2012 to February 2013. Previously, Mr. Babich had been retired since 2005 after serving for nine years in various executive and senior level positions at The Pep Boys Manny Moe & Jack, an automotive retail and service chain. Most recently, Mr. Babich served as President of Pep Boys from 2004 to 2005 and as President and Chief Financial Officer from 2002 to 2004. Prior to joining Pep Boys, Mr. Babich held various financial executive positions with Morgan, Lewis & Bockius LLP, The Franklin Mint, PepsiCo Inc. and Ford Motor Company.

 

Mr. Babich’s executive and senior management experience enables him to provide a wide range of perspectives on corporate governance, management, operations and strategic planning. In addition, his long experience as a financial executive enables him to assist the Board in addressing a variety of financial and budgeting matters.

 

Gretchen R. Haggerty  -  

Ms. Haggerty, 63,65, has been a director of Teleflex since 2016 and currently serves as a member of the Audit Committee. Ms. Haggerty retired in August 2013 after a37-year career with United States Steel Corporation, an integrated global steel producer, and its predecessor, USX Corporation, which, in addition to its steel production, also conducted energy operations, principally through Marathon Oil Corporation. From March 2003 until her retirement, she served as Executive Vice President & Chief Financial Officer and also served as Chairman of the U. S. Steel & Carnegie Pension Fund and its Investment Committee. Earlier, she served in various financial executive positions at U. S.U.S. Steel and USX, beginning in November 1991 when she became Vice President & Treasurer. Ms. Haggerty is currently a director of USG Corporation and Johnson Controls International plc.

 

Ms. Haggerty’s background in executive management of a large, complex global corporation, as well as her experience gained through other public company directorships, enables her to share valuable perspectives with the Board on a wide range of financial and business matters. Her lengthy tenure as a financial executive renders her well-qualified to assist the Board with a variety of financial and budgeting matters, and in its oversight of our financial statements and internal controls.

 

Benson F. SmithLiam J. Kelly

 - 

Mr. Smith, 71,Kelly, 54, has been a director of Teleflex since 20052018 and Chairman since January 2011. In December 2017, Mr. Smith retired from Teleflex after serving as our Chief Executive Officer for eight years. He alsohas served as our President from January 2011 to April 2016. Previously, Mr. Smith was the managing partner of Sales Research Group, a research and consulting organization, and also served as the Chief Executive Officer of BFS & Associates LLC, which specialized in strategic planning and venture investing. Earlier, Mr. Smith held several executive and senior level positions at C.R. Bard, Inc. during his approximately25-year tenure at that company. Most recently, Mr. Smith served as C.R. Bard’s President and Chief Operating Officer from 1994 to 1998.

Mr. Smith’s extensive experience in the medical device industry and past experience as our Chief Executive Officer enables him to share meaningful perspectives regarding our operations, strategic planning and growth initiatives. In addition, his management and consulting experience enables Mr. Smith to provide a wide range of perspectives on management issues.

Terms Expiring in 2021

Candace H. Duncan

-

Ms. Duncan, 64, has been a director of Teleflex since 2015 and currently serves as chair of the Audit Committee. Ms. Duncan retired in November 2013 after a35-year career with KPMG LLP, a public accounting firm. From 2009 until her retirement, she was the managing partner of KPMG’s Washington, D.C. office and served on KPMG’s board of directors. Earlier, Ms. Duncan served in various capacities at KPMG, including managing partner for audit for theMid-Atlantic area and audit partner in charge of KPMG’s Virginia business unit. Ms. Duncan is currently a director of Discover Financial Services and FTD Companies, Inc.

Ms. Duncan’s extensive experience in public accounting enables her to provide helpful insights to the Board on financial matters. Her background renders her especially well-qualified to assist the Board in addressing a variety of financial and budgeting matters and in its oversight of the integrityChairman of our financial statements and our internal controls.

Liam J. Kelly-

Mr. Kelly, 52, has been a director of TeleflexBoard since 2018.May 2020. He became our President and Chief Executive Officer onin January 1, 2018. From May 2016 to December 31, 2017, Mr. Kelly served as our President and Chief Operating Officer, and from April 2015 to April 2016, he served as our Executive Vice President and Chief Operating Officer. Mr. Kelly also served as our Executive Vice President and President, Americas from April 2014 to April 2015, and as our Executive Vice President and President, International from June 2012 to April 2014. Earlier, he held several positions with regard to our EMEA segment, including President from June 2011 to June 2012, Executive Vice President from November 2009 to June 2011, and Vice President of Marketing from April 2009 to November 2009. Prior to joining Teleflex, Mr. Kelly held various senior level positions withHill-Rom Holdings, Inc., a medical device company, from October 2002 to April 2009, serving as its Vice President of International Marketing and R&D from August 2006 to February 2009. Mr. Kelly is currently a director of Colfax Corporation.

 

Mr. Kelly’s extensive experience in the medical device industry and intimate knowledge of our business enables him to provide meaningful perspectives regarding our operations, strategic planning and growth initiatives.

Stephen K. Klasko, M.D.-Dr. Klasko, 65, has been a director of Teleflex since 2008 and currently serves as a member of the Nominating and Governance Committee. Since June 2013, he has been the President and Chief Executive Officer of Thomas Jefferson University and Jefferson Health. From September 2004 to June 2013, Dr. Klasko served as Dean of the College of Medicine of the University of South Florida. From 2009 to June 2013, Dr. Klasko also served as the Chief Executive Officer of USF Health, which encompasses the University of South Florida’s colleges of medicine, nursing and public health. He was a Vice President of USF Health from 2004 to 2009. Dr. Klasko served as Dean of the College of Medicine of Drexel University from 2000 to 2004.

Dr. Klasko’s background in medicine and business enables him to provide valuable insights with regard to our strategic and growth initiatives. His background in medicine enables him to provide a unique and practical perspective regarding the application and marketing of our medical device products, as well as trends in global healthcare markets.

Stuart A. Randle-

Mr. Randle, 59, has been a director of Teleflex since 2009 and currently serves as chair of the Nominating and Governance Committee and as a member of the Compensation Committee. Mr. Randle retired in December 2018 after serving for three years as the Chief Executive Officer of Ivenix, Inc., a medical device company that provides infusion delivery systems. Previously, Mr. Randle had been retired since September 2014 after serving for 10 years as President and Chief Executive Officer of GI Dynamics, Inc., a medical device company. From 2003 to 2004, he served as Interim Chief Executive Officer of Optobionics Corporation, a medical device company. From 2002 to 2003, Mr. Randle held the position of Entrepreneur in Residence of Advanced Technology Ventures, a healthcare and information technology venture capital firm. From 1998 to 2001, he was President and Chief Executive Officer of Act Medical, Inc. Prior to 1998, Mr. Randle held various senior management positions with Allegiance Healthcare Corporation and Baxter International Inc. Mr. Randle currently serves as a director of Beacon Roofing Supply, Inc. and Flex Pharma, Inc.

Mr. Randle’s medical device company experience, coupled with past senior management positions at medical device companies, enables him to provide valuable insights regarding a variety of business, management and technical issues.

CORPORATE GOVERNANCE

Corporate Governance Principles and Other Corporate Governance Documents

Our Corporate Governance Principles, which include guidelines for the determination of director independence, the operation, structure and meetings of the Board and the committees of the Board and other matters relating to our corporate governance, are available on the Investors page of our website, www.teleflex.com. Also available on the Investors page are other corporate governance documents, including the Code of Ethics, the Code of Ethics for Chief Executive Officer and Senior Financial Officers and the charters of the Audit, Compensation and Nominating and Governance Committees. You may request these documents in print form by contacting us at Teleflex Incorporated, 550 East Swedesford Road, Suite 400, Wayne, Pennsylvania 19087, Attention: Secretary. Any amendments to, or waivers of, the codes of ethics that apply to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar function and that relate to any element of the code of ethics definition enumerated in Item 406(b) of the SEC’s Regulation S-K will be disclosed on our website promptly following the date of such amendment or waiver.

Board Independence

The Board has affirmatively determined that George Babich, Jr., Candace H. Duncan, Gretchen R. Haggerty, John C. Heinmiller, Stephen K. Klasko, Andrew A. Krakauer, Richard A. Packer and Stuart A. Randle are independent within the meaning of the listing standards of the New York Stock Exchange (the “NYSE”). All of the independent directors meet the categorical standards set forth in the Corporate Governance Principles described below, which were adopted by the Board to assist it in making determinations of independence. The Board has further determined that the members of the Audit, Compensation and Nominating and Governance Committees are independent within the meaning of the NYSE listing standards, and that the members of the Audit and Compensation Committees meet the additional independence requirements of the NYSE and the SEC applicable to audit committee and compensation committee members. In making its determination with respect to Dr. Klasko, the Board considered the Company’s sale of products to an entity for which he serves as chief executive officer, and inofficer. In making its determination with respect to Mr. Packer, the Board considered the Company’s sale of products to an entity for which he serves as non-executive Chairman. In making its determination with regard to Mr. Heinmiller, the Board considered the Company’s sale of products to an entity for which he serves as a director. Based on its review, and after considering the amounts involved and the lack of Dr. Klasko’s, Mr. Packer’s or Mr. Heinmiller’s direct or indirect involvement in the respective transactions, and the amounts involved, the Board concluded that Dr. Klasko’s, Mr. Packer’s and Mr. Heinmiller’s relationships with the respective entities did not impair their independence.

To assist the Board in making independence determinations, the Board has adopted the following categorical standards that, if applicable, automatically would result in a determination that the director is not independent. The Board may determine that a director is not independent notwithstanding that none of the following categorical disqualifications apply. However, if any of the following categorical disqualifications apply to a director, he or she may not be considered independent:

 

A director who is an employee of our company, or whose immediate family member is an executive officer of our company, may not be considered independent until the expiration of three years after the end of such employment.

 

A director who has received, or who has an immediate family member (unless such immediate family member has ceased to be an immediate family member or has become incapacitated) that has been an executive officer of ours who, while an executive officer, has received more than $120,000 in direct compensation from us during any twelve-month period during the preceding three years, other than director and committee fees, pension or other forms of deferred compensation for prior service (provided such compensation is not contingent in any way on continued service) and compensation received by the director for former service as an interim Chairman or CEO may not be considered independent.

other forms of deferred compensation for prior service (provided such compensation is not contingent in any way on continued service) and compensation received by the director for former service as an interim Chairman or CEO may not be considered independent.

 

A director who is a current partner or is employed by, or whose immediate family member is a current partner of a firm that is our internal or external auditor, or is an immediate family member who is a current employee of such a firm and personally works on the Company’s audit, may not be considered independent.

member who is a current employee of such a firm and personally works on the Company’s audit, may not be considered independent.

 

A director who was, or whose immediate family member was, during the immediately preceding three years, a partner or employee of a firm that is our internal or external auditor and personally worked on our audit during that period may not be considered independent.

 

A director who is employed, or whose immediate family member is employed, as an executive officer of another company where any of our present executives serve on such other company’s compensation committee may not be considered independent until the expiration of three years after the end of such service or employment relationship or such person ceases to be an immediate family member or becomes incapacitated, as may be applicable.

 

A director who is an employee, or whose immediate family member is an executive officer, of a company that makes payments to us, or receives payments from us, for property or services in an amount which, in any single fiscal year, exceeds the greater of $1 million or 2% of such other company’s consolidated gross revenues may not be considered independent until the expiration of the three years after such receipts or payments fall below such threshold or after such person ceases to be an immediate family member or becomes incapacitated, as may be applicable.

Lead Director

The Lead Director is an independent director of the Board whose authority, duties and responsibilities include:

 

coordinating and developing the agenda for, and presiding over, executive sessions of the Board’s independent directors;

ability to call meetings of the independent directors;

 

discussing with our directors any concerns our directors may have about our company and our performance, relaying those concerns, where appropriate, to the full Board, and consulting with our Chief Executive Officer regarding those concerns;

 

providing our Chief Executive Officer with feedback regarding matters discussed by the independent directors in executive sessions;

consulting with our senior executives as to any concerns they may have;

 

providingtogether with the Chairman of the Board, withdevelop and approve Board meeting agendas, and provide input as to the agendas for Board and Board committee meetings;chairs on committee meeting agendas;

 

advising the Chairman of the Board as to the quality, quantity and timeliness of the flow of information from our management to the Board that is necessary for the independent directors to effectively and responsibly perform their duties; the Lead Director may ask company management to include certain material in the information provided to the Board;

 

interviewing, along with the Nominating and Governance Committee Chair, and making recommendations to the Nominating and Governance Committee and the Board concerning Board candidates; and

providing input to the members of the Compensation Committee regarding the Chief Executive Officer’s performance, and, along with the Compensation Committee Chair, meeting with the Chief Executive Officer to discuss the Board’s evaluation.evaluation; and

if requested, consult and directly communicate with shareholders, government authorities and other interested parties on behalf of the independent directors.

The Lead Director is appointed annually by the independent directors of the Board. The independent directors of the Board have the authority to modify the Lead Director’s duties and responsibilities, remove the Lead Director and appoint a successor. Mr. Babich currently serves as our Lead Director.

PositionsBoard Leadership Structure

The Board’s goal is to achieve the best board leadership structure for effective oversight and management of our company. The Board believes there is no single, generally accepted approach to providing effective board leadership, and that the leadership structure of a board must be considered in the context of the individuals involved and the specific circumstances facing the company. Accordingly, what the Board determines to be the right board leadership structure for Teleflex may vary from time to time as circumstances warrant.

The Board appointed Mr. Kelly to succeed Mr. Benson Smith as Chairman, effective May 2020. In making its decision to appoint Mr. Kelly as Chairman, our Board determined that, in his role as our President and Chief Executive Officer, Mr. Kelly is the director most familiar with our business and most capable of effectively identifying strategic priorities and leading the discussion and execution of strategy. Moreover, Mr. Kelly is able to effectively communicate Board strategy to the other members of management and efficiently implement Board directives.

Mr. Smith previously served as our Chairman and Chief Executive Officer. Following his retirement as Chief Executive Officer on December 31, 2017, he has continued to serve as

non-executive ChairmanAll of the Board. Therefore, effective January 1, 2018,other directors on our Board are independent, which facilitates the positionsprovision of Chairmanindependent oversight and Chief Executive Officer were separated. We believe thatinput. Mr. Smith’s leadership skills, demonstrated by his service as our Chief Executive Officer over the past seven years, coupled with his intimate knowledgeKelly is not a member of our operationsprincipal Board committees, and the medical device industry generally, make him well qualified to serveindependent directors regularly meet in executive session outside the presence of management and under the leadership of our Lead Director, as ourdiscussed in more detail below under “Executive Sessions of non-executiveNon-Management ChairmanDirectors.” The activities of the Board. TheLead Director further enhance the Board’s ability to evaluate management performance and otherwise fulfill its oversight responsibilities. Moreover, the Lead Director is consulted on the proposed agendas for Board does not have a policy with respectand committee meetings in order to the separationmake sure that key issues and concerns of the roles of Chairman and Chief Executive Officer.Board are addressed.

Executive Sessions ofNon-Management Directors

Directors who are not executive officers or otherwise employed by us or any of our subsidiaries, whowhom we refer to as the“non-management directors,” meet regularly in accordance with a schedule adopted at the beginning of each year and on such additional occasions as aany non-management director may request. Such meetings are held in executive session, outside the presence of any directors who are executive officers. The ChairmanLead Director presides over such meetings.

Stockholders or other interested persons wishing to communicate with members of the Board should send such communications to Teleflex Incorporated, 550 East Swedesford Road, Suite 400, Wayne, Pennsylvania 19087, Attention: Secretary. These communications will be forwarded to specified individual directors, or, if applicable, to all the members of the Board as deemed appropriate. Stockholders or other interested persons may also communicate directly and confidentially with the Lead Director, thenon-management directors as a group or the Chairman or other members of the Audit Committee through the Teleflex ethics line website at www.teleflexethicsline.com.

The Board and Board Committees

The Board held sevensix meetings in 2018.2020. Each of the directors attended at least 75 percent of the total number of meetings of the Board and the Board committees of which the director was a member during 2018.2020. The Board does not have a formal policy concerning attendance at our annual meeting of stockholders, but encourages all directors to attend. All of theour Board members attended the 20182020 annual meeting of stockholders.

The Board has established a Nominating and Governance Committee, a Compensation Committee and an Audit Committee. The Board also has established aNon-Executive Equity Awards Committee, whose sole member is Mr. Kelly. TheNon-Executive Equity Awards Committee has authority to grant equity awards, under specified circumstances, to employees who are neither executive officers nor persons reporting to the Chief Executive Officer. See “Compensation Discussion and Analysis – 20182020 Compensation – Our Equity Grant Practices” for additional information.

Nominating and Governance Committee

The Nominating and Governance Committee is responsible for identifying qualified individuals to be nominees for election to the Board. In addition, the Nominating and Governance Committee reviews and makes recommendations to the Board as to the size and composition of the Board and Board committees, eligibility criteria for Board and Board committee membership and board compensation. The Nominating and Governance Committee also is responsible for developing and recommending to the Board corporate governance principles and overseeing the evaluation of the Board and management.Board.

The Nominating and Governance Committee considers candidates for Board membership. Our Corporate Governance Principles provide that directors are expected to possess the highest character and integrity, and to have business, professional, academic, government or other experience which is relevant to our business and operations. In addition, directorswe also seek candidates with the potential to contribute to the diversity of the Board, including with respect to gender, race, ethnicity, national origin and other differentiating characteristics. Directors must be able to devote substantial time to our affairs. The charter of the Nominating and Governance Committee provides that in evaluating nominees, the Nominating and Governance Committee should consider the attributes set forth above.

To assist in identifying candidates for nomination as directors, the Nominating and Governance Committee sometimes employs a third-party search firm and also receives recommendations of candidates from Board members. Mr. Heinmiller was initially recommended by one of the Company’s external advisors.

In addition, the Nominating and Governance Committee will consider recommendations for director candidates from stockholders. Stockholders can recommend candidates for nomination by delivering or mailing written recommendations to Teleflex Incorporated, 550 East Swedesford Road, Suite 400, Wayne, Pennsylvania 19087, Attention: Secretary. In order to enable consideration of thea candidate in connection with our 20202022 Annual Meeting, a stockholder must submit the following information by February 3, 2020:January 30, 2022:

 

the name of the candidate and information about the candidate that would be required to be included in a proxy statement under SEC rules;

 

information about the relationship between the candidate and the recommending stockholder;

 

the consent of the candidate to serve as a director; and

 

proof of the number of shares of our common stock that the recommending stockholder owns and the length of time the shares have been owned.

We have also adopted a “proxy access” bylaw provision which allows eligible stockholders to nominate candidates for election to our Board and include such candidates in our proxy statement and proxy card subject to the terms, conditions, procedures and deadlines set forth in Article II, Section 2.2.2 of our bylaws. Our proxy access bylaw provides that holders of at least 3% of our

outstanding shares, held by up to 20 stockholders, holding the shares continuously for at least three years, can nominate up to the greater of two directors or 20% of our Board for election at an annual stockholders’ meeting.

For more specific information regarding these deadlines in respect of the 2022 annual meeting of stockholders, see “Stockholder Proposals” below. You should consult our bylaws for more detailed information regarding the processes summarized above.

In considering any candidate proposed by a stockholder, the Nominating and Governance Committee will reach a conclusion based on the criteria described above. The Nominating and Governance Committee may seek additional information regarding the candidate. After full consideration, the stockholder proponent will be notified of the decision of the Nominating and Governance Committee. The Nominating and Governance Committee will consider all potential candidates in the same manner regardless of the source of the recommendation.

The current members of the Nominating and Governance Committee are Dr. Klasko and Messrs. Klasko, Packer and Randle. Mr. Randle currently serves as chair of the Nominating and Governance Committee. The Nominating and Governance Committee held sixfour meetings in 2018.2020.

Compensation Committee

The duties and responsibilities of the Compensation Committee include, among others, the following:

 

review and recommend to the Board for approval all compensation plans in which any director or executive officer may participate;

 

review and recommend to the independent directors for approval corporate goals and objectives relevant to the compensation of our Chief Executive Officer and, together with the Lead Director, evaluate annually our Chief Executive Officer’s performance in light of those goals and objectives;

 

review and recommend to the independent directors for approval our Chief Executive Officer’s compensation and any employment agreements, severance agreements, retention agreements, change in control agreements and other similar agreements for the benefit of our Chief Executive Officer;

 

review and approve compensation of our senior executives, which include our executive officers (other than our Chief Executive Officer) and such other executives of our company as the Compensation Committee may determine (other than our Chief Executive Officer), and any employment agreements, severance agreements, retention agreements, change in control agreements and other similar agreements for the benefit of any of our senior executives (other than our Chief Executive Officer);

establish goals for performance-based awards under incentive compensation plans (including stock compensation plans);

 

administer and grant, or recommend to the Board the grant of, stock options and other equity-based compensation awards under our stock compensation plans (the Board has delegated to itsNon-Executive Equity Awards Committee, whose sole member is Mr. Smith,Kelly, authority to grant equity awards under specified circumstances to employees other than executive officers and persons reporting to the Chief Executive Officer);

 

review and recommend to the other independent directors for approval all material executive benefits and perquisites for the Chief Executive Officer’s benefit; and

 

review and approve all material executive benefits and perquisites for the benefit of any of our senior executives (other than the Chief Executive Officer).

The Compensation Committee has the authority to select, retain and terminate compensation consultants, legal counsel and other advisers to assist it in connection with the performance of its responsibilities. During 2018,2020, the Compensation Committee considered the recommendations of and data provided by its compensation consultant, Frederick W. Cook & Co., Inc. See “Compensation Discussion and Analysis” for additional information.

The current members of the Compensation Committee are Messrs. Babich, Krakauer and Randle. Mr. Babich currently serves as chair of the Compensation Committee. The Compensation Committee held sevenfive meetings in 2018.2020.

Audit Committee

The Audit Committee has responsibility to assist the Board in its oversight of the following matters, among others:

 

the integrity of our financial statements;

 

our internal control compliance;

 

our compliance with legal and regulatory requirements;

 

our independent registered public accounting firm’s qualifications, performance and independence;

 

the performance of our internal audit function;

 

our risk management process; and

 

the funding of our defined benefit pension plan and the investment performance of plan assets.

The Audit Committee has sole authority to appoint, retain, compensate, evaluate and terminate our independent registered public accounting firm, and reviews and approves in advance all audit and lawfully permittednon-audit services performed by the independent registered public accounting firm and related fees. In addition, the Audit Committee periodically meets separately with management, our independent auditors and our own internal auditors. The Audit Committee also periodically discusses with management our policies with respect to risk assessment and risk management.

Stockholders and other persons may contact our Audit Committee to report complaints about our accounting, internal accounting controls or auditing matters by writing to the following address: Teleflex Incorporated, 550 East Swedesford Road, Suite 400, Wayne, Pennsylvania 19087, Attention: Audit Committee. Stockholders and such other persons, including employees, can report their concerns to the Audit Committee anonymously or confidentially.

The current members of the Audit Committee are Mses. Duncan and Haggerty and Mr. Heinmiller. Ms. Duncan currently serves as chair of the Audit Committee. The Audit Committee held seven meetings in 2018.2020. The Board has determined that each of the Audit Committee members is an “audit committee financial expert” as that term is defined in SEC regulations.

Risk Oversight and Management

The Board, acting principally through the Audit Committee, is actively involved in the oversight and management of risks that could affect us. It fulfills this function largely through its oversight of our annual company-wide risk assessment process, which is designed to identify our key strategic, operational, compliance and financial risks, as well as steps to mitigate and manage each risk. The risk assessment process is conducted by our compliance officer, who surveys and interviews several of our key business leaders, functional heads and other managers to identify and discuss the key risks

pertaining to Teleflex, including the potential magnitude of each risk and likelihood of occurrence of adverse consequences of such risk. As part of this process, the senior executive responsible for managing the risk, the potential impact of the risk and management’s initiatives to manage the risk are identified and discussed. After receiving a report of the risk assessment results from the compliance officer, members of Teleflex senior management review and discuss the results with the Audit Committee. Thereafter, the Audit Committee providesand our Chief Executive Officer provide the full Board with an overview of the risk assessment process, the key risks identified and measures being taken to address those risks. Due to the dynamic nature of risk, the overall status of our enterprise risks is updated periodically during the course of each year and reviewed with the Audit Committee. We believe this process facilitates the Board’s ability to fulfill its oversight responsibilities with respect to risks that we encounter.

The Compensation Committee oversees the review and assessment of our compensation policies and practices. We use a number of approaches to mitigate excessive risk taking in designing our compensation programs, including significant weighting towards long-term incentive compensation, inclusion of qualitative goals in addition to quantitative metrics in our incentive programs and maintenance of equity ownership guidelines. We believe the risks arising from our compensation policies and practices for our employees are not reasonably likely to have a material adverse effect on our company.

Director Compensation – 20182020

Each director who is not a Teleflex employee receives compensation for his or her service as a director, which consists of an annual cash retainer, payable in equal monthly installments, an annual stock option grant, a restricted stock unit award and meeting attendance fees. Our chairman (if he or she is not a Teleflex employee) and the chairpersons of our Audit, Compensation and Nominating and Governance Committees receive an additional annual cash retainer, and our Lead Director receives an additional annual restricted stock unit award. In addition, upon their first election or appointment to the Board,non-management directors receive a grant of an option to purchase shares of our common stock.

For 2018,2020, the amounts payable under ournon-management director compensation program were as follows:

 

•  Annual Cash Retainer – AllNon-Management Directors

   $55,000

•  Additional Annual Cash Retainer – Chairman

$100,000 

•  Additional Annual Cash Retainer – Committee Chairs:

  

¡   Audit Committee Chair

   $20,00022,500 

¡   Compensation Committee Chair

   $15,00017,500 

¡   Nominating and Governance Committee Chair

   $12,00014,000 

•  Annual Equity Grants – AllNon-Management Directors:

  

¡   Restricted Stock Units

   $102,000117,000 

¡   Stock Options

   $68,00078,000 

•  Additional Annual Equity Grant – Lead Director:

  

¡   Restricted Stock Units

   $25,00040,000 

•  Stock Option Grant Upon Initial Election

   $136,000156,000 

•  Meeting Fees (per meeting):

¡   Board of Directors (participation in person)

$2,000

¡   Board of Directors (participation by telephone)

$1,000

¡   Committees (participation in person or by telephone)

$1,000

In February 2021, our Board approved changes with respect to certain components of its annual compensation, effective immediately after conclusion of the Annual Meeting. Specifically, the Board approved increases in the value of the annual equity awards granted to all non-management directors and the value of stock options granted to non-management directors upon their initial election to the Board. The Board approved these changes after considering the results of a director compensation review undertaken by its compensation consultant, Frederic W. Cook & Co., Inc. The amounts payable under our director compensation program, as revised, are as follows:

•  Annual Cash Retainer – All Non-Management Directors

$55,000

•  Additional Annual Cash Retainer – Committee Chairs:

¡   Audit Committee Chair

$22,500

¡   Compensation Committee Chair

$17,500

¡   Nominating and Governance Committee Chair

$14,000

•  Annual Equity Grants – All Non-Management Directors:

¡   Restricted Stock Units

$127,000

¡   Stock Options

$84,000

•  Additional Annual Equity Grant – Lead Director:

¡   Restricted Stock Units

$40,000

•  Stock Option Grant Upon Initial Election

$168,000

•  Meeting Fees (per meeting):

  

¡   Board of Directors (participation in person)

   $2,000 

¡   Board of Directors (participation by telephone)

   $1,000 

¡   Committees (participation in person or by telephone)

   $1,000 

The table below summarizes the compensation paid tonon-management directors during the fiscal year ended December 31, 2018.2020.

 

Name

  Fees
Earned
Or Paid in
Cash

(1)
   Stock
Awards
(2)
   Option
Awards

(3)
   Change
in Pension
Value and
Nonqualified

Deferred
Compensation

Earnings
  All Other
Compensation
  Total   Fees
Earned
Or Paid in
Cash
(1)
   Stock
Awards
(2)
   Option
Awards
(3)
   Change
in Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
(4)
   All Other
Compensation
   Total 

George Babich, Jr.

  $86,083   $125,336   $67,035       $278,454   $87,667   $174,796   $86,793   $393       $349,649 

Candace H. Duncan

  $78,500   $100,527   $67,035       $246,062   $94,667   $130,247   $86,793           $311,707 

W. Kim Foster(4)

  $56,833   $100,527   $67,035       $224,395 

Gretchen R. Haggerty

  $71,833   $100,527   $67,035       $239,395   $70,000   $130,247   $86,793           $287,040 

John C. Heinmiller

  $69,000   $130,247   $86,793           $286,040 

Stephen K. Klasko

  $68,833   $100,527   $67,035       $236,395   $66,000   $130,247   $86,793   $229       $283,269 

Andrew A. Krakauer

  $64,083   $128,568   $179,429       $372,080   $67,000   $130,247   $86,793   $111       $284,151 

Richard A. Packer

  $71,833   $100,527   $67,035       $239,395   $67,000   $130,247   $86,793           $284,040 

Stuart A. Randle

  $91,833   $100,527   $67,035       $259,395   $85,333   $130,247   $86,793           $302,373 

Benson F. Smith(5)

  $150,750   $100,527   $67,035       $318,312   $54,666           $10,258       $64,924 

 

(1)

Includes, forFor each of Ms. Duncan, Dr. Klasko and Mr. Klasko, $50,833 and $47,083, respectively,Krakauer, includes $55,000 in cash fees that they elected to allocatedallocate to their respective deferral accounts under our Deferred Compensation Plan. See “Nonqualified Deferred Compensation – 2018”2020” for additional information regarding our Deferred Compensation Plan, the terms of which generally apply in the same manner with respect to deferrals of directors’ cash fees as they apply with respect to deferrals of executives’ cash compensation. We do not, however, provide matching contributions to ournon-employee directors under the Deferred Compensation Plan.

 

(2)

The amounts shown in this column represent the aggregate grant date fair value of the restricted stock units we granted to eachnon-employee director in 2018,2020, determined in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, “Compensation – Stock Compensation” (“ASC Topic 718”). A discussion of the assumptions used in calculating grant date fair values may be found in Notes 1 and 1314 to the consolidated financial statements included in our Annual Report on Form10-K for the fiscal year ended December 31, 2018,2020, as filed with the SEC. In May 2018,2020, we granted to eachnon-management director 389383 restricted stock units, and we granted to Mr. Babich an additional 96131 restricted stock units in respect of his service as Lead Director. The restricted stock units each had a grant

 date fair value per share of $258.43$340.07 and vested six months after the date of grant. In connection with Mr. Krakauer’s initial election to the Board, we granted to him, in January 2018, 113 restricted stock units, which vested six months after the date of grant (the amount of the restricted stock units was prorated to reflect the portion of the annual period between restricted stock unit grants that elapsed prior to Mr. Krakauer’s election to the Board). The restricted stock units granted to Mr. Krakauer in January 2018 had a grant date fair value per share of $248.14. Upon vesting, the restricted stock units are settled by the delivery to a director of shares of our common stock on the basis of one share of common stock for each restricted stock unit held by the director. Ms. Duncan, Dr. Klasko and Mr. KlaskoKrakauer deferred receipt of the common stock underlying 100% of the restricted stock units granted to them in 2018,2020, the value of which was credited to a deferral account under our Deferred Compensation Plan. See “Nonqualified Deferred Compensation – 2018”2020” for additional information regarding our Deferred Compensation Plan, which generally operates in the same manner with respect to deferrals of directors’ receipt of common stock underlying restricted stock units as it does with respect to such deferrals by executives.

 

(3)

The amounts shown in this column represent the aggregate grant date fair value of the stock option awards we granted to eachnon-employee director in 2018,2020, determined in accordance with ASC Topic 718. A discussion of the assumptions used in calculating grant date fair values may be found in Notes 1 and 1314 to the consolidated financial statements included in our Annual Report on Form10-K for the fiscal year ended December 31, 2018,2020, as filed with the SEC. We granted to eachnon-management director stock options to purchase 1,1311,187 shares in May 2018,2020, which had a grant date fair value per share of $59.27.$73.12. These options are fully vested at the time of grant. In connection with Mr. Krakauer’s election to the Board, we granted to him, in January 2018, stock options to purchase 2,178 shares, which had a grant date fair value per share of $51.60. The options granted to Mr. Krakauer in January 2018 vested six months after the date of grant. As of December 31, 2018,2020, the number of shares underlying options held by the current directors listed in the table were: Mr. Babich: 2,541;4,704; Ms. Duncan: 9,376;11,539; Ms. Haggerty: 5,931;8,094; Mr. Heinmiller: 4,494; Dr. Klasko: 20,816;18,979; Mr. Krakauer: 3,309;5,472; Mr. Packer: 3,951;6,114; and Mr. Randle: 20,816; and Mr. Smith: 508,696.18,979.

 

(4)

Mr. Foster retired from the Board on August 1, 2018.The amounts shown in this column reflect above-market interest earned in respect of deferred compensation under our Deferred Compensation Plan.

(5)

Mr. Smith retired as a director on May 1, 2020.

Director Stock Ownership Guidelines

We have stock ownership guidelines for ournon-management directors to further align the interests of our directors with those of our stockholders. The stock ownership guidelines require ournon-management directors to own shares of our common stock with an aggregate value equal to five times the annual cash retainer paid to our directors (exclusive of additional amounts provided to the committee chairs), which, based on the current $55,000 annual cash retainer, is equal to $275,000. Directors may not sell shares of stock underlying equity awards granted to them in respect of their service on our Board until such time as they have met the required ownership level; provided, however, that, prior to meeting the required ownership level, directors may sell shares to cover the exercise price of stock options and taxes.

As set forth in the table below, at December 31, 2018,2020, each of our currentnon-management directors other than Mr. Heinmiller, who was elected to the Board in January 2019, satisfied the stock ownership requirements. As a result of Mr. Heinmiller’s purchases of our common stock subsequent to December 31, 2018, he also has satisfied the stock ownership guidelines.

 

Name

  Stock Ownership Value
at 12/31/2018(1)
   Stock Ownership Value
at 12/31/2020(1)
 

George Babich, Jr.

  $2,649,930   $4,667,054 

Candace H. Duncan

  $1,002,273   $2,279,464 

Gretchen R. Haggerty

  $734,792   $1,759,480 

John C. Heinmiller

      $990,099 

Stephen K. Klasko

  $3,727,908   $6,126,128 

Andrew A. Krakauer

  $398,757   $1,123,828 

Richard A. Packer

  $602,869   $1,450,555 

Stuart A. Randle

  $2,991,757   $3,614,341 

Benson F. Smith(2)

  $50,666,226 

  

 (1)

Stock ownership value is calculated based on the number of shares owned by the director or members of his or her immediate family residing in the same household and the number of restricted stock units held by the director, multiplied by $258.48,$411.57, which was the closing stock price of a share of our common stock on December 31, 2018,2020, as reported by the New York Stock Exchange. In addition, stock ownership value includesone-half of the aggregate amount by which shares underlying vested,“in-the-money” stock options held by the director, multiplied by the closing stock price of a share of our common stock December 31, 2018,2020, exceeds the aggregate exercise price of those options.

(2)

Mr. Smith retired as our Chief Executive Officer on December 31, 2017.

AUDIT COMMITTEE REPORT

The Audit Committee assists the Board in its oversight of the integrity of Teleflex’s financial statements, Teleflex’s internal control over financial reporting, the performance and independence of Teleflex’s independent registered public accounting firm, the performance of the internal audit function and compliance with legal and regulatory requirements. Management has primary responsibility for preparing Teleflex’s consolidated financial statements and for its financial reporting process. Management also has the responsibility to assess the effectiveness of Teleflex’s internal control over financial reporting. PricewaterhouseCoopers LLP, Teleflex’s independent registered public accounting firm, is responsible for expressing an opinion on (i) whether Teleflex’s financial statements present fairly, in all material respects, its financial position and results of operations in accordance with generally accepted accounting principles and (ii) the effectiveness of Teleflex’s internal control over financial reporting.

In this context, the Audit Committee has:

 

reviewed and discussed with management and PricewaterhouseCoopers LLP Teleflex’s audited consolidated financial statements for the fiscal year ended December 31, 2018;2020;

 

discussed with PricewaterhouseCoopers LLP the matters required to be discussed pursuant toby the applicable requirements of the Public Company Accounting Oversight Board Auditing Standard No. 1301, “Communications with Audit Committees;”and the Securities and Exchange Commission; and

 

received the written disclosures and the letter from PricewaterhouseCoopers LLP regarding PricewaterhouseCoopers LLP’s independence, as required by the applicable requirements of the Public Company Accounting Oversight Board, and has discussed with PricewaterhouseCoopers LLP that firm’s independence.

Based on the review and discussions referred to above, the Audit Committee recommended to the Board, and the Board has approved, the inclusion of the audited consolidated financial statements in Teleflex’s Annual Report onForm 10-K for the year ended December 31, 2018,2020, for filing with the Securities and Exchange Commission.

 

 AUDIT COMMITTEE 
 CANDACE H. DUNCAN, CHAIR 

GRETCHEN R. HAGGERTY

  JOHN C. HEINMILLER

COMPENSATION DISCUSSION AND ANALYSIS

The Compensation Discussion and Analysis describes in general our executive compensation program and also includes a discussion of modifications made to that program with respect to 2020 in connection with the impact of the global pandemic caused by the COVID-19 novel strain of coronavirus that impacted world economic and business conditions generally, and our operations and financial results in particular, during the year. As discussed below, the Compensation Committee of our Board of Directors consulted with its independent compensation consultant regarding the impact of COVID-19 on our executive compensation programs, and concluded that the decisions it ultimately made are generally consistent with similar actions taken by our peer companies and in the market generally, and that such decisions are appropriate to recognize strong performance by our executive officers in the context of the challenges presented by the pandemic.

INTRODUCTION

In this Compensation Discussion and Analysis, we address the compensation paid or awarded to the following current and former executive officers of our company, who are listed in the Summary Compensation Table that follows this discussion and who we refer to as our “named executive officers”:

 

Name

  

Title

Liam J. Kelly

  President and Chief Executive Officer

Thomas E. Powell

  Executive Vice President and Chief Financial Officer

James J. Leyden

  Corporate Vice President, General Counsel and Secretary

Cameron P. Hicks

  Corporate Vice President Globaland Chief Human Resources Officer

Karen T. BoylanJames Winters

  Corporate Vice President, Global Strategic Projects

Thomas A. Kennedy

Former Senior Vice President, Global OperationsManufacturing and Supply Chain

During 2018, Ms. Boylan wasIn October 2020, Mr. Leyden notified us that he will retire on March 31, 2021 to pursue a career in public interest. Mr. Leyden served in his role as Corporate Vice President, General Counsel and Secretary until December 31, 2020, and will remain with us through March 31, 2021 as a senior advisor until his retirement date. Daniel V. Logue became our Corporate Vice President. Global Regulatory AffairsPresident, General Counsel and Quality Assurance. She assumed her current position onSecretary effective January 1, 2019.2021.

EXECUTIVE COMPENSATION OVERVIEW

Compensation Objectives

Our executive compensation program is designed to promote the achievement of specific annual and long-term goals by our executive management team and to align our executives’ interests with those of our stockholders. In this regard, the components of the compensation program for our executives, including the named executive officers, are intended to meet the following objectives:

 

Provide compensation that enables us to attract and retain highly-skilledhighly skilled executives. We refer to this objective as “competitive compensation.”

 

Create a compensation structure that in large part is based on the achievement of performance goals. We refer to this objective as “performance incentives.”

 

Provide long-term incentives to align executive and stockholder interests. We refer to this objective as “stakeholder incentives.”

 

Provide an incentive for long-term continued employment with us. We refer to this objective as “retention incentives.”

We fashioned the components of our 20182020 executive compensation program to meet these objectives as follows:

 

Type of Compensation

  

Objectives Addressed

Salary

  Competitive Compensation

Annual Bonus

  Performance Incentives
  Competitive Compensation

Equity Incentive Compensation

  Stakeholder Incentives
  Performance Incentives
  Competitive Compensation
  Retention Incentives

Key Compensation Practices and Policies

What we do

What we don’t do

•  Practice pay-for-performance, under which a significant percentage of our named executive officer compensation is at-risk and subject to achievement of corporate and individual performance goals

•  The Compensation Committee’s independent consultant performs no other work for the Company

•  We do not guarantee annual bonus or guarantee salary increases

•  No excise tax gross-ups for any change in control payments

•  Executives are prohibited from hedging or pledging our stock

•  Re-pricing of stock options is prohibited without stockholder approval

•  Set challenging incentive plan goals

•  Maintain an industry-specific peer group for benchmarking compensation

•  Target named executive officer compensation to be within a competitive range of the median of companies referenced in the comparative data reviewed by the Compensation Committee

•  Require our senior executives to satisfy meaningful stock ownership guidelines to strengthen the alignment with our stockholders’ interests

•  Maintain a clawback policy that allows us to recover annual and long-term performance-based compensation if we are required to restate our financial results, other than a restatement due to changes in accounting principles or applicable law

•  Hold an advisory vote on executive compensation on an annual basis to provide our stockholders with an opportunity to give feedback on our executive compensation program

•  Maintain an independent Compensation Committee

•  Consult with an independent compensation advisor on compensation levels and practices

Role of Compensation Committee, Chief Executive Officer and Compensation Consultant

The Compensation Committee of the Board is responsible for the oversight of our executive compensation program. In 2018,2020, the Compensation Committee generally made all decisions concerning compensation awarded to the named executive officers other than Mr. Kelly. Determinations concerning Mr. Kelly’s compensation were made by the independent members of the Board. In making these compensation decisions, both the Compensation Committee and the independent members of the Board were assisted by the Compensation Committee’s independent compensation consultant, Frederic W. Cook & Co., Inc., which we refer to below as “FW Cook.” FW Cook was engaged directly by the Compensation Committee. The Compensation Committee has assessed the independence of FW Cook pursuant to SECNYSE rules and concluded that the work of FW Cook has not raised any conflict of interest in connection with its service as an independent consultant to the Compensation Committee.

Mr. Kelly, with the assistance of our human resources department and FW Cook, provided statistical data to the Compensation Committee to assist it in determining appropriate compensation levels for our executives. He also provided the Compensation Committee with recommendations as to components of the compensation of our executives. Mr. Kelly did not make recommendations as to his own compensation. While the Compensation Committee utilized this information and considered Mr. Kelly’s observations with regard to other executive officers, the ultimate determinations regarding compensation for our executive officers, other than Mr. Kelly, were made by the Compensation Committee. The Compensation Committee also provided recommendations regarding Mr. Kelly’s compensation, subject to approval by the independent directors.members of the Board.

Determination of Compensation

In making its compensation determinations and recommendations for 2018,2020, the Compensation Committee considered anmaterials regarding executive compensation review report preparedprovided by FW Cook in late 2016, whichDecember 2019 and January 2020. Specifically, with respect to Mr. Kelly, the Compensation Committee previously used in 2017 to assess compensation for executives of other companies serving in capacities similar to the named executive officers. Specifically, thereviewed a report provided by FW Cook that analyzed the compensation of our named executive officersMr. Kelly in comparison to compensation provided to executiveschief executive officers serving in similar capacities for companies within our designated peer group (with respect to Messrs. Kelly, Powell and Leyden) and included in selected national survey data (with respect to all of our named executive officers).group. The peer group compensatory data and survey compensatory data referenced in the executive compensation review report was adjusted to January 1, 2018,2020, using a 3% per annum rate of increase.

Generally, in selecting a peer group company, we use the following selection criteria:

 

Operations and Scale – We seek companies that haveone-third to three times our market capitalization andone-half to two times our revenues.

 

Business Characteristics –

 

Industry – The peer group company should be similar to Teleflex and included in the HealthcareHealth Care Equipment & Supplies Industry Group within the Global Industry Classification Standard (GICS).

 

Demographics – The peer group company should be publicly traded in the United States, similar in terms of items such as business complexity and should operate in economiclabor markets and have levelsserve as a potential source of complexity that are similar to ours.executive talent.

 

Business model – The peer group company should have a similar business model to ours.

 

Prevalence as a Peer – We give preference to companies already in the peer group, companies named as a peer by fivefour or more of our already designated peers, companies that name us as a peer and companies that a major proxy advisory firm includes in our peer group for purposes of its analysis of our executive compensation.

To assistThe peer group that we utilized for 2020 was the same as the peer group we utilized for 2019, which was selected by the Compensation Committee in selectingfollowing consideration of a peer group,report provided by FW Cook biannually provides a reportin October 2018 that includesincluded recommendations regarding the composition of the peer group; with respect to 2018 compensation, the Compensation Committee considered a report provided by FW Cook in late 2016.group. Not every company in the peer group we ultimately selected meets all of the peer group selection criteria. Nevertheless, we believe that each of the companies we selected represents a reasonable peer from the standpoint of size and business attributes.

The Compensation Committee selected the same peer group for 2018 as it used in 2017. On December 29, 2017, C.R. Bard, Inc. was acquired by Becton, Dickinson and Company. However, the Compensation Committee referenced the peer group data included in the FW Cook’s executive compensation report described above, which adjusted historical compensation data to January 1, 2018 using a 3% per annum rate of increase. Therefore, we did not remove C.R. Bard from the peer group, which2020 included the following companies (sometimes referred to below as the “Executive Compensation Peer Group”):

 

•  Align Technology, Inc.

  

•  Hologic, Inc.

•  CONMEDIntegra LifeSciences Holdings Corporation

•  IDEXX Laboratories, Inc.

•  The Cooper Companies, Inc.

  

•  Integra LifeSciences Holdings Corporation

•  C.R. Bard, Inc.

•  ResMedIntuitive Surgical, Inc.

•  DENTSPLY SIRONA Inc.

  

•  STERIS plcLivaNova, PLC

•  Edwards Lifesciences Corporation

  

•  Varian Medical Systems, Inc.

•  Haemonetics Corporation

•  West Pharmaceutical Services,NuVasive, Inc.

•  Hill-Rom Holdings, Inc.

  

•  ResMed Inc.

•  Hologic, Inc.

•  STERIS plc

•  ICU Medical, Inc.

•  Varian Medical Systems, Inc.

To provide an additional competitive reference source for Messrs. Kelly, Powell and Leyden, and a reference source forIn addition to reviewing information from the other named executive officers,peer group, the Compensation Committee also considered data included in FW Cook’sevaluates executive compensation review reportby reviewing surveys that was derived fromcover a wider group of relevant companies. The Committee reviews these surveys to help assess the Radford Global Technology Survey relatingbroader market in which the Company competes for talent to companies with revenues insupplement the range of$1-3 billion.peer group perspective. In reviewing the survey data, the Compensation Committee considered only the aggregated data provided by the surveys. The identity of the individual companies comprising the survey data was not reviewed or considered by the Compensation Committee in its evaluation process. Therefore, the Compensation Committee does not consider the identity of the companies comprising the survey data to be material information in this context.

The historical data provided by FW Cook was adjusted to January 1, 2020, using a 3% per annum rate of increase, unless forward-looking compensation was disclosed. The peer group data and the survey data described above were the Compensation Committee’s primary sources of comparative data that it used in making compensation determinations.

Over the past several years, weWe generally sought to position target total direct compensation of our executives between the median and the 75th percentile of companies referenced in the comparative data reviewed by the Compensation Committee. In January 2019, following a review of our historical compensation practices, evolving best practices generally and the recommendation of FW Cook, the Compensation Committee determined that going forward we generally will seek to position target total direct compensation of our executives within a competitive range of the median of companies referenced in the comparative data reviewed by the Compensation Committee. However, this range is intended to serve only as a guideline in setting and adjusting our compensation programs, and we may make adjustments to take into consideration other factors, such as importance of an executive’s role to Teleflex, experience, performance, skill set, anticipated difficulty in replacing an executive, and performance.internal pay parity. Therefore, our executives’ target compensation may be more or less than the competitive range in any given year.

Appointment of Liam J. Kelly as President and Chief Executive Officer

On February 21, 2017, the Board appointed Mr. Kelly to the position of President and Chief Executive Officer, effective January 1, 2018. At the time of the Board action, Mr. Kelly was our President and Chief Operating Officer.

In connection with the Board’s appointment of Mr. Kelly, the Board set the following compensatory terms for him, effective as of January 1, 2018:

Base salary of $850,000;

Annual incentive plan target award equal to 115% of base salary;

Personal benefits, including personal use of the corporate aircraft for up to a maximum of 50 hours per year, subject to a maximum incremental cost to us of $190,000 (Mr. Kelly is fully responsible for personal income tax liability associated with personal use of the corporate aircraft), a company automobile and term life insurance coverage equal to three times his base salary (not to exceed $3 million);

A revised severance arrangement, under which he will receive benefits if we terminate his employment for any reason other than death, disability or cause, or if he terminates his employment for “good reason” within three months after occurrence of the event constituting good reason (collectively, the “Payment Criteria Events”), except in circumstances covered by his change in control arrangement. Specifically, under the revised severance agreement he will be eligible to receive, among other things, continued payment of base salary for 24 months and, if his termination occurs after completion of at least six months of a performance period under our annual incentive plan, a prorated portion of the award for that performance period.

A revised change in control arrangement under which, if any of the Payment Criteria Events occur within two years following a change in control, he will be eligible to receive, among other things, payment of his base salary for 36 months, and three times the amount of his target bonus under any cash bonus plan payable in the year following termination; and

Continued participation in the Company’s 401(k) and deferred compensation plans.

In addition, in February 2018, our Board approved a 2018 long-term incentive compensation award for Mr. Kelly with a target value of $3,100,000.

In making its compensation recommendations with respect to Mr. Kelly’s promotion, the Compensation Committee referenced the peer group data and survey data in the executive compensation review report prepared by FW Cook in late 2016, described above under “Executive Compensation Overview – Determination of Compensation.”

See “2018 Compensation – Equity Incentive Compensation – Performance Stock Units” below for information regarding performance stock units granted in June 2018 to our named executive officers, including Mr. Kelly.

20182020 COMPENSATION

Salaries

Base salary ranges for our executives are considered annually during the first quarter of the year and determined based on each executive’s position and responsibility. In addition, salary reviews may occur at other times due to events such as a promotion or other change in job responsibility.

Mr. Kelly’s salary for 2018 was set in conjunction with the Board’s February 21, 2017 action appointing him as our President and Chief Executive Officer. See “Executive Compensation Overview – Appointment of Liam J. Kelly,” above. The Compensation Committee adjustedincreased salaries for the otherall named executive officers within a rangeother than Mr. Winters by approximately 3.0-5.0 percent. Mr. Winters’ salary was increased by approximately 26.5 percent in light of no increase to a 3.0 percent increase, excepthis increased duties upon his appointment as noted below. Mr. Leyden’s 8.0 percent increase and Mr. Hicks’ 5.0 percent increase reflected peer group and survey data indicating that their salaries were considerably below the median salaries of executivesCorporate Vice President, Manufacturing & Supply Chain in a similar position within the peer group companies (with respect to Mr. Leyden) and survey group companies (with respect to both Mr. Leyden and Mr. Hicks).February 2020.

Annual Executive Incentive Compensation

General

Under our annual incentive program, we provide meaningful cash incentive opportunities that are principally based upon the achievement of financial performance objectives. As a result, a significant amount of an executive’s total cash compensation is subject to the achievement of these objectives. In 2018,2020, for our named executive officers generally,Messrs. Kelly, Powell, Leyden and Hicks, 90 percent of the target award opportunity was based on financial performance measures. For Mr. Kennedy, who ceased being an executive officer on October 30, 2018,Winters, 50 percent of the target award opportunity was based on financial performance measures and 40 percent was based on performance measures related to our Global Operations function. The remaining ten percent of an executive officer’s target award opportunity was based on individual performance. We continue to believe that emphasizing financial performance encourages a unified commitment by our executives to performance that we believe can enhance stockholder value.

As discussed below, the impact of the COVID-19 pandemic on our operations and financial results during 2020 caused achievement with respect to the targets set for our 2020 annual incentive program, which were established before the impacts of the pandemic were foreseen, not to be reflective of the strong performance of our executives in significant respects during 2020, and as a result, our Compensation Committee elected to adjust the annual incentive compensation payable to our executives for 2020 as compared to what measurement against these targets would have reflected.

20182020 Award Components

The Compensation Committee determined to use the same corporate financial performance measures in 20182020 as it used in 2017.2019, except in the case of Mr. Winters, who in addition to corporate financial performance measures was also assigned certain measures relating to global operations. The weighting assigned to the corporate financial performance measures for Messrs. Kelly, Powell, Leyden and Hicks also was unchanged.

In addition to the adjustments pertaining to specific financial performance measures described below, some adjustments, which are referred to below as the “general adjustments,” were made with respect to each of the financial performance measures. The general adjustments principally include adjustments to address events with respect to business acquisitions and divestitures not contemplated in our annual operating plan. Specifically, the general adjustments relating to acquisitions and divestitures were as follows (we did not make adjustments for acquisitions of distributors of our products effected as part of our ongoing program to convert sales of our products through third party distributors to direct sales or, where the acquired distributor was a master distributor that sold our products throughsub-distributors, to enable us to directly administer product distribution through the existingsub-distributors or newsub-distributors (our “distributor to direct” sales conversion strategy)):

To address the effect on each of the financial performance measures resulting from acquisitions of assets or entities during 2018 that were not anticipated in our annual operating plan, the target amount for each financial performance measure was adjusted to reflect forecasted performance of such acquired assets or entities.

To address costs and expenses related to 2018 acquisitions to the extent that such costs and expenses were not contemplated by our annual operating plan, the actual results for each financial performance measure were adjusted to eliminate the effect of such costs and expenses.

These adjustments were made to reduce the possibility that participants unduly benefit or suffer as a result of meaningful increases or decreases in actual results due to acquisition activities not contemplated by our annual operating plan. However, we did not make adjustments with regard to acquisitions that were part of our “distributor to direct” strategy because the principal focus of those acquisitions was to convert certain of our distributor sales channels to direct sales or to direct distribution throughsub-distributors rather than to expand our operations through the acquisition of new businesses or products. While general adjustments also could be applied to business divestitures, we had no divestitures in 2018.

The general adjustments also included adjustments to the actual results with respect to each performance measure to eliminate the impact of any changes in accounting rules and applicable laws, to the extent not contemplated in our annual operating plan, or, if approved by the Compensation Committee in its sole discretion, to adjust target amounts and/or actual results with respect to each

performance measure to address any extraordinary, unusual,non-recurring or otherwise unanticipated events. No such adjustments were made in 2018.

The performance measures under our 20182020 annual incentive program for our named executive officers, other than Mr. Kennedy,Winters, are set forth immediately below. All of these targets were established early in 2020 and without regard to the potential impacts of the COVID-19 pandemic.

 

Forty percent of the target award was based on the amount of our “corporate revenue,” which is defined as our consolidated revenues, adjusted to reflect the general adjustments described above, and further adjusted to eliminate the effect of foreign currency exchange rate fluctuations.

We use corporate revenue as a performance measure because we believe that our success going forward will, to a meaningful extent, be dependent on our ability to generate sales growth. We eliminated the effect of foreign currency exchange rate fluctuations from this measure because we wanted to focus on the growth of our ongoing business exclusive of giving effect to such fluctuations, which are outside the control of management.

 

Thirty-five percent of the target award was based on the amount of our “EPS,” which is defined as our consolidated earnings per share, adjusted to reflect the general adjustments described above, and further adjusted to eliminate the following, net of any tax effect:

 

restructuring and other special charges;

 

intangible amortization expense;

 

increases or decreases in the accounting dilution associated with warrants that we issued in 2010impact of costs incurred as part of an arrangement to hedge against a portionresult of the potential dilution ofrequirement, under the EU Medical Device Regulation (“MDR”), that medical devices previously registered under the EU Medical Device Directive be re-registered, to the extent that such costs are among adjustments resulting in non-GAAP financial measures included in our common stock resulting from conversions of our previously outstanding 3.875% Convertible Notes due 2017;public disclosures;

costs incurred in connection with acquisitions;

 

the impact of our repurchases, if any, of our common stock;

gains or losses with respect to investments in non-core, non-controlled affiliates made by us prior to 2012;

 

gains or losses on sales of businesses and assets to the extent not included in our annual operating plan;

 

any debt refinancing or other transactions affecting theour capital structure, of our company, to the extent not otherwise contemplated by our annual business plan;

 

the impact of increases or decreases in the liabilities associated with our contingent consideration payment obligations related to completed acquisitions;

 

the impact of GAAP-mandated decreases in sales and related cost of goods sold as a result of our repurchase of inventory from a distributor in connection with our “distributor to direct” sales conversion strategy, as well as decreases in cost of goods sold required under GAAP as such repurchased inventory subsequently is sold;

 

the impact of settling, partially settling or otherwise concluding any tax audits or the filing of amended tax returns with respect to prior years, including any changes to reserves related to uncertain tax positions (calculated in accordance with Financial Accounting Standards Board Accounting Standards CodificationSection 740-10-25, “Income Taxes – Overall – Recognition”), net of any costs of settlement or other conclusion of such matters), but not including normal return to accrual adjustments booked in the ordinary course;

 

tax benefits or detriments resulting from the retroactive application to any prior year of any newly enacted tax legislation;

 

the impact of federal tax reform legislation that was enacted in December 2017, commonly referred to as the Tax Cuts and Jobs Act (“TCJA”) booked during the “measurement period” as described in SEC Staff Accounting Bulletin No. 118; and

the impact of any statutory rate changes on deferred taxes.

As used with respect to adjustments for restructuring and other special charges, the term “special charges” includes restructuring related charges incurred in connection with any restructuring plan approved by our Board or, if such charges were not incurred in connection with a Board approved restructuring plan, to the extent adjustments relating to such charges have been approved by the Compensation Committee. Special charges also include charges incurred in connection with the integration of acquisitions completed during the year, to the extent that such charges are among adjustments resulting in non-GAAP financial measures included in our public disclosures; charges incurred in connection with the relabeling of products and product registrations associated with the relocation of a specified United States facility; and certain one-time, extraordinary charges.

As used with respect to adjustments for restructuring and other special charges, the term “special charges” includes restructuring related charges incurred in connection with any restructuring plan approved by our Board or, if such charges were not incurred in connection with a Board approved restructuring plan, to the extent such charges have been approved by the Compensation Committee. Special charges also include certainone-time, extraordinary charges.

We use EPS as a performance measure because we believe that it provides a good indication of management’s overall performance with respect to our enterprise. We also believe that EPS is a key metric affecting share price and, therefore, stockholder value. We made the further adjustments to EPS described in the preceding paragraphWe use EPS as a performance measure because we believe that it provides a good indication of management’s overall performance with respect to our enterprise. We also believe that EPS is a key metric affecting share price and, therefore, stockholder value. We made the further adjustments to EPS described above because we do not believe these items reflect the performance of our executives.

 

Fifteen percent of the target award was based on “cash flow,” which is defined as cash flow from operations, adjusted to reflect the general adjustments described above, and further adjusted to eliminate the effect of:

 

cash expended in connection with any debt financing or other transaction affecting our capital structure, to the extent not otherwise contemplated by our annual operating plan;

 

tax payments resulting from a gain on the sale of divested assets;

payments made (or refunds received) in connection with the settlement of tax audits or the filing of amended tax returns with respect to any prior tax years;

 

payments made to fund our defined benefit pension plans;

 

reductions in tax payments related to the retroactive application to any prior year of any newly enacted tax legislation;

restructuring or restructuring related payments not contemplated in our annual operating plan in connection with any Board approved restructuring plan or, if such payments were not made in connection with a Board approved restructuring plan, to the extent adjustments relating to any other restructuring plan adopted during the year have been approved by the Compensation Committee; and

 

anycontingent consideration payments related to acquisitions, to the extent not contemplated in our annual operating plan.

We use cash flow as a performance measure because we believe it is an important indicator of our ability to service indebtedness, make capital expenditures and provide flexibility with regard to the pursuit of other operating initiatives. We made the further adjustments to cash flow described above because the adjusted payments or refunds, if not excluded, would impair the utility of theone-time tax on the deemed repatriation on undistributed earnings and profits required under the TCJA. performance measure as a reflection of management’s overall performance in 2020.

We use cash flow as a performance measure because we believe it is an important indicator of our ability to service indebtedness, make capital expenditures and provide flexibility with regard to the pursuit of other operating initiatives. We made the further adjustments to cash flow described in the preceding paragraph because the adjusted payments or refunds, if not excluded, would impair the utility of the performance measure as a reflection of management’s overall performance in 2018.

 

Ten percent of the target award was based principally either on satisfaction of individual performance objectives that were established in the early part of the year or, in one case, principally on a retrospective performance assessment.year. For 2018,2020, the individual performance objectives established for Mr. Kelly principally included goals related to leading our organization through the COVID-19 pandemic, achievement of certain objectives related to our strategic growth objectives, integration of the Vascular Solutionsacquired businesses, execution on new product development initiatives and NeoTract businesses, increased gross margin, enhanced corporate compliance and several qualityimplementation of certain succession planning initiatives. The individual performance objectives established for all but one of our other named executive officers included objectives related to their respective functions.

We include individual performance as a performance measure in order to focus our executives on their individual performance and our corporate performance outside of the context of specified financial performance measures. Mr. Kelly’s satisfaction of his individual performance objectives was evaluated by our independent directors following a recommendation by the Compensation Committee. The Compensation Committee determined the amount of the award to be allocated to each of the other named executive officers with respect to their performance after considering Mr. Kelly’s recommendations.

For Mr. Kennedy, who had responsibility with respect to our Global Operations, which generally encompassestheir performance after considering Mr. Kelly’s recommendations.

For Mr. Winters, who has responsibility for management of our supply chain and our manufacturing and distribution operations and supply chain, 50 percent of his target award was based upon the achievement of the corporate financial performance measures described above (22.5 percent based on corporate revenue, 20 percent on EPS and 7.5 percent on cash flow). We included the corporate financial performance measures because we believe all participants in the annual incentive program should have a stake in the performance of our company as a consolidated entity. An additional 40 percent of Mr. Kennedy’sWinters’ target award was based upon the following performance measures related to Global Operations:our global operations:

 

Twenty-FourTwenty-four percent of the target award was based on “Global Operations Financial Performance,the amount of our “global operations financial performance,” which is defined as the sum of total operational variances plus fixed expenses within our consolidated income statement (other than with respect to our OEM and Interventional Urology segments), as approved in our 2018 Global Operations Budget,annual budget for global operations, subject to certain exclusions and adjusted to reflect the general adjustments described above; to eliminate the impacttranslational and transactional impacts of foreign currency fluctuations with respectand to both currency translation and transactional impact; and otherwise to maketake into account the same adjustments as we madeprovided for with respect to the EPS financial measure described above,metric to the extent applicable. other thanapplicable, except for adjustments with respectrelated to the restructuring related costs.costs which are factored into the global operations financial performance target.

We use global operations financial performance as a performance measure for Mr. Winters because we believe it is a reliable overall measure of the performance of our global operations function. Therefore, we believe a significant portion of the target award for an executive who is responsible for operations management should be based on this metric.

We include Global Operations Financial Performance because we believe it is a reliable overall measure of the performance of our Global Operations function. Therefore, we believe a significant portion of the target award for an executive who is responsible for operations management should be based on this metric. The results of our OEM and Interventional Urology segments are excluded from Global Operations Financial Performance because Mr. Kennedy did not have responsibility for managing the operations of those segments.

 

Ten percent of the target award was based on the amount of “Global Operations Service Performance,our “global operations service performance,” which generally measures the percentageis determined based on a measurement of the proportion of our total number of customer order line items (other than with respectorders, subject to our Interventional Urology segmentcertain exclusions and our distributor network for EMEA (Europe, Middle East and Africa), Latin America and South East Asia) (a) shipped to third party customersadjustments, that we ship in full on or before the agreed upon shipmentship date (the percentage calculation is exclusivefor such orders provided.

We use global operations service performance as a performance measure to focus our global operations team on the timely delivery of shipments delayed dueproducts to our designation of collection/credit holds at the scheduled shipping date or due to acts of God) and (b) made available to third party customers, for pickup by thewhich we believe is a key factor in maintaining high customer or the customer’s freight forwarder on or before the agreed upon pickup date, in each case adjusted to reflect the general adjustments described above.satisfaction levels.

We use Global Operations Service Performance as a performance measure to focus our global operations team on the timely delivery of products to our customers, which we believe is a key factor in maintaining high customer satisfaction levels. We excluded the results of our Interventional Urology segment from this measure because Mr. Kennedy did not have responsibility for that segment. We excluded the distributor network for EMEA, Latin America and South East Asia because the distributors have principal responsibility for satisfying customer deliveries or pickups.

 

Six percent of the target award was based on “Global Operations Inventory Turns,“global operations inventory turns,” which is defined as the number of times our consolidated inventory turns over during the year, based oncalculated using the average of our “Inventory Turns Rates”the inventory turns rates for each fiscal quarter during the year. The Inventory Turns Rateinventory turn rate for each fiscal quarter is calculated by dividing our consolidated cost of goods sold for each fiscalsuch quarter by the average of the inventory amounts shownset forth on our consolidated balance sheet as of the end offor each fiscal month during thesuch quarter. The actual Global Operations Inventory Turns results are adjusted to reflect the general adjustments described above, and further adjusted to exclude the impact of foreign currency fluctuations

with respect to currency translation and the impact of inventorybuild-up relating to global footprint consolidation initiatives. In addition, Global Operations inventory results exclude the inventory in our OEM and Interventional Urology segments because Mr. Kennedy did not have responsibility for those segments.

We use Global Operations Inventory TurnsWe use global operations inventory turns as a performance measure because of the impact that inventory management can have on our working capital and operating efficiency.

As was the case for all of our other named executive officers, the remaining 10 percent of Mr. Kennedy’sWinters’ target award was based on the achievement of individual performance objectives.

With respect to each of the financial and Global Operations performance measures generally, an executive’s incentive award could range from a minimum of 25 percent for threshold performance to a maximum of 200 percent of the target award, depending on the degree of variation from the target amount of the performance measure; theremeasure. There is no award with respect to a performance measure if performance is below the threshold level. In addition, the Compensation Committee may, in its discretion, reduce or eliminate awards payable to the named executive officers with respect to each financial performance measure.

With respect to the 20182020 award ranges, for EPS, upon taking into consideration our historical performance and expected market dynamics and growth rates, the Compensation Committee established targets to incentivize achievement of business objectives and stretch goals. In this regard, the Compensation Committee referenced a group of companies consisting of industry peers, which we refer to as the “Performance Peer Group,Group. in determining the award ranges with respect to the EPS performance measure. The Performance Peer Group differs from the Executive Compensation Peer Group described above in that it consists of companies whose businesses, irrespective of size differences, are more like ours than some of the companies in the Executive Compensation Peer Group. SomeTwo companies are in both peer groups. While we believe the Executive Compensation Peer Group is better suited as a reference for total compensation due to the more relatively similar size of the constituent companies to ours, we believe the Performance Peer Group provides a better frame of reference for establishing our relative performance with respect to the markets in which we operate.

The Performance Peer Group consisted of the following companies:

 

•  AngioDynamics, Inc.

  

•  Hill-Rom Holdings, Inc.

•  Becton, Dickinson and CompanyAvanos Medical, Inc.

  

•  Medtronic plc

•  Boston Scientific CorporationBecton, Dickinson and Company

  

•  Stryker Corporation

•  Edwards LifesciencesBoston Scientific Corporation

  

•  Zimmer Biomet Holdings, Inc.

•  Avanos Medical, Inc.

     (formerly Halyard Health, Inc.)Edwards Lifesciences Corporation

  

For 2018, we removed C.R. Bard, Inc. from the Performance Peer Group because it was acquired by Becton, Dickinson and Company on December 29, 2017. In contrast to the Executive Compensation Peer Group, which we looked to for historical data as adjusted for inflation, our determination of award ranges for the EPS financial measure included, as described above, consideration of expected market dynamics and growth rates, which could no longer be applied to C.R. Bard, Inc. as a stand-alone entity.

Based on the foregoing considerations, the target established for each performance measure, and the percentage of target performance that would entitle a participant to a minimum or maximum award with respect to each measure and the amount achieved in respect of each performance measure were as follows (percentages are approximate):

 

Percentage of Target Performance
(and Amount) Required For

Performance Measure

Target
    Performance*    
Minimum Award
    (25% of Target)*    
Maximum Award
    (200% of Target)*    

Corporate Revenue

$2,418.7 million95%
($2,297.8 million)
105%
($2,539.6 million)

EPS

$9.3490%

($8.41)

110%

($10.27)

Cash Flow

$499.8 million80%
($399.8 million)
120%
($599.8 million)

Global Operations Financial Performance

$81.1 million109%
($88.2 million)
84.6%
($67.8 million)

Global Operations Service Performance

93%92%
(98.9%)
94%
(101.08%)

Global Operations Inventory Turns

2.70097.48%
(2.632)
105.13%
(2.767)
    Percentage of Target Performance
(and Amount) Required For
  

Performance Measure

 Target
    Performance*
    
 Minimum Award
    (25% of Target)*    
 Maximum Award
    (200% of Target)*    
 Amount Achieved

Corporate Revenue

 $2,740.1 million 95%
($2,603.1 million)
 105%
($2,877.1 million)
 $2,519.6 million

EPS

 $12.27 90%
($11.05)
 110%
($13.50)
 $10.66

Cash Flow

 $497.6 million 80%
($398.1 million)
 120%
($597.1 million)
 $444.5 million

Global Operations Financial Performance

 $105.8 million 112%
($118.4 million)
 88%
($93.1 million)
 $108.6 million

Global Operations Service Performance

 82.5% 97%
(80.0%)
 103%
(85.0%)
 85%

Global Operations Inventory Turns

     2.40 98%
(2.35)
 103%
(2.47)
    2.40

 

*

Target Performance and Minimum and Maximum Award performance levels reflect the adjustments described above, to the extent applicable.

20182020 Executive Incentive Compensation Targets and Awards

The target award payable to a named executive officer for 20182020 if the target financial performance-based objectives were achieved and 100 percent of the individual performance award opportunity was paid is equal to a specified percentage of the executive’s salary, as shown on the following table:

 

Name

  Target Award
Opportunity as
a percentage of Salary
 Target Award
Opportunity
   Target Award
Opportunity as
a
 percentage of Salary
 Target
Award
Opportunity

Liam J. Kelly

   115 $972,519    115% $1,084,915

Thomas E. Powell

   75 $401,541    75% $445,716

James J. Leyden

   45 $156,467    50% $193,575

Cameron P. Hicks

   45 $143,011    50% $177,272

Karen T. Boylan

   45 $115,960 

Thomas A. Kennedy*

   45 $148,251 

James Winters*

   50% $183,988

 

 *

Ms. Boylan’s and Mr. Kennedy’sWinters’ cash compensation is payable in euros. We determined the dollar amount of their respectivehis target award opportunitiesopportunity set forth in the table above by converting their salarieshis salary to U.S. dollars using the exchange rate in effect as of December 31, 20182020 of 0.87370.815291 euros per dollar.

The target award opportunity as a percentage of salary indicated in the table above reflected the following changesfor each named executive officer is unchanged from the 2017 percentages. In connection with his appointment as our President2019 for Messrs. Kelly and Chief Executive Officer, Mr. Kelly’s target award opportunity as a percentage of salary wasPowell, increased from 80%45% to 115%. The target award opportunity as a percentage of salary50% for each of Messrs. Leyden and Hicks and Ms. Boylan was increased from 40% to 45%, so that their percentages more closely approached the 50th percentile of comparable executives addressed in FW Cook’s executive compensation review report.50% for Mr. Winters.

The following table provides information for each named executive officer regarding the applicable performance measures, target awards for each performance measure and actual payments with respect to each performance measure based on actual performance in 2018:2020:

 

Name

 

Performance

Measure

 Performance
Measure as
a percentage of

Total Target
Award
Opportunity
 Target Amount
Achieved
 Actual
Award
 Actual Award
as a percentage
of Target Award
Opportunity for the
Performance
Measure
  

Performance

Measure

  Performance
Measure as
a
 percentage of
Total Target
Award
Opportunity
 Actual
Award
  Actual Award
as a percentage
of Target  Award
Opportunity for the
Performance
Measure

L. Kelly

 Corporate Revenue 40% $2,418.7 million $2,453.5 million $457,590 117.6%  Corporate Revenue   40% $   %
 EPS 35% $9.34 $9.89 $525,549 154.4%  EPS   35% $   %
 Cash Flow 15% $499.8 million $459.8 million $102,115 70.0%  Cash Flow   15% $97,642   60.0%
 Individual Performance 10% N/A N/A $116,702 120%  Individual Performance   10% $119,341   110%

T. Powell

 Corporate Revenue 40% $2,418.7 million $2,453.5 million $188,933 117.6%  Corporate Revenue   40% $   %
 EPS 35% $9.34 $9.89 $216,993 154.4%  EPS   35% $   %
 Cash Flow 15% $499.8 million $459.8 million $42,162 70.0%  Cash Flow   15% $40,114   60.0%
 Individual Performance 10% N/A N/A $52,200 130%  Individual Performance   10% $49,029   110%

J. Leyden

 Corporate Revenue 40% $2,418.7 million $2,453.5 million $73,621 117.6%  Corporate Revenue   40% $   %
 EPS 35% $9.34 $9.89 $84,555 154.4%  EPS   35% $   %
 Cash Flow 15% $499.8 million $459.8 million $16,429 70.0%  Cash Flow   15% $17,422   60.0%
 Individual Performance 10% N/A N/A $18,776 120%  Individual Performance   10% $21,293   110%

C. Hicks

 Corporate Revenue 40% $2,418.7 million $2,453.5 million $67,290 117.6%  Corporate Revenue   40% $   %
 EPS 35% $9.34 $9.89 $77,283 154.4%  EPS   35% $   %
 Cash Flow 15% $499.8 million $459.8 million $15,016 70.0%  Cash Flow   15% $15,954   60.0%
 Individual Performance 10% N/A N/A $17,161 120%  Individual Performance   10% $19,500   110%

K. Boylan

 Corporate Revenue 40% $2,418.7 million $2,453.5 million $54,562 117.6%
 EPS 35% $9.34 $9.89 $62,664 154.4%
 Cash Flow 15% $499.8 million $459.8 million $12,176 70.0%
 Individual Performance 10% N/A N/A $13,915 120%

T. Kennedy

 Corporate Revenue 22.5% $2,418.7 million $2,453.5 million $29,347 117.6%

J. Winters*

  Corporate Revenue   22.5% $   %
 EPS 20% $9.34 $9.89 $34,240 154.4%  EPS   20% $   %
 Cash Flow 7.5% $499.8 million $459.8 million $5,821 70.0%  Cash Flow   7.5% $8,269   60.0%
 Global Operations Financial Performance 24% $81.1 million $82.6 million $22,355 84.0%  Global Operations Financial Performance   24% $36,836   83.4%
 Global Operations Service Performance 10% 93% 87.9% $0 0%  Global Operations Service Performance   10% $36,798   200%
 Global Operations Inventory Turns 6% 2.70 2.433 $0 0%  Global Operations Inventory Turns   6% $11,039   100%
 Individual Performance 10% N/A N/A $11,088 100%  Individual Performance   10% $27,599   150%

*

Mr. Winters’ cash compensation is payable in euros. We determined the dollar amount of his target award opportunity set forth in the table above by converting his salary to U.S. dollars using the exchange rate in effect as of December 31, 2020 of 0.815291 euros per dollar.

Based on the applicable levels of achievement described above, aggregate payments to each of the named executive officers were as follows:

 

Named

Executive Officer

  Target Award
Opportunity
  Actual Award  Award Based on
Performance Achieved

(% of Target Award)
  Target Award
Opportunity
  Actual
Award
  Award Based on
Performance Achieved
(% of Target Award)

Liam J. Kelly

   $997,519   $1,201,956   123.59%   $1,084,915   $216,983   20%

Thomas E. Powell

   $401,541   $500,287   124.59%   $445,716   $89,143   20%

James J. Leyden

   $156,467   $193,381   123.59%   $193,575   $38,715   20%

Cameron P. Hicks

   $143,011   $176,750   123.59%   $177,272   $35,454   20%

Karen T. Boylan

   $115,960   $143,317   123.59%

Thomas A. Kennedy

   $148,251   $102,852   92.75%

James Winters*

   $183,988   $120,541   66%

*

Mr. Winters’ cash compensation is payable in euros. We determined the dollar amount of his target award opportunity set forth in the table above by converting his salary to U.S. dollars using the exchange rate in effect as of December 31, 2020 of 0.815291 euros per dollar.

The actual award payments to our named executive officers under the terms of our 2020 annual incentive program are reflected in the“Non-Equity Incentive Compensation” column of the Summary

Compensation Table. As discussed below under “Impact on our Executive Compensation Program Relating to COVID-19 Pandemic,” our Compensation Committee elected to pay additional amounts to our named executive officers for their performance in 2020, which are reflected in the “Bonus” column of the Summary Compensation Table.

Equity Incentive Compensation

Our equity incentive compensation program is designed to promote achievement of corporate goals, encourage the growth of stockholder value, enable participation in our long-term growth and profitability and serve as an incentive for continued employment. In addition, the value of our equity

compensation also is designed to reflect the contribution of each executive officer to our company’s objectives,business strategy, the executive’s individual performance and other factors. In setting the value of our equity incentive compensation for executives, we generally considered the extent to which the equity incentive compensation value would enable the target total direct compensation paid to our executives to be within the competitive range of companies referenced in the comparative data that the Compensation Committee reviewed. As discussed above, we previously considered the competitive range to be between the median and 75th percentile of the comparative data. However, going forward we will seek to position target total direct compensation of our executives within a competitive range of the median of companies referenced in the comparative data. See “Executive Compensation Overview – Determination of Compensation” for additional information.

In addition,this regard, we increased the value oftotal target equity compensation provided to eachopportunity for Messrs. Powell, Leyden and Hicks by 3.0% in recognition of the named executive officers also reflected the contribution of each executive to our Company’s business strategy, the executive’s individual performance and other factors.their performance. We increased Mr. Kelly’s incentive award opportunity initiallytotal target equity compensation by 16.9% to more closely approximate median compensation referenced in the comparative data. Mr. Winters’ total target equity compensation was determinedincreased by the Board in February 2017 in conjunction with56.3% as a result of his increased duties upon his appointment as ourCorporate Vice President, and Chief Executive Officer, effective January 1, 2018. See “Executive Compensation Overview-Appointment of Liam J. Kelly as President and Chief Executive Officer.”

Subsequently,Manufacturing & Supply Chain in June 2018, the Board, upon the recommendation of the Compensation Committee, approved the grant of performance stock units, sometimes referred to below as “PSUs,” to specified senior managers of our company, including all of our continuing named executive officers. The performance stock units were a new component of our equity incentive compensation program.February 2020.

We determined to grant the performance stock units to increase management’s focus on longer-term, profitable growth opportunities, including both internal growth and growth through acquisitions, while maintaining stockholder value. In addition, we believe the performance criteria for vesting of the performance stock units, which are described below, appropriately conditions superior pay on superior performance, consistent with our objective to create a compensation structure that in large part is based on achievement of performance goals. We also granted the performance stock units in response to views of investors, compensation advisors and others that equity awards contingent upon performance with respect to specified financial measures should constitute a component of a long-term equity incentive program.

Our grant of performance stock units increased each named executive officer’s 2018 equity incentive award opportunity by approximately 25%, assuming target performance and without giving effect to a provision of the performance stock units that we call the “RTSR Modifier,” which is based on relative total stockholder return, or “RTSR.” As described in more detail below, application of the RTSR Modifier, which entails a comparison of our total stockholder return to the total stockholder return of a designated group of public companies, may result in an increase or decrease in the number of performance stock units underlying the performance stock unit award, and a corresponding increase or decrease of the number of shares of our common stock issuable upon vesting and conversion of the performance stock units (each performance stock unit is convertible into one share of our common stock upon vesting).

The following table shows the value of the initialtotal target equity incentive compensation opportunity approved for each of our named executive officers in February 2018 (comprised of stock options and restricted stock units), the performance stock unit target award opportunity provided to our named executive officers in June 2018 and the total target equity incentive award opportunity (including the performance stock unit target award opportunity) available to our named executive officers, based upon target performance and without giving effect to the RTSR Modifier:for 2020:

 

Name

  Initial Equity
Incentive
Compensation
Opportunity
   PSU Target
Award
Opportunity
 Total Target
Equity
Incentive
Compensation
Opportunity
   Total Target
Equity
Incentive
Compensation
Opportunity

Liam J. Kelly

  $3,100,000   $775,000  $3,875,000    $4,850,000

Thomas E. Powell

  $1,400,000   $350,000  $1,750,000    $2,008,500

James J. Leyden

  $712,000   $178,000  $890,000    $927,000

Cameron P. Hicks

  $479,000   $119,750  $598,750    $618,000

Karen T. Boylan

  $220,000   $55,000  $275,000 

Thomas A. Kennedy

  $495,000    (1)  $495,000 

James Winters

   $500,000

(1)

In May 2018, Mr. Kennedy advised the Board that he will retire on March 31, 2019. Because the performance stock units granted in 2018 generally can vest upon retirement only if a holder retires on or after June 30, 2019, Mr. Kennedy was not granted any performance stock units.

Initially, the Board authorized implementation of a performance stock unit component of our equity incentive compensation program for 2018 only. In February 2019,the Board, upon the recommendation of the Compensation Committee, determined to make the performance stock units an ongoing component of our equity incentive compensation program. In making its recommendation to the Board, the Compensation Committee considered the factors described above. In addition, after a review of peer group and survey data provided by FW Cook, the Compensation Committee determined that without the continuation of the performance stock unit component of our equity incentive compensation program, the value of equity incentive compensation for our named executive officers at target levels generally would be below our general competitive range guidelines. In this regard, the Compensation Committee noted that, prior to 2018, the amount of equity incentive compensation provided to our named executive officers generally was below the median level of companies included in the comparative data it reviewed. This was the case despite prior increases in the value of the equity compensation opportunity for most of our executive officers. By adding the performance stock awards component to our equity incentive compensation program on an ongoing basis, we believe that we will more closely approximate our general competitive range guideline, thereby enabling us to provide equity compensation that strengthens the utility of our equity incentive program as an incentive for continued employment and enhances our ability to compete for executive talent.

Components of the Equity Incentive Compensation Program

As in previous years,In 2020, our target equity incentive compensation for 2018 includedopportunity consisted of grants of stock options, and restricted stock units. We designed these components to align the interests of our named executive officers to our stockholders by providing an incentive to our executives to achieve performance that should have a favorable impact on the value of our common stock. In addition, as described above, the Board approved the grant ofunits and performance stock units, to specified senior managers, including most of our named executive officers.

In 2018, we allocated 52in the same proportions as in 2019. We allocated 55 percent of the total target equity incentive compensation opportunity to stock options because we continue to believe that stock price appreciation should be the principal determinant of the economic return received by our executives from equity compensation, and absent such appreciation, stock options would have no value. As such, we consider stock options to be performance-based compensation that provides a strong alignment between return to stockholders and the compensation of executives.

We allocated 2825 percent of the total equity incentive compensation

opportunity to restricted stock units, which we granted to provide incentives to our executives to continue as employees of our company and increase stockholder value. The remaining

Finally, we allocated 20 percent of the total equity incentive compensation opportunity was allocated to performance stock units, or “PSUs.” We granted performance stock units to increase management’s focus on longer-term, profitable growth opportunities, including both internal growth and growth through acquisitions, while maintaining stockholder value. In addition, we believe the performance criteria for vesting of the reasons set forth above.performance stock units, which are described below, appropriately condition superior pay

on superior performance, consistent with our objective to create a compensation structure that in large part is based on achievement of performance goals. Finally, we believe that the potential adjustment of the number of vested units based on changes in our stock price relative to a specified peer group, as described below, adds a useful competitive element and directly aligns our executives’ incentives with long-term stockholder returns.

Stock Option Awards

In accordance with the equity award allocation described above, we granted stock options to our named executive officers in 20182020 that represented 5255 percent of their respective total equity incentive compensation opportunities. Using a Black-Scholes methodology, we valued the stock options granted in February 20182020 at $58.11$85.03 per underlying share.

As a result of these computations, the named executive officers received stock options for the respective numbers of underlying shares set forth below:

 

Name

  Number of Shares
Underlying Options

Liam J. Kelly

   34,67631,371

Thomas E. Powell

   15,66012,992

James J. Leyden

   7,9645,996

Cameron P. Hicks

   5,3583,997

Karen T. BoylanJames Winters

   2,461

Thomas A. Kennedy

3,234
5,537

In contrast to the valuation we use to determine the number of shares underlying stock options that we grant to the named executive officers, the dollar amounts for option awards included in the “Option Awards” column of the Summary Compensation Table generally reflects the aggregate grant date fair value of each named executive officer’s award, determined in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, “Compensation Stock Compensation,” which we refer to below as “ASC Topic 718.” See note 3 to the Summary Compensation Table for further information.

For additional information regarding terms of stock options granted to the named executive officers, see the footnotes accompanying the Grants of Plan-Based Awards table.

Restricted Stock Units

In February 2018,2020, we granted restricted stock units to our named executive officers that represented 2825 percent of their respective total target equity incentive compensation opportunities. Upon vesting, a restricted stock unit is converted into one share of our common stock. We valued the restricted stock units granted in February 20182020 at $263.35$377.19 per unit. This value was determined based upon the30-day trailing average closing price of our common stock as of the date on which the grant of the restricted stock units were approved, discounted by the present value of estimated future dividends to be declared on our common stock during the applicable vesting period, as the holders of restricted stock units do not have dividend rights.

As a result of these computations, the named executive officers received restricted stock units for the respective numbers of shares set forth below:

 

Name

  Number of
Restricted Stock Units

Liam J. Kelly

   4,1203,215

Thomas E. Powell

   1,8611,331

James J. Leyden

   946614

Cameron P. Hicks

   637410

Karen T. BoylanJames Winters

   292

Thomas A. Kennedy

331
658

In contrast to the valuation we use to determine the number of restricted stock units awarded to the named executive officers, the dollar amounts for restricted stock units included in the Summary Compensation Table, which constitute a portion of the amount included in the “Stock Awards” column of the Summary Compensation Table, generally reflect the aggregate grant date fair value of each named executive officer’s award, determined in accordance with ASC Topic 718. See note 2to2to the Summary Compensation Table for further information.

For additional information regarding restricted stock unit terms, see the footnotes accompanying the Grants of Plan-Based Awards table.

Performance Stock Units

The performance stock units are designed to focus our executives’ efforts on specific long-term goals. Unlike our other equity awards, the number of performance stock units ultimately underlying a performance stock award is principally dependent upon our performance during the 2018-20202020-2022 period (the “Performance Period”) with respect to two financial performance measures. In addition, the number of performance stock units that ultimately are converted into shares of our common stock upon vesting is subject to further adjustment based on application of the “RTSR Modifier,” which is based on a comparison of our total stockholder return to the total stockholder return of a designated group of public companies. The RTSR Modifier asis described in more detail below.

While the performance targets associated with the performance stock units were established early in 2020 and without regard to the potential impacts of the COVID-19 pandemic, and our ability to achieve these targets was affected by the impacts of the pandemic through 2020 and continuing into 2021, these targets have not been adjusted.

The financial measures used with respect to the performance stock units are similar to the corporate revenue and EPS financial measures that we use in connection with our annual incentive program. However, there are some meaningful differences. Prominent among the differences is the fact that the performance stock unit financial measures cover a three-year period rather than aone-year period, which we believe provides an incentive for the achievement of sustained, longer-term performance. In addition, as explained in more detail below, the application of the financial measures over a three-year period enables a year-over-year assessment of acquisitions (utilizing pro forma adjustments, as appropriate), which we believe facilitates an assessment of management’s ability to effectively integrate acquisitions within our operations in a manner that enhances our “core” growth.

Additional information regarding the financial measures utilized in connection with the performance stock units granted in 20182020 to participating executive officers is set forth below:

 

Sixty percent of the performance stock unit target award opportunity is based on “constant currency revenue growth,” which will be calculated by taking the average of our constant currency revenue growth for each year during the Performance Period. “Constant currency revenue growth” means the change in our consolidated net revenues, expressed as a percentage, during a calendar year (the “Comparison Year”), as compared to the previous year (the “Base Year”), adjusted to eliminate the impact of translating the results of international subsidiaries at differentforeign currency exchange ratesrate fluctuations from year to year, as well as the impact of any changes in accounting rules or in their application, or in applicable laws, to the extent not contemplated as part of our longer term business plan.

If, during the Performance Period, we acquire another entity or all or substantially all of the assets of another entity (an “Acquired Business,” which does not include a distributor that we acquire as part of our “distributor to direct” sales strategy), constant currency revenue growth for the year in which such acquisition occurs will be calculated on a pro forma basis to include the actual results of the Acquired Business for (a) any interim period prior to the acquisition date for the year in which the acquisition occurs and (b) the year preceding the

If, during the Performance Period, we acquire another entity or all or substantially all of the assets of another entity (an “Acquired Business,” which does not include a distributor that we acquire as part of our “distributor to direct” sales strategy), constant currency revenue growth for the year in which such acquisition occurs will be calculated on a pro forma basis to include the actual results of the Acquired Business for (a) any interim period prior to the acquisition date for the year in which the acquisition occurs and (b) the year preceding the year in which the acquisition occurs. Similarly, if we divest any of our businesses (a “Divested Business”) during the performance period, constant currency revenue growth for the year in which such divestiture occurs will be calculated on a pro forma basis to exclude the actual results of the Divested Business for (a) any interim period prior to the divestiture date for the year in which the divestiture occurs and (b) the year preceding the year in which the divestiture occurs.

We use constant currency revenue growth as a performance measure because we believe that our success going forward will, to a meaningful extent, be dependent on our ability to generate sales growth over the long-term.

year in which the acquisition occurs. Similarly, if we divest any of our businesses (a “Divested Business”) during the Performance Period, constant currency revenue growth for the year in which such divestiture occurs will be calculated on a pro forma basis to exclude the actual results of the Divested Business for (a) any interim period prior to the divestiture date for the year in which the divestiture occurs and (b) the year preceding the year in which the divestiture occurs.

We use constant currency revenue growth as a performance measure because we believe that our success going forward will, to a meaningful extent, be dependent on our ability to generate sales growth over the long term. Moreover, by providing for the inclusion in the computation of constant currency revenue growth of Acquired Businesses and exclusion of Divested Businesses (including pro forma inclusion or exclusion for designatedpre-acquisition orpre-disposition periods), we seek to focus management on the achievement of effective year-over-year “core” growth throughout the Performance Period. We eliminated the effect of foreign currency exchange rate fluctuations from this measure because we wanted to focus on the growth of our ongoing business exclusive of giving effect to such fluctuations, which are outside the control of management.

As initially granted, the number of stock units underlying a performance stock award is equal to the target number of performance stock units, and 60 percent of the target number of performance stock units granted to an executive are subject to adjustment based to our performance with respect to the constant currency revenue growth financial measure. The actual number of performance stock units ultimately underlying a performance stock award, before giving effect to the RTSR Modifier, could range from a minimum of one percent of the target number of performance stock units for threshold performance to a maximum of 200 percent of the target number of performance stock units, depending on the degree of variation from the target percentage of the constant currency revenue growth financial measure; no performance stock units will be available for vesting if performance is below the threshold level.

Information with respect to performance targets for the constant currency revenue growth financial measure during the pendency of the Performance Period is not considered material to an understanding of our compensation arrangements and is not addressed in this proxy statement because it represents confidential business or financial information that we do not otherwise disclose to the public. Disclosing the information could cause significant competitive harm to Teleflex. We believe that the performance target for the constant currency revenue growth financial measure was set at an appropriate level to be challenging, but sufficiently realistic to motivate the performance of our senior management. Information with respect to the constant currency revenue growth minimum, target and maximum award opportunities, and the actual number of shares awarded with respect to the constant currency revenue growth financial measure, will be disclosed in our proxy statement for the annual meeting in the year following conclusion of the Performance Period.

As initially granted, the number of stock units underlying a performance stock award is equal to the target number of performance stock units, and 60 percent of the target number of performance stock units granted to an executive are subject to adjustment based to our performance with respect to the constant currency revenue growth financial measure. The actual number of performance stock units ultimately underlying a performance stock award, before giving effect to the RTSR Modifier, could range from a minimum of one percent of the target number of performance stock units for threshold performance to a maximum of 200 percent of the target number of performance stock units, depending on the degree of variation from the target percentage of constant currency revenue growth financial measure (before application of the RTSR Modifier); no performance stock units will be available for vesting if performance is below the threshold level.

The target established with respect to the constant currency revenue growth financial measure, and the percentage of target performance that would that would entitle the holder to the minimum and maximum number of performance stock units for the financial measure, is indicated in the following table:

Percentage of Target Performance (and Amount) Required For

Target Performance*

Minimum AwardMaximum Award

6.8%

92.64%

(6.3%)

107.35%

(7.3%)

*

Target Performance and Minimum and Maximum Award performance levels reflect the adjustments described above, to the extent applicable, and are subject to further modification following application of the RTSR Modifier.

The number of performance stock units underlying the performance stock awards for performance between threshold and maximum performance will be adjusted proportionately.

 

Forty percent of the performance stock unit target award opportunity is based on “earnings per share growth,” which will be calculated based on the average of our adjusted earnings per share growth for each year during the Performance Period. “Earnings per share growth” means the change in our adjusted earnings per share in the Comparison Year as compared to the Base Year. “Adjusted earnings per share” is our adjusted diluted earnings per share, as reported in our earnings press releases. Earnings per share growth will be further adjusted to reflect the impact of any changes in accounting rules or in their application, or in applicable laws, to the extent not contemplated as part of our longer-term business plan.

If we acquire an Acquired Business during the Performance Period, earnings per share growth for the year in which such acquisition occurs will be calculated on a pro forma basis

If we acquire an Acquired Business during the Performance Period, earnings per share growth for the year in which such acquisition occurs will be calculated on a pro forma basis to include the actual results of the Acquired Business and interest expense related to the purchase price for the Acquired Business for (a) any interim period prior to the acquisition date for the year in which the acquisition occurs and (b) the year preceding the year in

which the acquisition occurs. In addition, if we make any contingent consideration payment during the Performance Period with respect to the Acquired Business, earnings per share growth for the year in which such contingent consideration payment is made will be calculated on a pro forma basis to include interest expense related to the contingent consideration payment for both the year in which the payment is made and the preceding year.

to include the actual results of the Acquired Business and interest expense related to the purchase price for the Acquired Business for (a) any interim period prior to the acquisition date for the year in which the acquisition occurs and (b) the year preceding the year in which the acquisition occurs. In addition, if we make any contingent consideration payment during the Performance Period with respect to the Acquired Business that is acquired during the Performance Period, earnings per share growth for the year in which such contingent consideration payment is made will be calculated on a pro forma basis to include interest expense related to the contingent consideration payment for both the year in which the payment is made and the preceding year.

If we divest a Divested Business during the Performance Period, earnings per share growth for the year in which such divestiture occurs will be calculated on a pro forma basis to exclude the actual results of the Divested Business and include interest savings related to the proceeds from divestiture of the Divested Business for (a) any interim period prior to the divestiture date for the year in which the divestiture occurs and (b) the year preceding the year in which the divesture occurs. In addition, if we receive a contingent consideration payment during the Performance Period with respect to a Divested Business that is divested during the Performance Period, earnings per share growth for the year in which such contingent consideration payment is made will be calculated on a pro forma basis to include interest savings related to the contingent consideration payment for both the year in which the payment is made and the preceding year.

We use earnings per share growth as a performance measure because we believe that it provides a good indication of management’s long-term overall performance with respect to our enterprise, including the results of businesses acquired during the Performance Period, without giving effect to results of businesses that we no longer own. We based the financial measure on our adjusted diluted earnings per share, as reported in our earnings press releases, because we believe it is a key financial measure used by investors, and by including it as a financial measure for the performance stock units, we can better focus on encouraging performance that addresses investors’ long-term expectations. As is the case with the constant currency revenue growth financial measure, we provide for the inclusion of Acquired Businesses and the exclusion of Divested Businesses to focus on management’s achievement of “core growth,” for which the results of Divested Businesses are not relevant. We determined to make adjustments for interest expense and interest savings, with respect to contingent consideration payments or receipts related to Acquired Businesses and Divested Businesses, respectively, because they offset variations in year over year results that otherwise may result from the timing of contingent consideration payments.

As is the case with respect to the constant currency revenue growth financial measure, the minimum award with respect to the earnings per share growth metric is one percent of the target number of performance stock units for threshold performance to a maximum of 200 percent of the target number of performance stock units, depending on the degree of variation from the target percentage of the earnings per share growth financial measure (before application of the RTSR Modifier); no performance stock units will be available for vesting if performance is below the threshold level.

If we divest a Divested Business during the Performance Period, earnings per share growth for the year in which such divestiture occurs will be calculated on a pro forma basis to exclude the actual results of the Divested Business and include interest savings related to the proceeds from the Divested Business for (a) any interim period prior to the divestiture date for the year in which the divestiture occurs and (b) the year preceding the year in which the divesture occurs. In addition, if we receive a contingent consideration payment during the Performance Period with respect to the Divested Business, earnings per share growth for the year in which such contingent consideration payment is made will be calculated on a pro forma basis to include interest savings related to the contingent consideration payment for both the year in which the payment is made and the preceding year.

We use earnings per share growth as a performance measure because we believe that it provides a good indication of management’s long-term overall performance with respect to our enterprise, including the results of businesses acquired during the Performance Period, without giving effect to results of businesses that we no longer own. We based the financial measure on our adjusted diluted earnings per share, as reported in our earnings press releases, because we believe it is a key financial measure used by investors, and by including it as a financial measure for the performance stock units, we can better focus on encouraging performance that addresses investors’ long-term expectations. As is the case with the constant currency revenue growth financial measure, we provide for the inclusion of Acquired Businesses and the exclusion of Divested Businesses to focus on management’s achievement of “core growth,” for which the results of Divested Businesses are not relevant. We determined to make adjustments for interest expense and interest savings, with respect to contingent consideration payments or receipts related to Acquired Businesses and Divested Businesses, respectively, because they offset variations in year over year results that otherwise may result from the timing of contingent consideration payments.

As is the case with respect to the constant currency revenue growth financial measure, the minimum award with respect to the earnings per share growth metric is one percent of the target number of performance stock units for threshold performance to a maximum of 200 percent of the target number of performance stock units, depending on the degree of variation from the target percentage of the earnings per share growth financial measure (before application of the RTSR Modifier); no performance stock units will be available for vesting if performance is below the threshold level.

Information with respect to performance targets for the earnings per share growth financial measure during the pendency of the Performance Period is not considered material to an understanding of our compensation arrangements and is not addressed in this proxy statement because it represents confidential business or financial information that we do not otherwise disclose to the public. Disclosing the information could cause significant competitive harm to Teleflex. We believe that the performance target for the earnings per share growth financial measure was set at an appropriate level to be challenging, but sufficiently realistic to motivate the performance of our senior management. Information with respect to performance targets for the earnings per share growth financial measure during the pendency of the Performance Period is not considered material to an understanding of our compensation arrangements and is not addressed in this proxy statement because it represents confidential business or financial information that we do not otherwise disclose to the public. Disclosing the information could cause significant competitive harm to Teleflex. We believe that the performance target for the earnings per share growth financial measure was set at an appropriate level to be challenging, but sufficiently realistic to motivate the performance of our senior management. Information

with respect to the earnings per share growth minimum, target and maximum award opportunities, and the actual number of shares awarded with respect to the earnings per share growth financial measure, will be disclosed in our proxy statement for the annual meeting in the year following conclusion of the Performance Period.

After the number of performance stock units underlying a performance stock unit award is determined as set forth above, the number of performance stock units underlying a performance stock award is subject to further modificationan adjustment, referred to below as the “RTSR Modifier.” The RTSR Modifier is based on our total stockholder return relative to the total stockholder return of 28 companies, included in one or moreall of the following:

Companieswhich are within the Standard & Poor’s Midcap 400 Index that are in the same Global Industry Classification Standards (GICS)sub-industry industry group (Health Care Equipment)Equipment & Supplies) as Teleflex;

Companies within the Standard & Poor’s 500 Index that are within the same GICSsub-industry as Teleflex; and

The Executive Compensation Peer Group (other than C.R. Bard, which was acquired by Becton, Dickinson and Company in December 2017).

The entities described aboveTeleflex. These companies, collectively are referred to as the “RTSR Peer Group.Group,Setare set forth below is a list of the companies initially in the RTSR Peer Group (as described below, it is possible that, based on subsequent events, a company may be removed from the RTSR Peer Group):

 

•  Abbott Laboratories

  

•  Hologic,ICU Medical, Inc.

•  ABIOMED, Inc.

  

•  IDEXX Laboratories, Inc.

•  Align Technology, Inc.

  

•  Integra Lifesciences Holding Corporation

•  Baxter International Inc.

  

•  Intuitive Surgical, Inc.

•  Becton, Dickinson and Company

  

•  LivaNova PLC

•  Boston Scientific Corporation

  

•  Masimo Corporation

•  Cantel Medical Corp.

  

•  Medtronic plc

•  CONMED CorporationThe Cooper Companies, Inc.

  

•  NuVasive, Inc.

•  The Cooper Companies,Danaher Corporation

•  Penumbra, Inc.

•  DENTSPLY SIRONA Inc.

  

•  ResMed Inc.

•  DanaherEdwards Lifesciences Corporation

  

•  STERIS plc

•  DENTSPLY SIRONAGlobus Medical, Inc.

  

•  Stryker Corporation

•  Edwards Lifesciences CorporationHill-Rom Holdings, Inc.

  

•  Varian Medical Systems, Inc.

•  Globus Medical,Hologic, Inc.

  

•  West Pharmaceutical Services, Inc.

•  Haemonetics Corporation

•  Zimmer BionetBiomet Holdings, Inc.

•  Hill-Rom Holdings, Inc.

The RTSR Modifier will be applied based on the extent to which our rate of return reflecting stock price appreciation of our common stock from December 29, 201731, 2019 to December 31, 20202022 exceeds the rate of return reflecting stock price appreciation of the common stock (or equivalent security) of each of the RTSR Peer Group companies during the same period. For the purposes of this calculation, the price of our common stock and the stock price of the companies in the RTSR Peer Group will be based upon the average of the stock price on the principal stock exchange on which the stock is traded for the 20 trading days immediately preceding the first and last day of the Performance Period. Based upon the percentage of RTSR Peer Group companies whose total stockholder return is exceeded by our total stockholder return during the three-year Performance Period (the “RTSR Ranking”), the number of performance stock units that would vest solely as a result of financial measure performance will be modified as follows:

 

Teleflex RTSR Ranking

 

Percentage Modification of


PSUs Underlying a

PSU Award

< 25%

25% to 40%

> 40% to 60%

> 60% to 75%

> 75%

 

- 25%

- 25% to 0%*

0%

0% to 25%*

25%

 

*   Amounts within the indicated ranges will be determined using linear interpolation.

The RTSR Peer Group will be subject to the following adjustments:

 

If a RTSR Peer Group company files for bankruptcy and/or liquidation or is operating under bankruptcy protection (each of which is referred to below as a “bankruptcy event”), it will be deemed to have a total stockholder return during the Performance Period of minus 100%.

 

If a RTSR Peer Group company is acquired and is no longer existing as a public company whose stock is traded on its primary stock exchange (other than due to a bankruptcy event), it will be removed from the RTSR Peer Group.

A RTSR Peer Group company will continue to be included in the RTSR Peer Group so long as its shares remain publicly traded, even if the company is no longer included in the S&P Midcap 400 Index, the S&P 500 Index or the Executive Compensation Peer Group.traded. If, as a result of a reorganization of a RTSR Peer Group member, an entity is a successor to all or substantially all of the primary business of the RTSR Peer Group member, that entity will be deemed to be a Peer Group member, subject to the adjustments described above. No companies will be added to the RTSR Peer Group during the Performance Period.

We included the RTSR Modifier with respect to the calculation of the number of shares, if any, to be provided upon vesting of the performance stock units because we wanted the ultimate number of shares underlying the performance stock units to be based in part on the performance of our common stock, thereby directly aligning management incentives with long-term stockholder returns. We based the RTSR Modifier on return relative to other companies to reduce the impact of changes in general market conditions that are outside of management’s control. Such changes could have a meaningful impact if we measured the total stockholder return of our common stock on an absolute basis (i.e., without reference to the total stockholder return of other companies). In addition, we selected the RTSR Peer Group to avoid penalizing or rewarding management with respect to industry-wide conditions generally affecting the members of the RTSR Peer Group.

Our June 2018February 2020 grant of performance stock units to the named executive officers other than Mr. Kennedy was based upon 2520 percent of their respective initial target total equity incentive compensation opportunity. Each performance stock unit is converted into one share of our common stock upon vesting. For purposes of determining the number of performance stock units granted to each named executive officer, we valued the performance stock units at $284.33$404.63 per unit. This value was determined using a Monte Carlo valuation model, which simulates a range of possible future stock prices for Teleflex and the companies in the RTSR Peer Group, considering the probable outcome with respect to performance conditions over the performance periodPerformance Period to determine value related to the RTSR Modifier. However, in contrast to the valuation used to determine the number of performance stock units to be granted to each named executive officer, the dollar amounts for performance stock units included in the Summary Compensation Table, which constitute a portion of the amount included in the “Stock Awards” column of the Summary Compensation Table, generally reflect the aggregate grant date fair value of each named executive officer’s award, determined in accordance with ASC Topic 718. See Note 2 to the Summary Compensation Table for additional information.

The number of performance stock units underlying a performance stock award initially were determined based on the target award, without giving effect to the RTSR Modifier. However, as described above, the number of performance stock units, if any, that ultimately will underlie a performance stock unit award (and be converted upon vesting into our common stock, on a one share per performance stock unit basis) will be adjusted based on our actual performance with respect to the two financial measures and the application of the RTSR Modifier.

The named executive officers received the respective numbers of performance stock units, based on target performance and without giving effect to the RTSR Modifier, set forth in the table below:

 

Name

  Target Number of PSUs

Liam J. Kelly

    2,7262,397

Thomas E. Powell

    1,231993

James J. Leyden

    626458

Cameron P. Hicks

    421305

Karen T. BoylanJames Winters

    193247

Impact on our Executive Compensation Program Relating to COVID-19 Pandemic

Annual Incentive Compensation

In February 2021, our Compensation Committee considered our performance in relation to the targets established in February 2020 with respect to our 2020 annual incentive program. The Compensation Committee concluded that, if adjustments were made for the estimated impact of the pandemic, certain of the performance measures, specifically revenue and EPS financial performance, would have exceeded target level performance established for those measures, while global operations financial performance would have significantly exceeded target level performance. However, actual performance resulted in no payouts with respect to the revenue and EPS targets and 83.4% for the global operations financial performance target.

In addition, the Compensation Committee considered the following elements of our performance during 2020:

Our achievement of solid financial results within the context of the operating environment, with particularly strong performance as we reached the end of 2020, allowing us to enter 2021 with positive momentum;

Our strong total shareholder return performance for 2020 as compared to our peer group;

Our consummation of two strategic acquisitions during the year;

Our strong global supply chain performance throughout the year, including with respect to increased demand for essential respiratory product delivery for COVID-19 patient treatment, in connection with which we increased manufacturing capacity of key products by over 200%;

We received external recognition of key elements of our corporate culture, with highlighted reference to COVID-19 related employee support; and

Our work through our Humanitarian Donations program to donate PPE to meet urgent needs of healthcare practitioners.

Taking these factors into consideration and factoring in the advice received from FW Cook regarding the practices of our peers and other companies generally, the Compensation Committee elected to award our named executive officers bonuses in the amounts set forth below. These bonuses, together with the amounts earned under the 2020 annual incentive program with respect to achievement against the performance targets established in February 2020, resulted in the named executive officers receiving amounts equal to 80% of their respective target awards under the 2020 annual incentive program.

Name

  2020 Bonus

Liam J. Kelly

   $650,949

Thomas E. Powell

   $267,429

James J. Leyden

   $116,145

Cameron P. Hicks

   $106,363

James Winters

   $26,649

This discretion was similarly applied with respect to the 2020 annual incentive compensation for over 800 other employees.

Outstanding Performance Share Unit Awards

Notwithstanding the substantial negative impact on our business due to the COVID-19 pandemic, the Compensation Committee did not make any adjustments with respect to any of our outstanding performance stock unit awards.

2018-2020 Performance Stock Unit Award Results

The three-year performance period for the performance stock unit awards granted in 2018 (referred to as the “2018 PSUs”) ended on December 31, 2020. The number of shares to be earned with respect to the 2018 PSUs was based on our performance against three-year average constant currency revenue and earnings per share growth targets approved by the Compensation Committee at the beginning of the performance period. The significant negative impact of the COVID-19 pandemic on our operations and financial results during 2020 resulted in our failure to achieve threshold performance levels with respect to both performance measures under the 2018 PSUs. Since threshold performance was not achieved, none of the shares underlying the 2018 PSUs were earned by our named executive officers. Actual performance for the completed three-year performance period is summarized in the table below.

      Average 3-Year Growth Rates  Actual 3-Year
Growth Rate
   

Performance Measure

  Weight  Threshold  Target  Maximum  Payout

Constant Currency Revenue Growth

  60%  6.3%  6.8%  7.3%  4.06%  0%

Payout Range

    1%  100%  200%    

Earnings Per Share Growth

  40%  12.9%  15.2%  17.3%  12.0%  0%

Payout Range

    1%  100%  200%    

Our Equity Grant Practices

Stock options, restricted stock units and restrictedperformance stock units granted under our equity incentive compensation program are granted in the first quarter of each year, effective on the third business day after we announce our financial results for the preceding year. Our stock options have an exercise price equal to the closing price of our common stock on the effective date of grant and generally vest in equal annual increments on the first three anniversaries of the effective date of grant. ToOur restricted stock units generally vest on the third anniversary of the date of grant and, to the extent that they vest, the performance stock units granted in 2020 to our named executive officers in 2018 willalso vest on February 27, 2021, which is the third anniversary of our 2018 annual grantsthe date of stock options and restricted stock units.grant. We believe that these vesting terms provide our

executives with a meaningful incentive for continued employment. The Board has delegated to Mr. Kelly, as the sole member of theNon-Executive Equity Awards Committee, the authority to grant equity awards to employees who are not executive officers and who do not otherwise report to the Chief Executive Officer. TheThese equity awards may be granted only in connection with commencement of employment, promotions to positions eligible to receive equity awards or recognition of performance for employees eligible to receive equity awards under guidelines approved by the Compensation Committee.

Personal Benefits

We provide our named executive officers with personal benefits that we believe are appropriate as part of a competitive compensation package designed to attract and retain highly skilled executives. The personal benefits provided to our named executive officers principally consist of a company automobile or automobile allowance, reimbursement for financial planning services, term life insurance coverage and executive physical examinations. In addition, we provide to Mr. Kelly personal use of our corporate aircraft for up to a maximum of 50 hours per year, provided that our incremental cost for providing such personal aircraft use may not exceed $190,000. We also provide to Mr. Powell personal use of our corporate aircraft for up to a maximum of 25 hours per year, provided that our incremental cost for providing such personal aircraft use may not exceed $95,000. Messrs. Kelly and Powell are each fully responsible for personal income tax liability associated with personal use of our corporate aircraft, and we do not provide tax assistance with respect to this imputed income (i.e., no“gross-ups”).

Additional information regarding personal benefits for our named executive officers is provided in the Summary Compensation Table and the accompanying footnotes. We periodically review the levels of perquisites and other personal benefits provided to our named executive officers and may make changes as we deem appropriate.

ONGOING AND POST-EMPLOYMENT ARRANGEMENTS

We have several plans and agreements addressing compensation for our named executive officers that accrue value as the executive continues to work for us, provide special benefits upon certain types of termination events and provide retirement benefits. These plans and agreements were designed to be a part of a competitive compensation package that encourage our executives to remain employed by us. Not all plans apply to each named executive officer, and the participants are indicated in the discussion below.

Executive Severance Arrangements

The severance agreements we have entered into with each of Messrs. Kelly, Powell, Leyden and Hicks provide payments and other benefits to the named executive officer if we terminate his employment for any reason other than death, disability or “cause” (as defined in the severance agreements) or if he terminates employment for “good reason” (as defined in the severance agreements), except in circumstances covered by the change in control agreements described below. The severance compensation for each executive officer consists of continued payment of the executive’s base salary during a “severance compensation period” (as defined in the severance agreements) following termination of 24 months for each of Messrs. Kelly and Powell, and nine to 12 months for each of Messrs. Leyden and Hicks, based on the length of his service. Under these agreements, in the event the executive is terminated before the last day, but after the completion of at least six months, of a performance period, the executive also may receive payment of apro-rated amount of the annual incentive award the executive would have been entitled to receive for the year in which his employment terminated (the“pro-rated payment”); for this purpose, target performance will be assumed with respect to any individual performance component. The agreements also provide the executive with continued health, life and accident insurance for up to the full severance compensation period, as well as certain additional benefits.

Ms. Boylan,

Mr. Winters, an Irish national, is subject to a contract of employment with us that reflects Irish compensation practices. Under the contract, we generally are required to provide herhim with six months prior notice of termination of herhis employment (the “notice period”), and we may choose to relieve herhim of herhis employee duties during the notice period while continuing to provide salary and contractual benefits to her.him. Our severance agreement with Ms. BoylanMr. Winters provides that, under circumstances similar to those specified in the other named executive officers’ severance agreements, we will continue to provide herhim base salary during a “severance compensation period” of 9nine to 12 months; however, unlike the provisions of the other named executive officers’ severance agreements, her severance agreement does not cover termination for disability, herhis severance compensation period begins on the date specified in the notice of termination under her contract of employment, and the severance compensation period under her severance agreement is reduced by the term of the notice period. If applicable, Ms. BoylanMr. Winters also is eligible to receive apro-rated payment payment of herhis annual incentive award for a performance period if shehe receives herhis notice of termination before the last day but after completion of at least six months of the performance period; for this purpose, target performance will be assumed with respect to any individual performance component. Ms. Boylan’sMr. Winters’ severance agreement also provides for continued health, life and accident insurance for up to the full severance compensation period, as well as certain additional benefits.

We believe that these severance arrangements provide a competitive benefit that enhances our ability to retain capable executive officers. See “Potential Payments Upon Termination or Change in Control” below for additional information regarding the terms of the severance agreements.

Mr. Kennedy’s severance arrangement with us, which is similar to Ms. Boylan’s, will no longer be in effect after his retirement on March 31, 2019.

Change in Control Arrangements

We have change in control agreements with each of the named executive officers, which provide for payments and other benefits to the executive if we terminate the executive’s employment for any reason other than disability or “cause” (as defined in the change in control agreements), or if the executive terminates employment for “good reason” (as defined in the change in control agreements), in each case within two years following a change in control. Such payments include, among other things, payment of the executive’s base salary for a specified period (three years for Mr. Kelly, two years for Mr. Powell, and 18 months for Mr. Leyden, Mr. Hicks and Ms. Boylan)Mr. Winters) following termination (or, in the case of Ms. Boylan,Mr. Winters, following the issuance of a notice of termination, subject to reduction if shehe receives certain benefits under herhis contract of employment or under Irish law). In

addition, such payments include specified multiples (generally, three times for Mr. Kelly, two times for Mr. Powell, and 1.5 times for Mr. Leyden, Mr. Hicks and Ms. Boylan)Mr. Winters) of the target bonus that would be payable under any company cash bonus plan in the year following termination (in the case of Ms. Boylan,Mr. Winters, the target bonus that would be payable in the year following the year in which herhis notice of termination is given). The agreements also provide for apro-rated target target bonus for the portion of the ongoing performance period under a company cash bonus plan that elapsed prior to the executive’s termination (or, in the case of Ms. Boylan,Mr. Winters, prior to the date herhis notice of termination is given). The agreements also provide to the executive continued health insurance for up to the period described above during which base salary will continue to be paid.

For a more detailed discussion of the change in control agreements, including a listing of additional payments and other benefits under the agreements, see “Potential Payments Upon Termination or Change in Control,” below. We do not provide tax“gross-ups” in connection with our change of control arrangements.

We entered into the change in control arrangements so that our executives can focus their attention and energies on our business during periods of uncertainty that may occur due to a potential change in control. In addition, we want our executives to support a corporate transaction involving a change in control that is in the best interests of our stockholders, even though the transaction may have an effect on the executive’s continued employment with us. We believe these arrangements provide an important incentive for our executives to remain with us.

Mr. Kennedy’s change in control arrangement with us, which is similar to Ms. Boylan’s, will no longer be in effect after his retirement on March 31, 2019.

Retirement Benefits

We provide certain retirement benefits to our executive officers that also are offered to our other employees. In addition, we maintain certain supplemental plans for our executives that are intended to

promote tax efficiency and replace the benefit opportunities lost due to regulatory limits on broad-basedtax-qualified plans.

Deferred Compensation Plan

We maintain a Deferred Compensation Plan, which is anon-qualified plan under which U.S.-based executives may defer specified amounts of their salary and compensation under the annual incentive compensation program. Salary deferral elections are made annually by eligible executives in respect of salary amounts to be earned in the following year. Deferral elections with regard to a cash incentive award are made by executives no later than six months prior to the end of the performance period applicable to the award. Participants may direct the investment of deferred amounts into a fixed interest fund or one or more notional funds, including a notional Teleflex stock fund. Executives also may defer receipt of shares upon vesting of restricted stock unit awards. Each of our named executive officers, other than Mr. Kennedy and Ms. Boylan,Winters, is eligible to participate in the Deferred Compensation Plan. Mr. Kennedy and Ms. Boylan participateWinters participates in a different plan, governed by Irish law, under which we provide contributions of 10 to 12 percent of base salary, depending upon the level of their respectivehis contributions under the plan.

In addition, the named executive officers, other than Ms. Boylan and Mr. Kennedy,Winters, are eligible to receive a company matching contribution of up to three percent of their annual cash compensation with respect to amounts they defer into the Deferred Compensation Plan. We also credit each named executive officer’s Deferred Compensation Plan account with an amount equal to a specified percentage of his annual cash compensation (five percent for Messrs. Kelly and Powell and three percent for Mr. Leyden and Mr. Hicks), less the maximum matching contribution the participant was eligible to receive under our 401(k) Plan.

See the Nonqualifiednarrative and table under “Nonqualified Deferred Compensation – 2018 table— 2020” for additional information.

Defined Benefit Arrangements

Through 2008, we provided retirement benefits primarily through a combination of defined benefit and defined contribution arrangements. The defined benefits principally were provided under the Teleflex Incorporated Retirement Income Plan, or “TRIP,” which was a tax qualified defined benefit plan designed to provide benefits to all salaried employees following retirement based upon a formula relating to years of service and annual compensation. Effective December 31, 2008, no further benefits are accrued under the TRIP. Mr. Leyden accrued benefits under the TRIP prior to December 31, 2008. No other named executive officer participated in the TRIP. See the Pensionnarrative and table under “Pension Benefits – 2018 table2020” and accompanying narrative, andthe discussion under “Potential Payments Upon Termination or Change in Control” for additional information.

TAX CONSIDERATIONS

Section 162(m) of the Internal Revenue Code (“Section 162(m)”) generally places a $1 million limitation on the deductibility of compensation paid by a publicly held company to certain of its executive officers. For tax years beginning prior to January 1, 2018 (and specifiedpre-existing contractual arrangements that provide for payment in 2018 and subsequent years, as described below), certain compensation is exempt from this deduction limitation if it meets the requirements of “performance-based compensation” under Section 162(m). In setting compensation prior to 2018, we structured our annual incentive program and stock options in a manner intended to qualify for this exemption.

As part of federal tax reform legislation that was enacted in December 2017, commonly referred to as the Tax Cuts and Jobs Act (the “TCJA”), the performance-based compensation exemption under Section 162(m) was eliminated for tax years commencing after December 31, 2017. The TCJA also expanded the number of executive officers who are subject to the deductibility limit. As a result, beginning in 2018, all compensation we pay to specified executive officers is subject to the deductibility limit, subjectlimit. The deductibility of stock-based compensation is uncertain at the time of grant due to payments under certain “written binding contracts”the fact that such determination is made subsequent to the grant date and is based on the income of such executive officers in effect on November 2, 2017, as described below.those subsequent periods. Nevertheless, as was the case in previous years, our principal consideration in authorizing compensation for our named executive officers is whether we believe such compensation facilitates the achievement of the objectives described above under “Executive Compensation Overview – Compensation Objectives.” Accordingly, we believe it is important to retain the flexibility to compensate executives in a manner designed to meet these objectives, even if such compensation is potentially not deductible for tax purposes.

The TCJA provides that its elimination of the performance-based compensation exemption under Section 162(m) does not apply with respect to compensation under a “written binding contract” that was in effect on November 2, 2017 and is not materially modified thereafter. We believe that compensation expense we incur with respect to the exercise of stock options and, under certain limited circumstances, restricted stock units granted prior to November 2, 2017 will continue to be deductible under applicable regulations. However, due to uncertainties in the interpretation and implementation of the changes to Section 162(m) under the TCJA, including the scope of the regulatory relief for thesepre-existing arrangements, we can offer no assurance regarding the extent to which, if any, compensation payable in 2018 and subsequent years underpre-existing arrangements with covered employees will be deductible.

CLAWBACK POLICY

Effective February 19, 2019,Under our Policy Regarding Recoupment of Executive Incentive-Based Compensation, the Board approved a clawback policy under whichmay, to the Board mayextent permitted by governing law, direct us to recover or cancel all or a portion of any incentive-based compensation awarded to any of our current or former executive officers (including,(defined to include, for this purpose, any current or former chief accounting officer) based upon the achievement of certain financial results if:

 

the financial results upon which the award or payout was based were subsequently the subject of an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws;

 

the current or former executive officer engaged in fraud, willful misconduct or gross negligence that was a significant contributing factor in causing the restatement; and

 

a lower award would have been made to the current or former executive officer based upon the restated financial results.

The amount of incentive-based compensation that we may seek to recover is, to the extent permitted by applicable law and subject to the discretion of the Board, the amount received by the current or former executive officer during the three-year period preceding the date on which we are required to prepare an accounting restatement that is in excess of the amount that the current or former executive officer would have received under the accounting restatement.

In determining whether to require a current or former executive officer to reimburse us or forfeit an award, and, if required, the amount of any such reimbursement or forfeiture, the Board may take into account such considerations as it deems appropriate. The Board also may delegate one or more of its duties or powers under the policy to one or more committees of the Board consisting solely of independent directors.

Any recoupment under the policy will be in addition to, and will not preclude, any other remedies that may be available to the Company.Teleflex.

STOCK OWNERSHIP GUIDELINES

We maintain stock ownership guidelines for our named executive officers and other executives to further align the interests of management with those of our stockholders and to further encourage long-term performance. The ownership guidelines are expressed in terms of stock ownership value, which consists of the value of common stock owned by the executive and members of his or her immediate family who reside with the executive, and the value attributable to shares in our 401(k) plan, restricted stock units and a portion of stock options held by the executive (described below), as a multiple of that executive’s base salary, as follows:

 

Position

  Required Stock Ownership Value
(as a multiple of base salary)

Chief Executive Officer

  5 x base salary

Other Executive Officers

  2 x base salary

Each of our executive officers has until five years after the date of his or her appointment or promotion to an executive officer position to satisfy the required stock ownership value. The guidelines applicable to each of our current executive officers at December 31, 2018,2020, and the executive officer’s progress towards achieving the required stock ownership value, are shown on the following table:

 

Name

  Applicable
Base Salary(1)
   Required Stock
Ownership Value
   Stock Ownership
Value at 12/31/2018(2)
   Applicable
Base Salary(1)
  Required Stock
Ownership Value
  Stock Ownership
Value at 12/31/2020(2)

Liam J. Kelly

   $850,000    $4,250,000    $15,080,000    $920,000   $4,600,000   $32,101,000

Thomas E. Powell

   $539,620    $1,079,240    $8,861,000    $578,040   $1,156,080   $12,090,000

James J. Leyden

   $354,780    $709,560    $6,838,000    $376,380   $ 752,760   $9,895,000

Cameron P. Hicks

   $321,930    $643,860    $3,907,000    $344,850   $ 689,700   $5,416,000

Karen T. Boylan

   $259,580    $519,160    $1,728,000 

James Winters

   $378,131   $ 756,262   $543,000

 

 (1)

Applicable base salary refers to the base salaries in effect on December 31, 2018.2020. We pay Ms. Boylan’sMr. Winters’ cash compensation in euros. The applicable base salary for Ms. BoylanMr. Winters was converted to U.S. dollars using the exchange rate in effect as of December 31, 20182020 of 0.87370.815291 euros per dollar.

 

 (2)

Stock ownership value is calculated based on the number of shares owned by the executive or members of his or her immediate family residing in the same household, shares held for the executive’s account in our 401(k) plan and restricted stock units held by the executive, multiplied by the closing market price of a share of our common stock on December 31, 2018,2020, as reported by the New York Stock Exchange. In addition, stock ownership value includesone-half of the aggregate amount by which shares underlying vested,“in-the-money” stock options held by the executive, multiplied by the closing stock price of a share of our common stock on December 31, 2018,2020, exceeds the aggregate exercise price of those options.

2018PLEDGING AND HEDGING POLICIES

We have a policy that prohibits our directors and executive officers, as well as certain other individuals who may be designated from time to time, from (i) purchasing Teleflex securities on margin, or borrowing against any account in which Teleflex securities are held, or pledging Teleflex securities as collateral for a loan, and (ii) trading in options, warrants, puts and calls or similar instruments on Teleflex’s securities or selling such securities “short,” as well as from engaging in any transactions (including variable forward contracts, equity swaps, collars and exchange funds) that are designed to hedge or offset any decrease in the market value of Teleflex’s equity securities.

2020 STOCKHOLDER ADVISORY VOTE ON EXECUTIVE COMPENSATION

At our 20182020 annual meeting, our stockholders approved, on an advisory basis, the compensation paid to our named executive officers, as disclosed under the SEC’s compensation disclosure rules, including the compensation discussion and analysis, the compensation tables and any related materials disclosed in the proxy statement for the 20182020 annual meeting. The stockholder vote in favor of named executive officer compensation totaled approximately 96.794.7 percent of all votes cast, including abstentions. We considered the results of the advisory vote and determined that, in light of this strong stockholder support, no revisions to our executive officer compensation program need be made in response to the vote.

COMPENSATION COMMITTEE REPORT

The Compensation Committee of Teleflex has reviewed and discussed with management the Compensation Discussion and Analysis. Based on this review and discussion, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement and, through incorporation by reference, in Teleflex’s Annual Report onForm 10-K for the year ended December 31, 2018.2020.

 

  COMPENSATION COMMITTEE
GEORGE BABICH, JR., CHAIR  
ANDREW A. KRAKAUER    STUART A. RANDLE

CEO PAY RATIO

SEC regulations require that we provide a comparison of the annual total compensation of Liam J. Kelly, our Chief Executive Officer in 2018,2020, to the median of the annual total compensation of our employees other than Mr. Kelly. For purposes of providing the comparison, in accordance with SEC regulations, we identified a “median employee” and compared Mr. Kelly’s annual total compensation to that of the median employee. For 2018,2020, our last completed fiscal year:

 

Mr. Kelly’s annual total compensation was $6,108,486.$6,328,349.

 

Our median employee’s annual total compensation was $43,225.$48,067.

 

The ratio of Mr. Kelly’s annual total compensation to our median employee’s annual total compensation was 141132 to 1.

SEC rules allow us to select a methodology for identifying our median employee in a manner that is most appropriate based on our size, organizational structure and compensation plans, policies and procedures. The methodology that we used to identify the median employee is described below. Annual total compensation is calculated in the same manner as the amount set forth in the “Total” column in the Summary Compensation Table. While, as explained below, the methodology involves several assumptions and adjustments, we believe the pay ratio information set forth above constitutes a reasonable estimate, calculated in a manner consistent with applicable SEC regulations.

Because other companies may use different methodologies to identify their median employees, the pay ratio set forth above may not be comparable to the pay ratios used by other companies.

Methodology

Date Used to Determine Employee Population and Median Employee

For purposes of identifying the median employee in 2020, we selected October 1, 20182020 to be the date as of which we would determine our employee population.

Composition of Employee Population

We determined that, as of October 1, 2018,2020, we had 14,11614,185 employees globally. Of that amount, 3,6093,854 were U.S. employees and 10,50710,331 werenon-U.S. employees. To simplify the determination of the median employee and as permitted by SEC regulations, we excluded 636688 employees (approximately 4.5%4.8% of our employees) located in 21 countries, comprising all employees in those countries, as set forth in the following table:

 

Country No. of Employees

Austria

 3635

Brazil

 47

Canada

 2832

Chile

 56

Colombia

 512

Greece

 28

Israel

129

Italy

 8999

Japan

 7280

South Korea

 2432

Netherlands

 2125

New Zealand

 79

Poland

 1615

Portugal

4

Country No. of Employees

Portugal

4

Singapore

 8778

Slovakia

 32

South Africa

 4744

Spain

 6568

Switzerland

 12

Taiwan

 515

Thailand

11

United Kingdom

 7773

Total

 636688

After excluding the employees listed above, we determined the identity of our median employee from a population of 13,48013,497 employees, including 3,6093,854 U.S. employees and 9,8719,643 non-U.S. employees.

Pay Data Used

To identify the median employee, we derived compensation information from our payroll records covering the12-month period from October 1, 20172019 to September 30, 2018.2020. Our payroll data includes cash compensation for each employee, including base pay, bonuses, commissions and overtime pay. We converted the amount of compensation paid tonon-U.S. employees to U.S. dollars using average foreign currency exchange rates for the period from October 1, 20172019 to September 30, 2018.2020. We also annualized compensation data for permanent full-time employees hired during the period from October 1, 20172019 to September 30, 2018.2020.

The employee whose cash compensation was the median of the cash compensation paid to the employee population, determined as described above, and after giving effect to the cost of living adjustment described below, is the median employee for purposes of the comparison to Mr. Kelly’s annual total compensation.

Cost of Living Adjustments

As part of the methodology we used to identify the median employee, we made cost of living adjustments to the compensation ofnon-U.S. employees to reflect the cost of living in the U.S., where Mr. Kelly resides. The cost of living adjustments were made through application of purchasing power parity conversion ratios that were obtained from numbeo.com, a public database of reported consumer prices and other statistics. We selected conversion ratios based upon the city closest to the facility in which our employees were employed. Because the median employee identified after application of the cost of living adjustment resides in the U.S., no cost of living adjustment was made with regard to the median employee’s compensation. Had we not made the cost of living adjustments with respect to ournon-U.S. employees, we would have had a different median employee, who works in the Czech RepublicMexico and whose annual total compensation would have been $19,642.$19,607. As a result, the ratio of Mr. Kelly’s compensation to the median employee’s compensation would have been 311323 to 1.

SUMMARY COMPENSATION TABLE – 20182020

The following table sets forth compensation information with respect to the persons who served as our Chief Executive Officer and Chief Financial Officer, and with respect to each of our fourfive other most highly compensated executive officers during 2018 (including Mr. Kennedy, who ceased to be an executive officer in October 2018),2020, determined in accordance with SEC regulations. These individuals are referred to in this Proxy Statement as the “named executive officers.”

 

Name and Principal

Position

 Year Salary
(1)
 Bonus Stock
Awards
(2)
 Option
Awards

(3)
 Non-Equity
Incentive

Plan
Compensation
(4)
 Change in
Pension
Value and
Non-qualified
Deferred
Compensation
Earnings
(5)
 All Other
Compensation
(6)
 Total

Liam J. Kelly(7)
President and Chief
Executive Officer

   

2018

2017

2016

 

 

 

   

$845,669

$616,777

$580,538

 

 

 

   


 

 

 

   

$1,804,153

$630,055

$531,816

 

 

 

   

$2,012,595

$1,156,313

$1,002,540

 

 

 

   

$1,201,956

$692,952

$534,790

 

 

 

   


 

 

 

   

$244,113

$203,958

$146,295

 

 

 

   

$6,108,486

$3,300,055

$2,795,979

 

 

 

Thomas E. Powell
Executive Vice President
and Chief Financial Officer

   

2018

2017

2016


   

$535,387

$520,454

$504,618

 

 

 

   



   

$814,840

$472,448

$459,127

 

 

 

   

$908,906

$867,225

$866,872

 

 

 

   

$500,287

$548,187

$444,693

 

 

 

   

$864

 

 

 

   

$127,291

$109,158

$112,447

 

 

 

   

$2,887,575

$2,517,472

$2,387,757

 

 

 

James J. Leyden
Vice President, General
Counsel and Secretary

   

2018

2017

2016


   

$347,705

$321,931

$301,366

 

 

 

   



   

$414,277

$259,060

$231,815

 

 

 

   

$462,231

$475,522

$437,759

 

 

 

   

$193,381

$235,296

$141,642

 

 

 

   

$51

$10,282

$2,946

 

 

 

   

$35,243

$31,299

$30,665

 

 

 

   

$1,452,888

$1,333,390

$1,146,193

 

 

 

Cameron P. Hicks
Vice President, Global
Human Resources and
Employee Communications

   

2018

2017

2016


   

$317,803

$304,581

$297,149

 

 

 

   



   

$278,809

$174,079

$158,344

 

 

 

   

$310,978

$319,420

$299,063

 

 

 

   

$176,750

$171,099

$139,660

 

 

 

   


 

 

 

   

$44,734

$47,041

$39,176

 

 

 

   

$1,129,074

$1,078,349

$933,392

 

 

 

Thomas Anthony Kennedy(8)(9)
Senior Vice President,
Global Operations

   

2018

2017

2016


   

$329,446

$339,165

$280,870

 

 

 

   



   

$164,351

$194,857

$163,833

 

 

 

   

$321,367

$357,722

$309,177

 

 

 

   

$102,852

$140,474

$137,011

 

 

 

   


 

 

 

   

$67,593

$46,131

$39,118

 

 

 

   

$985,609

$1,078,349

$930,009

 

 

 

Karen T. Boylan(8)
Vice President, Global
Strategic Projects

   2018    $257,689        $127,810    $142,836    $143,317        $59,250    $730,902 

Name and Principal Position

 Year Salary
(1)
 Bonus
(2)
 Stock
Awards
(3)
 Option
Awards

(4)
 Non-Equity
Incentive

Plan
Compensation
(5)
 Change in
Pension
Value and
Non-qualified
Deferred
Compensation
Earnings
(6)
 All Other
Compensation
(7)
 Total

Liam J. Kelly
Chairman, President and Chief Executive Officer

   

2020

2019

2018

 

 

 

   

$943,404

$868,635

$845,669

 

 

 

   

$650,949

 

 

 

   

$1,975,833

$2,047,401

$1,804,153

 

 

 

   

$2,343,414

$2,407,030

$2,012,595

 

 

 

   

$216,983

$1,197,048

$1,201,956

 

 

 

   


 

 

 

   

$197,766

$262,644

$244,113

 

 

 

   

$6,328,349

$6,782,758

$6,108,486

 

 

 

Thomas E. Powell
Executive Vice President and Chief Financial Officer

   

2020

2019

2018


   

$594,287

$551,451

$535,387

 

 

 

   

$267,429

 

 

 

   

$818,224

$962,044

$814,840

 

 

 

   

$970,502

$1,131,010

$908,906

 

 

 

   

$89,143

$495,609

$500,287

 

 

 

   

$8,914

$4,618

$864

 

 

 

   

$128,458

$157,914

$127,291

 

 

 

   

$2,876,957

$3,302,646

$2,887,575

 

 

 

James J. Leyden(8)
Corporate Vice President, General Counsel and Secretary

   

2020

2019

2018


   

$387,150

$362,555

$347,705

 

 

 

   

$116,145

 

 

 

   

$377,425

$444,183

$414,277

 

 

 

   

$447,901

$522,036

$462,231

 

 

 

   

$38,715

$194,363

$193,381

 

 

 

   

$13,470

$20,337

$51

 

 

 

   

$35,419

$34,998

$35,243

 

 

 

   

$1,416,225

$1,578,472

$1,452,888

 

 

 

Cameron P. Hicks
Corporate Vice President and Chief Human Resources Officer

   

2020

2019

2018


   

$354,543

$328,989

$317,803

 

 

 

   

$106,363

 

 

 

   

$251,725

$295,933

$278,809

 

 

 

   

$298,576

$348,024

$310,978

 

 

 

   

$35,454

$177,405

$176,750

 

 

 

   


 

 

 

   

$47,450

$51,469

$44,734

 

 

 

   

$1,094,111

$1,201,820

$1,129,074

 

 

 

James P. Winters(9)
Corporate Vice President, Manufacturing and Supply Chain

   2020   $367,976    $26,649    $203,500    $241,580    $120,541        $64,685    $1,024,931 

 

(1)

The amounts shown in this column reflect the actual amount of base salary paid to the named executive officers. The amount of salary actually received in any year may differ from the named executive officer’s annual base salary amount due to the number of payroll periods in the year and the timing of changes in base salary. Messrs. Kelly, Powell and PowellHicks deferred $67,653$75,472, $29,714 and $26,769,$10,636, respectively, of their 20182020 salary into a deferral account under our Deferred Compensation Plan. See “Nonqualified Deferred Compensation – 2018”2020” for additional information.

 

(2)

The amounts shown in this column represent the discretionary bonuses awarded to the named executive officers in 2020. See section entitled “Impact on our Executive Compensation Program Relating to COVID-19 Pandemic” under “Compensation Discussion and Analysis – 2020 Compensation,” for additional information regarding the bonus awards. Messrs. Kelly and Powell deferred $65,095 and $106,972, respectively, of their 2020 discretionary bonus awards into a deferral account under our Deferred Compensation Plan. See “Nonqualified Deferred Compensation – 2020” for additional information.

(3)

The amounts shown in this column include the aggregate grant date fair value of the restricted stock units and performance stock units we granted to each of the named executive officers in 2018,2020, determined in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, “Compensation – Stock Compensation” (“ASC Topic 718”). A discussion of the assumptions used in calculating these values is included in Notes 1 and 1314 to the consolidated financial statements included in our Annual Report on Form10-K for the fiscal year ended December 31, 2018,2020, as filed with the SEC. See “Grants of Plan-Based Awards – 2018”2020” for additional information.

The grant date fair value of the performance stock units granted to the named executive officers, assuming (i) the target level of performance will be achieved and (ii) the maximum payout level of performance will be achieved, determined in accordance with ASC Topic 718, is set forth in the table below.

 

Name

  Grant Date Fair Value at
Target Payout ($)
   Grant Date Fair Value at
Maximum Payout ($)
   Grant Date Fair Value at
Target Payout ($)
  Grant Date Fair Value at
Maximum Payout ($)

Liam J. Kelly

   $775,084    $1,550,167    $869,584    $1,739,167 

Thomas E. Powell

   $350,010    $   700,020    $360,241    $   720,481 

James J. Leyden

   $177,991    $   355,981    $166,153    $   332,306 

Cameron P. Hicks

   $119,703    $   239,406    $110,648    $   221,296 

Karen T. Boylan

   $  54,876    $   109,751 

James P. Winters

   $  89,607    $   179,213 

 

(3)(4)

The amounts shown in this column represent the aggregate grant date fair value of the stock options we granted to each of the named executive officers in 2018,2020, determined in accordance with ASC Topic 718. A discussion of the assumptions used in

calculating these values is included in Notes 1 and 1314 to the consolidated financial statements included in our Annual Report on Form10-K for the fiscal year ended December 31, 2018,2020, as filed with the SEC. See “Grants of Plan-Based Awards – 2018”2020” for additional information.

(4)(5)

The amounts shown in this column represent the amounts we paid to each of the named executive officers under the Company’s 20182020 annual incentive program. See the section entitled “Annual Executive Incentive Compensation” under “Compensation Discussion and Analysis – 20182020 Compensation,” for additional information regarding the annual incentive awards. Messrs. Kelly and Powell deferred $21,698 and Hicks deferred $120,196, $50,029 and $17,675,$35,657, respectively, of their 2018non-equity2020 annual incentive plan compensationprogram awards into a deferral account under our Deferred Compensation Plan. See “Nonqualified Deferred Compensation – 2018”2020” for additional information.

 

(5)(6)

The amountsamount shown in this column with respect to Messrs.Mr. Powell and Leyden reflectreflects above-market interest earned by Messrs.Mr. Powell in 2020 in respect of deferred compensation under our Deferred Compensation Plan. The amount shown in this column with respect to Mr. Leyden reflects an increase of $13,225 in the present value of Mr. Leyden’s accumulated pension benefit in 2020 and $245 in above-market interest earned by Mr. Leyden in 20182020 in respect of deferred compensation under our Deferred Compensation Plan. See “Nonqualified Deferred Compensation – 2018” for additional information. The present value of Mr. Leyden’s accumulated pension benefit decreased by $12,325 in 2018; this decrease is not reflected in the table. See2020” and “Pension Benefits – 2018”2020” for additional information, including the present value assumptions used in the calculation of Mr. Leyden’s accumulated pension benefit.

 

(6)(7)

The amounts shown in this column consist of the components set forth in the table below, which include the matching contributions we made with respect to each named executive officer’s 401(k)defined contribution retirement plan account, the dollar value of life insurance premiums that we paid for the benefit of each named executive officer and perquisites provided to each named executive officer. With respect to Messrs. Kelly, Powell, Leyden and Hicks, the amounts shown in this column also include thenon-elective and (except with respect to Mr. Leyden) matching contributions we made with respect to their deferred compensation accounts under our Deferred Compensation Plan. The amounts set forth below with respect to the costs we incurred to provide the named executive officers with a company automobile are based either on the lease and insurance costs we incurred with respect to the vehicle used by the named executive officer, together with our reimbursement of the named executive officer’s fuel and maintenance costs (with respect to Messrs. Kelly and Powell), or based on the amount of our automobile allowance (with respect to Messrs. Leyden and Hicks and Kennedy and Ms. Boylan)Winters). The amount set forth below with respect to the costs we incurred to provide Messrs. Kelly and Powell with personal use of the company aircraft is calculated based upon our actual incremental cost to operate the aircraft, including the cost of fuel, trip-related maintenance, crew travel expenses,on-board catering, landing fees, trip-related hangar and parking costs and other variable costs.

 

Name

  Defined
Contribution
Plan
Company
Contributions(a)
   Deferred
Compensation
Plan
Company
Contributions
   Life
Insurance
Premiums
   Perquisites(b)   Defined
Contribution
Plan
Company
Contributions
   Deferred
Compensation
Plan
Company
Contributions
   Life
Insurance
Premiums
   Perquisites(a) 

Mr. Kelly

  $13,750   $110,702   $4,896   $114,765   $14,250   $116,023   $4,896   $62,597 

Mr. Powell

  $13,750   $73,907   $2,050   $37,584   $14,250   $55,551   $3,299   $55,358 

Mr. Leyden

  $13,750   $9,565   $1,325   $10,603   $14,250   $8,179   $2,154   $10,836 

Mr. Hicks

  $13,750   $16,167   $1,214   $13,603   $14,250   $17,396   $1,968   $13,836 

Mr. Kennedy

  $45,744       $843   $21,006 

Ms. Boylan

  $37,599       $645   $21,006 

Mr. Winters

  $40,782       $1,189   $22,714 

 

 (a)

The amounts shown in this column with respect to Mr. Kennedy and Ms. Boylan include $10,398 and $5,416, respectively, in contributions that were made to correct a shortfall in the contributions made by the Company with respect to Mr. Kennedy’s and Ms. Boylan’s defined contribution accounts in 2017.

(b)

The amounts shown in this column include the following benefits: (a) for Mr. Kelly, $89,504$31,443 in incremental costs we incurred to provide him with personal use of our aircraft, $24,858$$29,228 in incremental costs we incurred to provide him with use of a company automobile, $1,290 in costs we incurred in connection with financial planning services and lesser amounts in respect of de minimis attendee gifts provided to him in connection with our corporate retreats for senior managers; (b) for Mr. Powell, $23,456$25,454 in incremental costs we incurred to provide him with personal use of our aircraft, $13,725$26,268 in incremental costs we incurred to provide the use of a company automobile, $3,000 in incremental costs we incurred in connection with an executive health exam and lesser amounts in respect of de minimis attendee gifts provided to him in connection with our corporate retreats for senior managers; (c) for Mr. Hicks, an automobile car allowance of $10,200, $3,000 in incremental costs we incurred in connection with an executive health exam and lesser amounts in respect of de minimis attendee gifts provided to him in connection with our corporate retreats for senior managers; and (d) for Messrs.Mr. Leyden and Kennedy and Ms. Boylan,Winters, an automobile allowance of $10,200 $20,603 and $20,603,$22,078, respectively, and lesser amounts in respect of de minimis attendee gifts provided to them in connection with our corporate retreats for senior managers.

 

(7)(8)

In connection with his retirement, Mr. Kelly was appointedLeyden served as our Corporate Vice President, General Counsel and Secretary until December 31, 2020. Thereafter, he has served in a senior advisor role to assist with the positiontransition of Presidenthis duties and Chief Executive Officer, effective January 1, 2018.will retire from the company on March 31, 2021.

 

(8)(9)

Mr. Winters was initially designated as an executive officer in February 2020. We pay Mr. Kennedy’s and Ms. Boylan’sWinters’ cash compensation in euros. The amounts reported for Mr. Kennedy and Ms. Boylanhim in the “Salary,” “Bonus,”“Non-Equity Incentive Plan Compensation” and the “All Other Compensation” columns (with respect to amounts included in that column other than amounts in the “Stock Awards” and “Option Awards” column) were converted to U.S. dollars using the exchange rate in effect as of December 31 of the year presented. The exchange rate used for 2020 was 0.8736700.815291 euros per dollar for 2018, 0.834696 euros per dollar for 2017 and 0.952754 euros per dollar for 2016.

(9)

Mr. Kennedy ceased to be an executive officer in October 2018, but continued to be an employee of Teleflex (he will retire on March 31, 2019). The amounts shown in the table include compensation he received as an employee throughout 2018.dollar.

GRANTS OF PLAN-BASED AWARDS – 20182020

The following table sets forth information regarding our grants of plan-based awards to the named executive officers during the fiscal year ended December 31, 2018.2020.

 

Name

 Grant
Date
  Approval
Date
  

 

Estimated Possible Payouts

UnderNon-Equity Incentive
Plan Awards(1)

  

 

Estimated Possible Payouts

Under Equity Incentive
Plan Awards(2)

  All Other
Stock
Awards:
Number
of

Shares
of

Stock or
Units(3)
  All Other
Option
Awards:
Number of
Securities

Underlying
Options(4)
  Exercise
or Base
Price of

Option
Awards(5)
  Grant Date
Fair Value
of Stock
and Option
Awards(6)
 
 Threshold  Target  Maximum  Threshold  Target  Maximum 

L. Kelly

  

2/20/201818/2020

2/27/201825/2020

2/27/201825/2020

6/22/20182/25/2020

 

 

 

 

  

2/20/201818/2020

2/20/201818/2020

2/20/201818/2020

6/22/20182/18/2020

 

 

 

 

  

$243,130271,229

 

 

 

 

  

$972,5191,084,915

 

 

 

 

  

$1,945,0382,169,830

 

 

 

 

  


2024

 

 

 

 

  


2,7262,397

 

 

 

 

  


6,8155,993

 

 

 

 

  


4,1203,215

 

 

 

 

  


34,67631,371

 

 

 

 

  


$253.72348.11

 

 

 

 

  


$2,012,5952,343,414

$1,029,0701,106,249

$775,084869,584

 

 

 

 

T. Powell

  

2/19/201817/2020

2/27/201825/2020

2/27/201825/2020

6/22/20182/25/2020

 

 

 

 

  

2/19/201817/2020

2/19/201817/2020

2/19/201817/2020

6/22/20182/17/2020

 

 

 

 

  

$100,385111,429

 

 

 

 

  

$401,541445,716

 

 

 

 

  

$803,082891,432

 

 

 

 

  


910

 

 

 

 

  


1,231993

 

 

 

 

  


3,0782,483

 

 

 

 

  


1,8611,331

 

 

 

 

  


15,66012,992

 

 

 

 

  


$253.72348.11

 

 

 

 

  


$908,906970,502

$464,830457,984

$350,010360,241

 

 

 

 

J. Leyden

  

2/19/201817/2020

2/27/201825/2020

2/27/201825/2020

6/22/20182/25/2020

 

 

 

 

  

2/19/201817/2020

2/19/201817/2020

2/19/201817/2020

6/22/20182/17/2020

 

 

 

 

  

$39,11748,394

 

 

 

 

  

$156,467193,575

 

 

 

 

  

$312,934387,150

 

 

 

 

  


5

 

 

 

 

  


626458

 

 

 

 

  


1,5651,145

 

 

 

 

  


946614

 

 

 

 

  


7,9645,996

 

 

 

 

  


$253.72348.11

 

 

 

 

  


$462,231447,901

$236,286211,271

$177,991166,153

 

 

 

 

C. Hicks

  

2/19/201817/2020

2/27/201825/2020

2/27/201825/2020

6/22/20182/25/2020

 

 

 

 

  

2/19/201817/2020

2/19/201817/2020

2/19/201817/2020

6/22/20182/17/2020

 

 

 

 

  

$35,75344,318

 

 

 

 

  

$143,011177,272

 

 

 

 

  

$286,022354,544

 

 

 

 

  


3

 

 

 

 

  


421305

 

 

 

 

  


1,053763

 

 

 

 

  


637410

 

 

 

 

  


5,3583,997

 

 

 

 

  


$253.72348.11

 

 

 

 

  


$310,978298,576

$159,106141,077

$119,703110,648

 

 

 

 

T. Kennedy


2/19/2018

2/27/2018

2/27/2018



2/19/2018

2/19/2018

2/19/2018



$37,063



$148,251



$296,502













658




5,537




$253.72




$321,367

$164,351


K. BoylanJ. Winters

  

2/19/201817/2020

2/27/201825/2020

2/27/201825/2020

6/22/20182/25/2020

 

 

 

 

  

2/19/201817/2020

2/19/201817/2020

2/19/201817/2020

6/22/20182/17/2020

 

 

 

 

  

$28,99045,997

 

 

 

 

  

$115,960183,988

 

 

 

 

  

$231,920367,976

 

 

 

 

  


2

 

 

 

 

  


193247

 

 

 

 

  


483618

 

 

 

 

  


292331

 

 

 

 

  


2,4613,234

 

 

 

 

  


$253.72348.11

 

 

 

 

  


$142,836241,580

$72,934113,894

$54,87689,607

 

 

 

 

 

(1)

Represents the threshold, target and maximum payments the named executive officer was eligible to receive based upon achievement of the performance measures under our 20182020 annual incentive program. The amounts we actually paid to each named executive officer under the program are reported in the“Non-Equity Incentive Plan Compensation” column of the Summary Compensation Table. See the section entitled “Annual Executive Incentive Compensation” under “Compensation Discussion and Analysis – 20182020 Compensation,” for additional information regarding the annual incentive awards.

 

(2)

Represents the threshold, target and maximum number of shares the named executive officer is eligible to receive based upon achievement of the performance measures with respect to performance stock units granted to each named executive officer under our 2014 Stock Incentive Plan. See the section entitled “Equity Incentive Compensation – Performance Stock Units” under “Compensation Discussion and Analysis – 20182020 Compensation” for additional information regarding the performance stock units. The threshold amount assumes the maximum reduction in PSUs underlying the PSU award after application of the RTSR Modifier, and the maximum amount assumes the maximum increase in PSUs underlying the PSU award after application of the RTSR Modifier.

 

(3)

The amounts shown in this column reflect the number of shares of our common stock underlying restricted stock units granted to each named executive officer under our 2014 Stock Incentive Plan. All of the restricted stock units granted to the named executive officers will vest on the third anniversary of the grant date. Upon vesting, the restricted stock units are settled by the delivery to a named executive officer of shares of our common stock on the basis of one share of common stock for each restricted stock unit held by the named executive officer, unless the named executive offer elects to defer receipt of the shares. See the section entitled “Equity Incentive Compensation” under “Compensation Discussion and Analysis – 20182020 Compensation,” for additional information regarding the restricted stock units.

 

(4)

The amounts shown in this column reflect the number of shares of our common stock underlying options we granted to each named executive officer under our 2014 Stock Incentive Plan. The options vest in three equal annual installments beginning on the first anniversary of the grant date. See the section entitled “Equity Incentive Compensation” under “Compensation Discussion and Analysis – 20182020 Compensation,” for additional information regarding the stock option awards.

 

(5)

Stock options awarded under our 2014 Stock Incentive Plan have an exercise price equal to the closing market price of our common stock on the effective date of grant.

 

(6)

The amounts shown in this column represent the aggregate grant date fair value of the restricted stock units, performance stock units and option awards granted in 2018,2020, determined in accordance with ASC Topic 718. A discussion of the assumptions used in calculating these values is included in Notes 1 and 1314 to the consolidated financial statements included in our Annual Report on Form10-K for the fiscal year ended December 31, 2018,2020, as filed with the SEC.

OUTSTANDING EQUITY AWARDS AT FISCALYEAR-END – 20182020

The following table sets forth information with respect to the outstanding stock options, unvested restricted stock units and unvested performance stock units held by each named executive officer on December 31, 2018.2020.

 

Name

 Grant
Date
  Option Awards Stock Awards  Grant
Date
   Option Awards Stock Awards 

 

Number of
Securities
Underlying
Unexercised
Options

 

 

Number of
Securities
Underlying
Unexercised
Options

  Option
Exercise
Price
 Option
Expiration
Date
 Number of
Shares or
Units of
Stock
That Have
Not

Vested(2)
 Market
Value of
Shares or
Units of
Stock
That Have
Not
Vested(3)
 Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested
(4)(5)
 Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That Have
Not
Vested(5)
 

 

Number of
Securities
Underlying
Unexercised
Options

   

 

Number of
Securities
Underlying
Unexercised
Options

  Option
Exercise
Price
 Option
Expiration
Date
 Number of
Shares or
Units of
Stock

That Have
Not

Vested(2)
 Market
Value of
Shares or
Units of
Stock
That Have
Not
Vested(3)
 Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested
(4)(5)
 Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That Have
Not
Vested(5)
 
Exercisable Unexercisable(1)  Exercisable   Unexercisable(1) 

L. Kelly

 6/22/2018                    2,726  $704,616  2/25/2020                      2,397  $986,533 
 2/25/2020                3,215  $1,323,198       
 2/25/2020        31,371  $348.11  2/25/2030             
 2/26/2019                      3,014  $1,240,472 
 2/27/2018              4,120  $1,064,938        2/26/2019                3,960  $1,629,817       
 2/27/2018     34,676  $253.72  2/27/2028              2/26/2019    11,757    23,516  $288.38  2/26/2029             
 2/28/2017              3,366  $870,044        6/22/2018                      2,726  $1,121,940 
 2/28/2017  9,721  19,442  $191.18  2/28/2027              2/27/2018                4,120  $1,695,668       
 5/3/2016              349  $90,210        2/27/2018    23,117    11,559  $253.72  2/27/2028             
 5/3/2016  2,244  1,122  $157.46  5/3/2026              2/28/2017    29,163      $191.18  2/28/2027             
 3/1/2016              3,398  $878,315        5/3/2016    3,366      $157.46  5/3/2026             
 3/1/2016  22,140  11,071  $144.79  3/1/2026              3/1/2016    33,211      $144.79  3/1/2026             
 5/5/2015  7,380     $123.04  5/5/2025              5/5/2015    7,380      $123.04  5/5/2025             
 2/25/2015  29,084     $121.00  2/25/2025              2/25/2015    29,084      $121.00  2/25/2025             
 4/1/2014  3,081     $107.47  4/1/2024              4/1/2014    3,081      $107.47  4/1/2024             
 2/26/2014  23,175     $101.12  2/26/2024              2/26/2014    23,175      $101.12  2/26/2024             
 3/14/2013  3,579     $82.26  3/14/2023              3/14/2013    3,579      $82.26  3/14/2023             
 2/26/2013  22,383     $78.62  2/26/2023              2/26/2013    22,383      $78.62  2/26/2023             
 6/25/2012  6,711     $59.96  6/25/2022              6/25/2012    6,711      $59.96  6/25/2022             
 2/28/2012  11,263     $59.75  2/28/2022              2/28/2012    11,263      $59.75  2/28/2022             

T. Powell

 6/22/2018                    1,231  $318,189  2/25/2020                      993  $408,689 
 2/27/2018              1,861  $481,031        2/25/2020                1,331  $547,800       
 2/27/2018     15,660  $253.72  2/27/2028              2/25/2020        12,992  $348.11  2/25/2030             
 2/28/2017              2,524  $652,404        2/26/2019                      1,416  $582,783 
 2/28/2017  7,290  14,582  $191.18  2/28/2027              2/26/2019                1,861  $765,932       
 3/1/2016              3,262  $843,162        2/26/2019    5,524    11,050  $288.38  2/26/2029             
 3/1/2016  21,254  10,628  $144.79  3/1/2026              6/22/2018                      1,231  $506,643 
 5/5/2015  4,613     $123.04  5/5/2025              2/27/2018                1,861  $765,932       
 2/25/2015  29,997     $121.00  2/25/2025              2/27/2018    10,440    5,220  $253.72  2/27/2028             
 2/26/2014  29,342     $101.12  2/26/2024              2/28/2017    21,872      $191.18  2/28/2027             
 3/1/2016    31,882      $144.79  3/1/2026             
 5/5/2015    4,613      $123.04  5/5/2025             
 2/25/2015    9,339      $121.00  2/25/2025             

J. Leyden

 6/22/2018                    626  $161,808  2/25/2020                      458  $188,499 
 2/27/2018              946  $244,522        2/25/2020                614  $252,704       
 2/27/2018     7,964  $253.72  2/27/2028              2/25/2020        5,996  $348.11  2/25/2030             
 2/28/2017              1,384  $357,736        2/26/2019                      654  $269,167 
 2/28/2017  3,997  7,996  $191.18  2/28/2027              2/26/2019              �� 859  $353,539       
 3/1/2016              1,647  $425,717        2/26/2019    2,550    5,100  $288.38  2/26/2029             
 3/1/2016  10,733  5,367  $144.79  3/1/2026              6/22/2018                      626  $257,643 
 2/25/2015  12,336     $121.00  2/25/2025              2/27/2018                946  $389,345       
 2/26/2014  5,513     $101.12  2/26/2024              2/27/2018    5,309    2,655  $253.72  2/27/2028             
 3/14/2013  402     $82.26  3/14/2023              2/28/2017    11,993      $191.18  2/28/2027             
 2/26/2013  1,832     $78.62  2/26/2023              3/1/2016    16,100      $144.79  3/1/2026             
 2/28/2012  2,513     $59.75  2/28/2022             
 3/1/2011  3,400     $57.78  3/1/2021             
 3/1/2010  3,200     $61.34  3/1/2020             
 3/2/2009  1,300     $46.12  3/2/2019             

 Grant
Date
  Option Awards Stock Awards 
 Number of
Securities
Underlying
Unexercised
Options
 Number of
Securities
Underlying
Unexercised
Options
  Option
Exercise
Price
 Option
Expiration
Date
 Number of
Shares or
Units of
Stock
That Have
Not

Vested(2)
 Market
Value of
Shares or
Units of
Stock
That Have
Not
Vested(3)
 Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested
(4)(5)
 Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That Have
Not
Vested(5)
 

Name

 Grant
Date
   Option Awards Stock Awards 

 

Number of
Securities
Underlying
Unexercised
Options

   

 

Number of
Securities
Underlying
Unexercised
Options

  Option
Exercise
Price
 Option
Expiration
Date
 Number of
Shares or
Units of
Stock

That Have
Not

Vested(2)
 Market
Value of
Shares
or Units
of Stock
That
Have Not
Vested(3)
 Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested
(4)(5)
 Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested(5)
 
 Grant
Date
  Exercisable Unexercisable(1)  Option
Exercise
Price
 Option
Expiration
Date
 Number of
Shares or
Units of
Stock
That Have
Not

Vested(2)
 Market
Value of
Shares or
Units of
Stock
That Have
Not
Vested(3)
 Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units or
Other
Rights
That
Have Not
Vested
(4)(5)
 Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights
That Have
Not
Vested(5)
  Exercisable   Unexercisable(1) 

C. Hicks

       2/25/2020                      305  td25,529 
             637  td64,652        2/25/2020                410  td68,744       
 2/27/2018     5,358  $253.72  2/27/2028              2/25/2020        3,997  $348.11  2/25/2030             
 2/28/2017              930  $240,386        2/26/2019                      436  $179,445 
 2/28/2017  2,685  5,371  $191.18  2/28/2027              2/26/2019                572  $235,418       
 3/1/2016              1,125  $290,790        2/26/2019    1,700    3,400  $288.38  2/26/2029             
 3/1/2016  7,332  3,667  $144.79  3/1/2026              6/22/2018                      421  $173,271 
 2/25/2015  9,227     $121.00  2/25/2025              2/27/2018                637  $262,170       
 2/26/2014  5,664     $101.12  2/26/2024              2/27/2018    3,572    1,786  $253.72  2/27/2028             
 4/8/2013  14,392     $85.54  4/8/2023              2/28/2017    8,056      $191.18  2/28/2027             
 3/1/2016    10,999      $144.79  3/1/2026             

T. Kennedy

 2/27/2018              658  $170,080       
 2/25/2015    9,227      $121.00  2/25/2025             
 2/26/2014    4,676      $101.12  2/26/2024             

J. Winters

 2/25/2020                      247  $101,658 
 2/27/2018     5,537  $253.72  2/27/2028              2/25/2020                331  $136,230       
 2/28/2017              1,041  $269,078        2/25/2020        3,234  $348.11  2/25/2030             
 2/28/2017     6,015  $191.18  2/28/2027              2/26/2019                427  $175,740       
 3/1/2016              1,164  $300,871        2/26/2019    1,071    2,143  $288.38  2/26/2029             
 3/1/2016     3,791  $144.79  3/1/2026              4/23/2018                205  $84,372       
 4/23/2018    1,152    577  $271.70  4/23/2028             

K. Boylan

 6/22/2018                    193  $49,887 
 2/27/2018              292  $75,476       
 2/27/2018     2,461  $253.72  2/27/2028             
 2/28/2017              427  $110,371       
 2/28/2017  1,233  2,467  $191.18  2/28/2027             
 3/1/2016              519  $134,151       
 3/1/2016  3,383  1,692  $144.79  3/1/2026             
 2/25/2015  5,616     $121.00  2/25/2025             
 7/28/2014  1,704                      
 2/26/2014  2,701     $101.12  2/26/2024             
 2/26/2013  2,149     $78.62  2/26/2023             

 

(1)

All stock options vest in three equal annual increments beginning on the first anniversary of the date of grant.

 

(2)

The outstanding restricted stock units fully vest on the third anniversary of the grant date.

 

(3)

The amounts set forth in this column represent the market value of the unvested restricted stock units held by the named executive officer based on a market price of $258.48$411.57 per share, which was the closing price of our common stock on December 31, 2018,2020, as reported by the New York Stock Exchange.

 

(4)

Subject to the actual level of performance achieved, performance stock units granted in (a) 2018 vested on February 27, 2021 and (b) 2019 and 2020 will vest on February 27, 2021.the third anniversary of the grant date.

 

(5)

Assumes that target performance is achieved with respect to the performance stock units, without application of the RTSR Modifier. If maximum performance is achieved (including the maximum increase in performance stock units after application of the RTSR Modifier), the number of shares (and market value of such shares) to be issued following vesting of performance stock units is as follows; Mr. Kelly, 6,815 shares ($1,761,541); Mr. Powell, 3,078 shares ($795,601); Mr. Leyden 1,565 shares ($404,521); Mr. Hicks, 1,053 shares ($272,179); and Ms. Boylan 483 shares ($124,846). The market value of the unvested performance stock units is calculated based on a market price of $258.48 per share, which was the closing price of our common stock on December 31, 2018, as reported by the New York Stock Exchange.follows:

  2020 Performance Stock
Units
  2019 Performance Stock Units  2018 Performance Stock Units 

Name

 Maximum
Number of
Shares
Issuable
  Market Value of
Maximum
Issuable
Shares
  Maximum
Number of
Shares Issuable
  Market Value of
Maximum
Issuable Shares
  Maximum
Number of
Shares Issuable
  Market Value of
Maximum
Issuable Shares
 

L. Kelly

  5,993   $2,466,539   7,535   $3,101,180   6,815   $2,804,850 

T. Powell

  2,483   $1,021,928   3,540   $1,456,958   3,078   $1,266,812 

J. Leyden

  1,145   $ 471,248   1,635   $672,917   1,565   $644,107 

C. Hicks

  763   $ 314,028   1,090   $448,611   1,053   $433,383 

J. Winters

  618   $ 254,350             

The market value of the unvested performance stock units is calculated based on a market price of $411.57 per share, which was the closing price of our common stock on December 31, 2020, as reported by the New York Stock Exchange. In February 2021, our Compensation Committee determined that the minimum thresholds established with respect to the performance criteria under the performance stock unit awards issued in 2018 had not been achieved and, as such, no shares vested with respect to such awards.

OPTION EXERCISES AND STOCK VESTED – 20182020

The following table sets forth information regarding the number of shares acquired on the exercise of stock options and upon the vesting of restricted stock units held by the named executive officers during the fiscal year ended December 31, 2018.2020.

 

Name

  Option Awards   Stock Awards   Option Awards  Stock Awards
Number of Shares
Acquired on Exercise
   Value Realized
on Exercise(1)
   Number of Shares
Acquired on Vesting
   Value Realized
on Vesting(2)
  Number of Shares
Acquired on Exercise
  Value Realized
on Exercise(1)
  Number of Shares
Acquired on Vesting(2)
  Value Realized
on Vesting(3)

Liam J. Kelly

           3,565    $921,460            3,366   $1,127,677

Thomas E. Powell

   65,968    $12,363,724    3,464    $891,390            2,524   $845,590

James J. Leyden

   1,500    $290,370    1,206    $307,856    29,196   $8,877,531   1,384   $463,668

Cameron P. Hicks

   2,000    $353,240    902    $230,254    6,380   $1,773,209   930   $311,569

Thomas Anthony Kennedy

   19,086    $2,618,218    1,007    $257,057 

Karen T. Boylan

           549    $140,143 

James P. Winters

                

 

(1)

The value realized is equal to the difference between the market price per share of the shares acquired on the date of exercise (the closing price per share of our common stock, as reported by the New York Stock Exchange, on the date of exercise) and the exercise price, multiplied by the number of shares underlying the options.

 

(2)

The amounts shown in this column reflect the number of shares of our common stock underlying restricted stock unit awards that vested in 2020. Mr. Kelly deferred 842 of these shares into a deferral account under our Deferred Compensation Plan. See “Nonqualified Deferred Compensation – 2020” for additional information.

(3)

The value realized is equal to the market price per share on the vesting date (the closing price per share of our common stock, as reported by the New York Stock Exchange, on the vesting date) multiplied by the number of restricted stock units that vested; the restricted stock units were settled upon vesting by the delivery to the named executive of shares of our common stock on the basis of one share for each restricted stock unit held.

PENSION BENEFITS – 20182020

We have sponsored the Teleflex Incorporated Retirement Income Plan (“TRIP”), a qualified defined benefit pension plan. Effective January 1, 2006, the TRIP was closed to new employees, and, effective January 1, 2009, no further benefits could be accrued under the TRIP.

Under the TRIP, a participant accumulated units of annual pension benefit for each year of service. With respect to the years of service applicable to the named executive officers, a participant’s unit was equal to 1.375% of his or her prior year’s annual plan compensation not in excess of social security covered compensation, plus 2.0% of such compensation in excess of the social security covered compensation. The annual plan compensation taken into account under this formula included base salary and annual incentive award payments.

Participants in the TRIP generally vested in their plan benefits after completing five years of qualifying service or, if earlier, upon reaching normal retirement age, which, for purposes of the TRIP, is age 65. In addition to the normal retirement benefit, the TRIP provides reduced benefits upon early retirement, which may occur after a participant has reached age 60 and has completed 10 years of qualifying service. The TRIP also provides limited benefits upon termination due to disability.

Mr. Leyden is the only named executive officer who currently participates in the TRIP and has vested in his plan benefits. Messrs. Kelly, Powell, Hicks and Kennedy and Ms. BoylanWinters have not participated in the TRIP because their employment commenced after the date on which the TRIP was closed to new participants. The table below shows, as of December 31, 2018,2020, the number of years of service credited under the TRIP to Mr. Leyden and the present value of the accumulated benefit payable to Mr. Leyden under the TRIP.

 

Name

  Plan Name   Number of Years
Credited Service
   Present Value
of Accumulated
Benefit(1)
   Payments
During Last
Fiscal Year
   Plan Name  Number of Years
Credited Service
  Present Value
of Accumulated
Benefit(1)
  Payments
During Last
Fiscal Year

James J. Leyden

   TRIP    4.0   $178,986        TRIP   4.0   $212,434    

 

(1)

The accumulated benefit is based on service and earnings for the period through December 31, 2008, after which no further benefits could be accrued. The present value has been calculated assuming Mr. Leyden will commence receipt of benefits at age 65, the age at which retirement may occur without any reduction in benefits, and that the benefit is payable under the available forms of annuity consistent with the assumptions described in note 1516 to the consolidated financial statements in our Annual Report on Form10-K for the fiscal year ended December 31, 2018,2020, as filed with the SEC. The discount rate assumption is 4.43%2.64%, and the mortality assumption is based on theRP-2014PRI-2012 white collar generational mortality table, using Scale MP 20182020 for projection of mortality improvement.

NONQUALIFIED DEFERRED COMPENSATION – 20182020

We maintain our Deferred Compensation Plan, under which executives, including certain of the named executive officers, may defer up to 100 percent of their cash compensation (salary and annual incentive awards). Participants also may defer receipt of shares of our common stock underlying restricted stock units and performance stock units. Salary and stock deferral elections are made by eligible executives in December of each year in respect of salary to be earned and restricted stock unit and performance stock unit awards to be granted in the following year. With respect to deferral elections for annual incentive awards, the election must be made no later than six months prior to the end of the performance period applicable to such award. Participants in our Deferred Compensation Plan may direct the investment of deferred cash amounts into a fixed interest fund or one or more notional funds, and the value of the participants’ investments will increase or decrease based on the applicable fixed income rate or performance of the underlying securities. Stock deferrals are invested in the Teleflex stock fund.

In addition, we provide a matching contribution to certain executives’ accounts with respect to cash amounts deferred by those executives into the Deferred Compensation Plan, generally up to an amount equal to three percent of the participant’s annual cash compensation. A participant will become vested in our matching contributions once the participant has completed two years of service or, if earlier, upon reaching age 65, or upon death or total disability. We also providenon-elective contributions to executives’ accounts in an amount equal to a specified percentage (five percent with respect to Messrs. Kelly and Powell and three percent with respect to all other executives eligible to receivenon-elective contributions, including Messrs. Leyden and Hicks) of the participant’s annual cash compensation, less the maximum matching contribution the participant is eligible to receive under our 401(k) Plan. A participant will become vested in the additional contribution once the participant has completed five years of service or, if earlier, upon reaching age 65, death or total disability.

The following table shows the notional funds available under the Deferred Compensation Plan and their respective annual rate of return for the calendar year ended December 31, 2018.2020. Account balances in the Teleflex stock fund must remain in that fund and cannot be transferred to any other investment option. Additionally, distributions of balances invested in the Teleflex stock fund are made in the form of shares of Teleflex stock; distributions from other funds are payable in cash.

 

Name of FundRate of Return

Vanguard Federal Money Market Fund

0.45%

Fixed Rate Fund

3.13%

Vanguard Total Bond Market Index Fund Admiral Shares

7.72%

Metropolitan West Total Return Bond Fund Plan Class

9.17%

Vanguard Inflation-Protected Securities Fund Admiral Shares

10.96%

Vanguard Lifestrategy Income Fund Investor Shares

3.64%9.13%

Vanguard Lifestrategy Conservative Growth Fund Investor Shares

11.51%

Vanguard Lifestrategy Moderate Growth Fund Investor Shares

13.59%

Vanguard Wellington Fund Admiral Shares

10.68%

Vanguard Lifestrategy Growth Fund Investor Shares

15.45%

Delaware Value Fund Class R6

0.21%

Vanguard 500 Index Fund Admiral Shares

-4.52%18.37%

VanguardMid-Cap Index U.S. Growth Fund Admiral Shares

-9.34%58.74%

VanguardMid-Cap Index Fund Admiral Shares

18.24%

Vanguard Strategic Equity Fund Investor Shares

10.27%

JPMorgan Small Cap Equity Fund Class R6

18.80%

Vanguard Small-Cap Index Fund Admiral Shares

-9.43%19.11%

Vanguard Explorer Fund Admiral Shares

31.48%

Name of FundRate of Return

American Funds New Perspective Fund Class R-6

33.81%

Vanguard Total World Stock Index Admiral Shares

16.69%

Vanguard Total International Stock Index Fund Admiral Shares

11.28%

Vanguard International Growth Fund Admiral Shares

59.74%

American Funds New World Fund Class R-6

25.30%

Vanguard Real Estate Index Fund Admiral Shares

-4.65%

Teleflex Stock Fund

4.42%9.69%

A participant may elect to receive payment of deferred amounts, either in alump-sum or in annual installments over a period of five or ten years, commencing upon separation from service, on a fixed date following separation from service or on an alternative date selected by the participant. Changes in the time or form of payment may be made in compliance with advance notice requirements under the plan, provided that the commencement of the revised payment schedule must be deferred by at least five years from the original commencement date.

The following table sets forth information for the fiscal year ended December 31, 20182020 regarding contributions, earnings and balances under our deferred compensation plan for each named executive officer.

 

Name

 Executive
Contributions
in Last
Fiscal Year(1)
 Registrant
Contributions
in Last
Fiscal Year(2)
 Aggregate
Earnings
in Last
Fiscal
Year(3)
 Aggregate
Withdrawals /
Distributions
 Aggregate
Balance at
Last Fiscal
Year-End(4)
   Executive
Contributions
in Last
Fiscal Year(1)
   Registrant
Contributions
in Last
Fiscal Year(2)
   Aggregate
Earnings
in Last
Fiscal
Year(3)
   Aggregate
Withdrawals /
Distributions
   Aggregate
Balance at
Last Fiscal
Year-End(4)
 

Liam J. Kelly

 $186,016  $110,702  -$53,514     $637,292    $357,559    $116,023    $364,687        $2,417,911 

Thomas E. Powell

 $81,588  $73,907  $28,861     $935,991    $29,714    $55,551    $72,311        $1,286,081 

James J. Leyden

    $9,565  $564     $21,316        $8,179    $969        $39,848 

Cameron P. Hicks

 $9,534  $16,167  -$4,622     $100,737    $10,636    $17,396    $35,847        $255,828 

Thomas Anthony Kennedy

               

Karen T. Boylan

               

James P. Winters

                    

 

(1)

The amounts set forth in this column with respect to each of our named executive officers, other than Mr. Kelly, consist of cash compensation amounts deferred by the named executive officer. TheseWith respect to Mr. Kelly, the amounts set forth in this column consist of cash compensation amounts and restricted stock awards deferred by Mr. Kelly. The value of the restricted stock awards deferred by Mr. Kelly was calculated based on the market price per share on the vesting date (the closing price per share of our common stock, as reported by the New York Stock Exchange, on the vesting date) multiplied by the number of restricted stock units that vested. The cash compensation amounts reflected in the table are included in the Summary Compensation Table for 20182020 in the “Salary” and“Non-Equity Incentive Plan Compensation” columns.

 

(2)

The amounts set forth in this column consist ofnon-elective and (other than with respect to Mr. Leyden) matching contributions made to each named executive officer’s account under our Deferred Compensation Plan.Non-elective contributions were made for Messrs. Kelly, Powell, Leyden and Hicks in the amounts of $64,490, $41,399, $9,565$87,721, $37,723, $8,179 and $6,633,$6,760, respectively. Matching contributions made for Messrs. Kelly, Powell and Hicks were $46,212, $32,507$28,302, $17,829 and $9,534,$10,636, respectively. The amounts set forth in this column are included in the Summary Compensation Table in the “All Other Compensation” column for 2018.2020.

 

(3)

The amounts set forth in this column consist of aggregate interest or other earnings or losses accrued during 20182020 for each named executive officer’s account. With respect to Messrs. Powell and Leyden, the amount set forth in this column also includes above-market earnings of $864$8,914 and $51,$245, respectively, which are included in the Summary Compensation Table for 20182020 in the “Change in Pension Value and Nonqualified Deferred Compensation Earnings” column.

 

(4)

The following amounts were reported in the Summary Compensation Table in prior years: Mr. Kelly, $150,651$413,025 (2015 through 2017)2019); Mr. Powell, $293,015$437,077 (2013 through 2017)2019); Mr. Leyden, $10,844$28,693 (2016 and 2017)through 2019); and Mr. Hicks $14,153 (2016)$52,270 (2016, 2018 and 2019).

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL

In this section, we describe payments and benefits that would be provided to our named executive officers upon several events of termination, including termination in connection with a change of control, assuming the termination event occurred on December 31, 2018.2020. The information in this section does not include information relating to the following:

 

Benefits payable under the Teleflex Retirement Income Plan. See “Pension Benefits – 2018”2020” for information regarding this plan;

 

distributions under our deferred compensation plan, other than enhanced payments in connection with a change in control. See “Nonqualified Deferred Compensation – 2018”2020” for information regarding this plan;

 

restricted stock units and shares underlying options that vested prior to the termination event. See the “Outstanding Equity Awards at FiscalYear-End2018”2020” table;

 

short-term incentive payments that would not be increased due to the termination event;

 

benefits that would be provided upon death or disability under supplemental life and/or disability insurance policies that we maintain for the benefit of our named executive officers; and

 

other payments and benefits provided on a nondiscriminatory basis to salaried employees generally upon termination of employment, including under our 401(k) plan.

Employment and Severance Arrangements

We have entered into agreements with each of our executive officers that provide for specified severance compensation and benefits in the event we terminate their employment without “cause,” as defined in the agreements, or if the executive terminates employment for “good reason,” as defined in the agreements, other than in connection with a change of control. The severance compensation consists of the following:

 

continued payment of the executive’s base salary for a period of 24 months with respect to Messrs. Kelly and Powell and three weeks for each year of full-time employment (subject to a minimum period of nine months and a maximum period of 12 months) with respect to Messrs. Leyden, Hicks and Kennedy and Ms. BoylanWinters (the “Severance Period”) (see footnote 1 to the table below for information regarding the length of the Severance Period for each named executive officer as of December 31, 2018)2020); provided that, in the case of Mr. Kennedy and Ms. Boylan,Winters, the severance period will be reduced by any contractual notice period to which they are entitled under theirhis employment agreementsagreement and the amount of theirhis base salary paymentspayment will be reduced by any statutory “redundancy payment” to which they arehe is entitled under Irish law;

 

if the executive is terminated before the last day (or, in the case of Mr. Kennedy and Ms. Boylan,Winters, if a notice of termination of employment is issued to him or her before the last day), but after the completion of at least six months, of a performance period under the annual incentive plan, the payment of a prorated amount of the annual incentive award the executive would have been entitled to receive for the year in which his or her employment was terminated (for purposes of the proration, the individual performance component will be equal to the target award for the component);

 

continued health, life and accident insurance, exclusive of costs that would have been borne by the executive in accordance with our applicable policy then in effect, until the end of the Severance Period or until the executive is eligible for such benefits in connection with future employment, whichever occurs first; at our option, we may choose to provide to the

 

executive a monthly cash payment equal to the executive’safter-tax cost to obtain comparable health insurance coverage from commercial sources, subject to the executive bearing a portion of the cost in accordance with our policy then in effect for employee cost sharing (provided that, in the case of Mr. Kennedy and Ms. Boylan,Winters, in the event continued coverage is not permitted under the relevant plan, we will pay, subject to statutory deductions, an amount equivalent to the cost of coverage on the same basis as if theyhe continued to participate);

 

with respect to Messrs. Kelly and Powell, a payment during the Severance Period of a cash allowance equal to the amount it would cost the executive to lease the automobile utilized by the executive at the time of his or her termination; and

 

reimbursement for executive outplacement services in an amount up to18,000 with respect to Mr. Kennedy and Ms. BoylanWinters and $20,000 with respect to each of the other executives.

The following table sets forth the potential post-termination payments and benefits the eligible named executive officers would be entitled to receive under the agreements and policies described above, assuming the triggering event under the agreements occurred on December 31, 2018. Upon2020. In connection with his retirement and related transition to a senior advisor role, as of January 1, 2021, Mr. Kennedy’s retirement from the Company on March 31, 2019, he willLeyden was no longer be entitledeligible to receive the benefits addressed in the table.

 

Name

 Base
Salary(1)
 Annual
Cash
Incentive
Award

Payments(2)
 Health
Benefits(3)
 Life and
Accident
Insurance(4)
 Auto-
mobile(5)
 Executive
Outplacement(6)
 Total  Base
Salary(1)
 Annual
Cash
Incentive
Award

Payments(2)
 Health
Benefits(3)
 Life and
Accident
Insurance(4)
 Auto-
mobile(5)
 Executive
Outplacement(6)
 Total 

L. Kelly

 $1,700,000  $1,201,956  $35,903  $9,792  $54,615  $20,000  $3,022,266  $1,840,000  $216,983  $35,552  $9,792  $57,398  $20,000  $2,179,725 

T. Powell

 $1,079,240  $500,287  $35,903  $4,099  $51,628  $20,000  $1,691,157  $1,156,080  $89,143  $35,552  $6,598  $38,075  $20,000  $1,345,448 

J. Leyden

 $266,085  $193,381  $11,210  $994     $20,000  $491,670  $325,713  $38,715  $13,592  $1,795     $20,000  $399,815 

C. Hicks

 $241,448  $176,750  $13,412  $911     $20,000  $452,520  $251,138  $35,454  $12,599  $1,476     $20,000  $320,667 

T. Kennedy(7)

 $247,084  $102,852  $3,677  $633     $20,603  $374,849 

K. Boylan(7)

 $194,685  $143,317  $2,735  $484     $20,603  $361,823 

J. Winters(7)

 $283,598  $120,541  $3,704  $892     $22,078  $430,813 

 

(1)

The amounts set forth in this column reflect the amounts the named executive officers would be entitled to receive based upon salaries in effect as of December 31, 2018,2020, and, in accordance with the terms of the applicable agreement, based upon the following respective periods for which the amounts will be provided: Messrs. Kelly and Powell, 24 months; Mr. Leyden, 10 months; and Messrs. Leyden, Hicks and Kennedy and Ms. Boylan,Winters, nine months.

 

(2)

The amounts set forth in this column reflect the actual cash incentive award each executive received for 2018,2020, as reflected in the “Non-Equity Incentive Plan Compensation” column of the Summary Compensation Table.

 

(3)

The amounts set forth in this column have been calculated based upon the health coverage rates in effect as of December 31, 2018,20120 and, in accordance with the terms of the applicable agreement, based upon the following respective periods for which coverage will be provided: Messrs. Kelly and Powell, 24 months; Mr. Leyden, 10 months; and Messrs. Leyden, Hicks and Kennedy and Ms. Boylan,Winters, nine months.

 

(4)

The amounts set forth in this column have been calculated based upon the life and accident insurance rates in effect as of December 31, 2018,2020, and, in accordance with the terms of the applicable agreement, based upon the following respective periods for which the insurance will be provided: Messrs. Kelly and Powell, 24 months; Mr. Leyden, 10 months; and Messrs. Leyden, Hicks and Kennedy and Ms. Boylan,Winters, nine months.

 

(5)

The amounts set forth in this column are based upon automobile lease rates in effect as of December 31, 2018,2020, and, in accordance with the terms of the applicable agreement, based upon the24-month period for which the vehicle allowance will be provided.

 

(6)

The amounts set forth in this column represent the maximum payment the named executive officer would be entitled to receive for outplacement services under the applicable agreement.

 

(7)

The amounts shown for Mr. Kennedy and Ms. Boylan,Winters, who receive theirreceives his cash compensation in euros, have been converted to U.S. dollars using an exchange rate of 0.8736700.815291 euros per dollar, which was the exchange rate in effect as of December  31, 2018.2020.

Change-in-Control Arrangements

We have entered into agreements with each of our executive officers that provide for specified severance compensation and benefits in the event that a Change in Control (as defined in the agreements) occurs, and the executive’s employment is terminated within two years after the Change

in Control either by the executive for “good reason,” as defined in the agreement, or by us for any reason other than “disability” or “cause,” each as defined in the agreements. The severance compensation consists of the following:

 

if no amount has been awarded to the executive under any plan providing for payment of a cash bonus in the year of termination (or, in the case of Mr. Kennedy and Ms. Boylan,Winters, in the year in which a notice of termination is given), the executive will receive a bonus payment equal to the target award under such plan;

 

the executive’s target bonus under each bonus plan providing for payment of a cash bonus in the year following the year in which the executive’s employment was terminated, prorated based on the number of days the executive was employed during the applicable performance period under such bonus plan (or, in the case of Mr. Kennedy and Ms. Boylan,Winters, the number of days during the applicable performance period prior to the date on which a notice of termination is given);

 

payment of the executive’s base salary (based on the highest salary rate in effect for the executive at the time of, or at any time after the Change in Control) for a specified period after termination of employment (or, in the case of Mr. Kennedy and Ms. Boylan,Winters, in the year in which a notice of termination is given), which period is equal to three years for Mr. Kelly, two years for Mr. Powell and 18 months for Messrs. Leyden, Hicks and Kennedy and Ms. BoylanWinters (the “CIC Severance Period”), provided that, in the case of Mr. Kennedy and Ms. Boylan,Winters, this amount will be reduced by any statutory “redundancy payment” to which he or she is entitled under Irish law and any base salary payments he or she receives during any termination notice period;

 

in the case of Messrs. Kelly and Powell, annual payments during the applicable CIC Severance Period, each equal to the sum of the target awards under each bonus plan providing for payment of a cash bonus in the year following the year in which the executive’s employment was terminated (collectively, the “Target Award”); and in the case of Messrs. Leyden, Hicks and Kennedy and Ms. Boylan,Winters, two annual payments during the CIC Severance Period, the first of which will be equal to 100 percent of the Target Award and the second of which shall be equal to fifty50 percent of the Target Award;

 

continuation of health insurance during the CIC Severance Period or, if the executive is not eligible for continued coverage after termination, reimbursement during the CIC Severance Period, on anafter-tax basis, of any premiums the executive is required to pay in order to maintain coverage at a level comparable to the coverage the executive last elected for himself or herself, and the executive’s spouse and dependents under our health care plan, exclusive of costs that would have been borne by the executive in accordance with our applicable policy then in effect for employee participation in premiums;

 

in the case of Messrs. Kelly and Powell, payment during the CIC Severance Period of a cash allowance equal to the amount it would cost the executive to lease the vehicle utilized by the executive at the time of his or her termination;

 

with respect to Messrs. Kelly, Powell, Leyden and Hicks, a cash payment equal to thenon-elective contribution the executive would have been entitled to receive under our Deferred Compensation Plan in respect of three additional years of service, in the case of Mr. Kelly, two additional years of service, in the case of Mr. Powell and 18 months of additional service, in the case of Messrs. Leyden and Hicks; and

 

reimbursement for executive outplacement services in an amount up to $20,000.

The executive change in control agreements have an initial term of three years, and automatically renew for successiveone-year periods unless we terminate the agreements. However, notwithstanding any termination by us, the executive change in control agreements will remain in effect for a period of at least two years following a Change in Control that occurs during the term of the agreement.

Our 2014 Stock Incentive Plan and 2008 Stock Incentive Plan provide that, on the date of a change in control, all unvested stock options will immediately vest. In addition, in the event of the termination of employment of an option holder within two years following a change in control for any reason other than death, retirement, disability or termination for cause, each vested stock option will remain exercisable until the first to occur of the third anniversary of termination (or any later date on which the stock option can be exercised under its terms) or the expiration if the stock option. Notwithstanding the foregoing, the Board or Board committee administering the plan may determine that, upon the occurrence of a change in control, all stock options will terminate within a specified number of days and/or that each option holder will receive with respect to each underlying share an amount equal to the excess of the fair market value of a share immediately prior to the change in control over the exercise price of the stock option. The 2014 Stock Incentive Plan also provides that, upon a change in control, all conditions and restrictions applicable to restricted stock units and performance stock units will lapse and the restricted stock units and performance stock units will be fully vested (in the case of the performance stock units, such vesting will be based on target performance).

The following table sets forth information regarding the potential payments and benefits the named executive officers would have been entitled to receive in connection with a change in control under the documents described above, assuming the triggering event under the agreements occurred on December 31, 2018. Upon2020. In connection with his retirement and related transition to a senior advisor role, as of January 1, 2021, Mr. Kennedy’s retirement from the Company on March 31, 2019, he willLeyden was no longer be entitledeligible to receive the benefits addressed in the table.

 

Name

 Base
Salary
 Annual
Cash
Incentive
Award
Payments(1)
 Vesting
Of
Unvested
Equity
Awards(2)
 Health
Benefits(3)
 Auto-
mobile(4)
 Deferred
Compen-
sation
Plan
Payments(5)
 Executive
Out-
placement(6)
 Total  Base
Salary
 Annual
Cash
Incentive
Award
Payments(1)
 Vesting
Of
Unvested
Equity
Awards(2)
 Health
Benefits(3)
 Auto-
mobile(4)
 Deferred
Compen-
sation

Plan
Payments(5)
 Executive
Out-
placement(6)
 Total 

L. Kelly

 $2,550,000  $4,134,456  $6,453,633  $54,084  $81,923  $193,470  $20,000  $13,487,566  $2,760,000  $3,390,983  $14,425,248  $53,558  $86,097  $185,545  $20,000  $20,921,431 

T. Powell

 $1,079,240  $1,309,717  $4,558,993  $36,056  $51,628  $82,799  $20,000  $7,138,433  $1,156,080  $956,203  $6,587,477  $35,705  $38,075  $80,490  $20,000  $8,874,030 

J. Leyden

 $532,170  $432,858  $2,375,997  $25,235     $14,347  $20,000  $3,400,607  $564,570  $321,000  $3,138,763  $24,581     $13,343  $20,000  $4,082,257 

C. Hicks

 $482,895  $394,053  $1,608,522  $26,939     $9,950  $20,000  $2,542,358  $502,275  $286,592  $2,224,521  $25,313     $11,113  $20,000  $3,069,814 

T. Kennedy(7)

 $494,169  $325,228  $1,602,193  $7,354        $20,000  $2,448,943 

K. Boylan(7)

 $389,369  $318,533  $739,992  $5,470        $20,000  $1,473,364 

J. Winters(7)

 $567,197  $404,139  $1,047,931  $7,408        $20,000  $2,046,675 

 

(1)

The amounts set forth in this column represent the sum of the actual cash incentive award payment the named executive officers received for the fiscal year ended December 31, 2018,2020, as reflected in the Summary Compensation Table, and additional payments to be made based upon the respective number of years for which target awards would be payable following the change of control, as follows: Mr. Kelly, three years; Mr. Powell, two years; and Messrs. Leyden, Hicks and Kennedy and Ms. Boylan,Winters, 18 months.

 

(2)

The amounts set forth in this column represent the value the named executive officer would realize upon the vesting of the unvested stock options, and upon vesting and conversion of unvested restricted stock units and target amount of performance stock units held by the named executive officer as of December 31, 2018.2020. The value of the unvested stock options was calculated based upon the difference between the aggregate market value of the shares of common stock underlying the unvested stock options and the aggregate exercise price of those stock options. The value of the shares of our common stock the named executive officer would receive following vesting and conversion of restricted stock units and performance stock units is equal to the aggregate market value of such shares. The market value was based on a price of $258.48$411.57 per share, which was the closing price of our common stock on December 31, 2018,2020, as reported by the New York Stock Exchange.

 

(3)

The amounts set forth in this column have been calculated based upon the health coverage rates for each named executive officer in effect as of December 31, 2018.2020.

 

(4)

The amounts set forth in this column are based upon automobile lease rates in effect as of December 31, 2018,2020, and, in accordance with the terms of the applicable agreement, based upon the following respective periods for which the automobile allowance will be provided: Mr. Kelly, three years; Mr. Powell, two years.

(5)

The amounts set forth in this column are equal to three times the amount of thenon-elective contribution we made to the Deferred Compensation Plan for the account of Mr. Kelly in 2018;2020; two times the amount of suchnon-elective contributions for the account of Mr. Powell in 2018;2020; and one andone-half times the amount of suchnon-elective contributions for the account of Messrs. Leyden and Hicks in 2018.2020.

(6)

The amounts set forth in this column represent the maximum payment we would be required to make to the named executive officers for outplacement services under the applicable agreement or company policy.

 

(7)

The amounts shown for Mr. Kennedy and Ms. BoylanWinters for benefits, other than the vesting of unvested equity awards, have been converted to U.S. dollars using an exchange rate of 0.8736700.815291 euros per dollar, which was the exchange rate in effect as of December 31, 2018.2020.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth, as of February 1, 20192021 (except as otherwise noted), information with respect to ownership of our securities by each person known by us to beneficially own more than 5% of our outstanding common stock, each director or nominee for director, each named executive officer and all such directors, nominees for director and named executive officers as a group. Except as otherwise indicated in the footnotes to the table, we have been informed that each person listed has sole voting power and sole investment power over the shares of common stock shown opposite his or her name.

 

Name and Address of Beneficial Owner

  Shares
Beneficially
Owned(a)
 Percent of
Outstanding
Common
Stock(b)
   Shares
Beneficially
Owned (a)
 Percent of
Outstanding
Common
Stock(b)
 

T. Rowe Price Associates, Inc.

   6,071,298  13.19

100 E. Pratt Street

   

Baltimore, MD 21202(c)

   

The Vanguard Group, Inc.

   4,984,029  10.67

100 Vanguard Boulevard

   

Malvern, PA 19355 (c)

   

BlackRock, Inc.

   4,970,782  10.80   4,976,722  10.66

55 East 52nd Street

      

New York, NY 10022(d)

   

New York, NY 10022 (d)

   

The Vanguard Group, Inc.

   4,774,626  10.37

100 Vanguard Boulevard

   

Malvern, PA 19355(e)

   

T. Rowe Price Associates, Inc.

   4,938,892  10.58

100 E. Pratt Street

   

Baltimore, MD 21202 (e)

   

Eaton Vance Management

   2,858,507  6.21

2 International Place

   

Boston, MA 02110(f)

   

Wellington Management Group LLP

   2,716,538  5.82

c/o Wellington Management Company LLP

280 Congress Street

   

Boston, MA 02210(f)

   

George Babich, Jr.

   12,618(g)  *    15,742(g)  * 

Karen T. Boylan

   22,030(h)  * 

Candace H. Duncan

   11,421(i)  *    14,333(h)  * 

Gretchen R. Haggerty

   8,080(j)  *    10,973(i)  * 

John C. Heinmiller

     *    6,608(j)  * 

Cameron P. Hicks

   52,030(k)  *    49,513(k)  * 

Liam J. Kelly

   183,507(l)  *    257,232(l)  * 

Thomas Anthony Kennedy

   10,636(m)  * 

Stephen K. Klasko

   28,696(n)  *    26,859(m)  * 

Andrew A. Krakauer

   4,811(o)  *    7,706(n)  * 

James J. Leyden

   68,714(p)  *    71,813(o)  * 

Richard A. Packer

   5,934(q)  *    8,827(p)  * 

Thomas E. Powell

   121,789(r)  *    101,412(q)  * 

Stuart A. Randle

   26,237(s)  *    21,877(r)  * 

Benson F. Smith

   555,458(t)  1.19

All directors and executive officers as a group (15 persons)

   1,111,962(u)  2.36

James P. Winters

   4,372(s)  

All directors and executive officers as a group (16 persons)

   631,383(t)  1.34

 

*

Represents holdings of less than 1%.

 

(a)

“Beneficial ownership” is determined in accordance with SEC regulations. Therefore, the table lists all shares as to which the person listed has or shares the power to vote or to direct disposition. In addition, shares issuable upon the exercise of outstanding stock options exercisable on February 1, 20192021 or within 60 days thereafter and shares issuable pursuant to restricted stock units that will vest within 60 days thereafter are considered outstanding and to be beneficially owned by the person holding such options or restricted stock units for the purpose of computing such person’s percentage of beneficial ownership, but are not considered outstanding for the purpose of computing the percentage of beneficial ownership of any other person.

 

(b)

Based on 46,022,20246,688,953 shares outstanding on February 1, 2019.2021.

(c)

T. Rowe Price Associates, Inc. (“Price Associates”)Of the shares listed in the table, The Vanguard Group has sole voting power with respect to 2,060,370none of the shares, listed in the table and sole dispositive power for all 6,071,298 shares listed in the table. T. Rowe PriceMid-Cap Growth Fund, Inc. has soleshared voting power with respect to 2,760,10078,130 shares, listed in the table. The securities listed in the table are owned by various individualsole dispositive power with respect to 4,778,307 shares and institutional investors for which Price Associates serves as an investment advisershared dispositive power with powerrespect to direct investments and/or sole power to vote the securities. For the purposes of the reporting requirements of the Securities Exchange Act of 1934, Price Associates is deemed to be a beneficial owner of such securities; however, Price Associates expressly disclaims that it is, in fact, the beneficial owner of such securities.205,722 shares. The information in the table and this footnote is derived from an amendment to

Schedule 13G filed by Price Associates and T. Rowe PriceMid-Cap Growth Fund, Inc.The Vanguard Group with the SEC on February 14, 2019,10, 2021, reporting beneficial ownership as of December 31, 2018.2020. The number of shares held by such reporting persons may have changed subsequent to December 31, 2018.

2020.

 

(d)

BlackRock, Inc. (“BlackRock”) is the parent of several subsidiaries that directly hold the shares listed in the table. Of the shares listed in the table, BlackRock has sole voting power with respect to 4,662,7744,464,386 shares and sole dispositive power with respect to all 4,970,7824,976,722 shares. The information in the table and this footnote is derived from an amendment to Schedule 13G filed by BlackRock, Inc. with the SEC on January 31, 2019,27, 2021, reporting beneficial ownership as of December 31, 2018.2020. The number of shares held by such reporting persons may have changed subsequent to December 31, 2018.2020.

 

(e)

Of the shares listed in the table, The Vanguard GroupT. Rowe Price Associates, Inc. (“Price Associates”) has sole voting power with respect to 52,9531,758,209 shares sharedlisted in the table and sole dispositive power for all 4,938,892 shares listed in the table. T. Rowe Price Mid-Cap Growth Fund, Inc. has sole voting power with respect to 10,205 shares, sole dispositive power with respect to 4,712,479 shares and shared dispositive power with respect to 62,147 shares. Two wholly-owned subsidiaries of The Vanguard Group, Inc. beneficially own an aggregate of 75,6372,150,000 shares listed in the table. The information in the table and this footnote is derived from an amendment to Schedule 13G filed by The Vanguard GroupPrice Associates and T. Rowe Price Mid-Cap Growth Fund, Inc. with the SEC on February 11, 2019, reporting beneficial ownership as of January 31, 2019. The number of shares held by such reporting persons may have changed subsequent to January 31, 2019.

(f)

The information in the table and this footnote is derived from an amendment to Schedule 13G filed by Eaton Vance Management with the SEC on February 14, 2019,16, 2021, reporting beneficial ownership as of December 31, 2018.2020. The number of shares held by such reporting persons may have changed subsequent to December 31, 2018.2020.

(f)

Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP each had shared voting power with respect to 2,383,383 shares and shared dispositive power with respect to 2,716,538 shares. Wellington Management Company LLP had beneficial ownership of 2,383,909 shares, shared voting power with respect to 2,246,085 shares and shared dispositive power with respect to 2,383,909 shares. The securities are owned of record by clients of one or more investment advisers directly or indirectly owned by Wellington Management Group LLP. The information in the table and this footnote is derived from a Schedule 13G filed by Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP with the SEC on February 4, 2021, reporting beneficial ownership as of December 31, 2020. The number of shares held by such reporting persons may have changed subsequent to December 31, 2020.

 

(g)

Includes 1,000 shares held indirectly by Mr. Babich through the Baylee Consulting Plan and 2,5414704 shares underlying stock options.

 

(h)

Includes 20,53111,539 shares underlying stock options and 519 shares underlying restricted stock units.options.

 

(i)

Includes 9,3768,094 shares underlying stock options.

 

(j)

Includes 5,9314,494 shares underlying stock options.

 

(k)

Includes 49,43842,548 shares underlying stock options, 1,125637 shares underlying restricted stock units and 3536 shares held for Mr. Hicks’ account in the Company’s 401(k) Savings Plan.

 

(l)

Includes 173,111241,044 shares underlying stock options and 3,3984,120 shares underlying restricted stock units.

 

(m)

Includes 8,643 shares underlying stock options and 1,164 shares underlying restricted stock units.

(n)

Includes 7,880 shares held indirectly by Mr.Dr. Klasko through the Stephen K. Klasko Revocable Trust and 20,81618,979 shares underlying stock options.

(n)

Includes 5,472 shares underlying stock options.

 

(o)

Includes 3,309 shares underlying stock options.

(p)

Includes 57,24443,155 shares underlying stock options, 1,647946 shares underlying restricted stock units and 1,4501,457 shares held for Mr. Leyden’s account in the Company’s 401(k) Savings Plan.

 

(q)(p)

Includes 1,154 shares held jointly by Mr. Packer and his spouse and 3,9516,114 shares underlying stock options.

 

(r)(q)

Includes 115,63593,221 shares underlying stock options, 3,2621,861 shares underlying restricted stock units and 388390 shares held for Mr. Powell’s account in the Company’s 401(k) Savings Plan.

 

(r)

Includes 18,979 shares underlying stock options.

(s)

Includes 20,8164,372 shares underlying stock options.

 

(t)

Includes 486,211526,739 shares underlying stock options, 7,9388,880 shares held indirectly by directors, 8,309 shares underlying restricted stock units and 619 shares held for Mr. Smith’s account in the Company’s 401(k) Savings Plan.

(u)

Includes 977,553 shares underlying stock options, 19,053 shares underlying restricted stock units and 2,4932,177 shares held for the account of some of the Company’s executive officers and directors in the Company’s 401(k) Savings Plan.

CERTAIN TRANSACTIONS

Related Person Transactions Policy

We maintain a Related Person Transactions Policy for review and approval, rejection or ratification of “related person transactions.” A related person transaction is any transaction, arrangement or relationship (i) involving an amount exceeding $120,000, (ii) in which Teleflex or any of its controlled subsidiaries participate and (iii) in which a “related person” has a direct or indirect material interest. A “related person” is any Teleflex director or executive officer, any holder of more than 5% of our outstanding shares of common stock, any immediate family member of any of these persons and certain of their affiliates.

The policy includes procedures under which directors, director nominees and executive officers must provide information to the General Counsel before entry into a transaction that could be a related person transaction. If the transaction is subject to the policy, it is considered by the Audit Committee, which may approve or reject the transaction. The policy also addresses procedures for Audit Committee consideration of ratification of related person transactions that occur without its prior approval, including procedures designed to minimize the possibilities of future occurrences of such transactions without prior Audit Committee approval. The Audit Committee will approve only those related person transactions it finds to be in, or not inconsistent with, the best interests of Teleflex and its stockholders.

On December 31, 2017, Benson F. Smith retired as our Chief Executive Officer. In connection with Mr. Smith’s retirement, the Board approved our entry into a consulting agreement with Mr. Smith, under which he provides support to Mr. Kelly with respect to specified transition matters. The consulting agreement has a term of two years, from January 1, 2018 through December 31, 2019. During the term of the Consulting Agreement, Mr. Smith receives an annual fee of $406,250, payable each year in twelve equal monthly installments. The amount of the fee is based upon the estimated 130 hours of time per year that Mr. Smith is expected to devote to his consulting efforts, at the rate of $3,125 per hour; any additional consulting work by Mr. Smith, for which he will be paid at the same hourly rate, will be subject to the approval of the Chief Executive Officer.

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), requires our directors, executive officers and persons who own more than ten percent of our common stock to file reports of ownership and changes in ownership of our common stock.

Based solely on a review of the copies of such reports and written representations from our directors and executive officers, we believe that, during the fiscal year ended December 31, 2018, all required filings under Section 16(a) were made on a timely basis.

PROPOSAL 2:

ADVISORY VOTE ON COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS

Section 14A of the Exchange Act enables our stockholders to vote on whether to approve, on an advisory(non-binding) basis, the compensation of our named executive officers as disclosed in this proxy statement in accordance with the SEC’s rules. Specifically, these rules address the information we must provide in the compensation discussion and analysis, compensation tables and related disclosures included in this proxy statement. In accordance with the advisory vote of our stockholders at our 20182017 Annual Meeting, we are providing to our stockholders the opportunity to vote annually to approve, on an advisory basis, the compensation of our named executive officers.

As noted above under “Compensation Discussion and Analysis,” our executive compensation program is designed principally to promote the achievement of specific annual and long-term goals by our executive management team and to align our executives’ interests with those of our stockholders. We believe that, as described under “Compensation Discussion and Analysis,” our compensation program incorporates, to a significant extent, apay-for-performance methodology that has operated effectively.

Accordingly, the Board recommends that our stockholders vote in favor of the following resolution:

RESOLVED, that the stockholders of Teleflex Incorporated approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the compensation discussion and analysis, the compensation tables and any related materials disclosed in the proxy statement for the 20192021 Annual Meeting.

This is an advisory vote, which means that the stockholder vote is not binding on us. Nevertheless, our Compensation Committee values the opinions expressed by our stockholders and will carefully consider the outcome of the vote when making future compensation decisions for our named executive officers.

THE BOARD OF DIRECTORS RECOMMENDS AN ADVISORY VOTE “FOR” THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

PROPOSAL 3:

RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Audit Committee has selected the firm of PricewaterhouseCoopers LLP to serve as our independent registered public accounting firm for 2019.2021. Representatives of PricewaterhouseCoopers LLP are expected to be present at the Annual Meeting and will be provided the opportunity to make statements and respond to appropriate questions from stockholders present at the meeting. Although stockholder ratification of our independent registered public accounting firm is not required by our Bylaws or otherwise, we are submitting the selection of PricewaterhouseCoopers LLP to our stockholders for ratification to permit stockholders to participate in this important corporate decision. If the Audit Committee’s selection is not ratified, the Audit Committee will reconsider the selection, although the Audit Committee will not be required to select a different independent registered public accounting firm.

Audit andNon-Audit Fees

The following table provides information regarding fees for professional services rendered by PricewaterhouseCoopers LLP for the audit of our annual financial statements for the years ended December 31, 20182020 and December 31, 2017,2019, and fees for other services provided by PricewaterhouseCoopers LLP during those periods.

 

Services rendered

  2018   2017   2020   2019 

Audit fees

  $4,927,618   $4,894,511   $5,805,586   $5,001,463 

Audit-related fees

   402,075    1,127,355    707,319    548,726 

Tax fees

   1,242,687    1,031,244    2,105,745    1,494,261 

All other fees

   9,731    8,280    11,136    23,234 
  

 

   

 

   

 

   

 

 
  $6,582,112   $7,061,390   $8,629,787   $7,067,684 
  

 

   

 

   

 

   

 

 

Audit-Related Fees. Audit-related fees consisted primarily of fees for support in connection with acquisition due diligence and financing transactions and consultation on accounting matters.

Tax Fees. Tax fees consisted primarily of fees for tax compliance activities in certain foreign jurisdictions ($566,678699,610 for 20182020 and $561,115$884,016 for 2017)2019), and tax planning and consultancy services ($676,0091,406,135 for 20182020 and $470,129$610,245 for 2017)2019).

All Other Fees. All other fees for 20182020 and 20172019 primarily consisted of license fees for utilization of technical databases.

Audit CommitteePre-Approval Procedures

The Audit Committee has established a policy requiringpre-approval of all audit and permissiblenon-audit services performed by the independent registered public accounting firm. Under the policy, the Audit Committee annuallypre-approves specific types of services, subject to certain dollar limitations set by the Audit Committee. Periodically throughout the year, the independent registered public accounting firm and management provide the Audit Committee with reports regardingpre-approved services under the policy for which the independent registered public accounting firm has been engaged. During the year, circumstances may arise when it may become necessary to engage the independent auditor for additional services not contemplated in the originalpre-approval. In those instances, the Audit Committee requires specificpre-approval before engaging the independent auditor to perform the additional services. The Audit Committee may delegatepre-approval authority to one or more of its members. The member to whom such authority is delegated reports anypre-approval decisions to the Audit Committee at its next scheduled meeting.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE RATIFICATION OF

PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED

PUBLIC ACCOUNTING FIRM FOR 2021.

PROPOSAL 4:

STOCKHOLDER PROPOSAL – BOARD DECLASSIFICATION

We have received notice of the intention of a stockholder to present the following proposal at the annual meeting. The text of the proposal and supporting statement appear exactly as received. All statements contained in a stockholder proposal and supporting statement are the sole responsibility of the proponent of this proposal. We will provide the proponent’s name and address and the number of shares the proponent beneficially owns upon oral or written request made to the Corporate Secretary of the Company.

The following is the text of the stockholder proposal:

Proposal 4 – Elect Each Director Annually

RESOLVED, shareholders ask that our Company take all the steps necessary to reorganize the Board of Directors into one class with each director subject to election each year for a one-year term.

Although our management can adopt this proposal topic in one-year and implementation in one-year is a best practice, this proposal allows the option to phase it in over 3-years.

Three-year terms for directors like the Teleflex Board have been found to be one of 6 entrenching mechanisms that are negatively related to company performance according to “What Matters in Corporate Governance” by Lucien Bebchuk, Alma Cohen and Allen Ferrell of the Harvard Law School.

Arthur Levitt, former Chairman of the Securities and Exchange Commission said, “In my view it’s best for the investor if the entire board is elected once a year. Without annual election of each director shareholders have far less control over who represents them.”

A total of 79 S&P 500 and Fortune 500 companies, worth more than $1 trillion, also adopted this important proposal topic since 2012. Annual election of each director could make directors more accountable, and thereby contribute to improved performance and increased company value at virtually no extra cost to shareholders. Thus it was not a surprise that this proposal topic won 96%-support at United Therapeutics Corporation in 2019.

Annual election of each director can be a first step to make the corporate governance of Teleflex more competitive and unlock shareholder value.

A number of governance best practices are just waiting to be adopted at Teleflex by an enlightened Board of Directors and an enlightened Chairman of the Governance Committee. For instance, a shareholder right to call a special shareholder meeting and a shareholder right to act by written consent. Shareholder proxy access is another governance best practice just waiting to be adopted. Management has the opportunity take the initiate on these topics.

It is also important to adopt this proposal to help make up for the loss of the right of shareholders to an in-person annual shareholder meeting.

With the near universal use of online annual shareholder meetings starting in 2020 shareholders no longer have the right to discuss concerns with other shareholders and with their directors at an annual shareholder meeting which can now be an online meeting which is an inferior format compared to a Zoom meeting.

Shareholders are also severely restricted in making their views known at an online shareholder meeting because all their questions and comments can be arbitrarily screened out. For instance Goodyear management hit the mute button right in the middle of a formal shareholder proposal presentation at its 2020 shareholder meeting to bar constructive shareholder criticism.

Please vote yes:

Elect Each Director Annually – Proposal 4

*    *     *    *

THE BOARD OF DIRECTORS’ STATEMENT IN RESPONSE TO THE STOCKHOLDER PROPOSAL

The Board has considered the stockholder proposal and has determined to neither oppose nor support the stockholder proposal, nor to provide a voting recommendation to stockholders. In its review of the proposal, the Board considered the common arguments in favor of, and in opposition to, a classified board structure. The Board views the stockholder proposal as an opportunity for stockholders to express their views on the topic without any influence that a voting recommendation from the Board might have.

This proposal will be approved if it receives the affirmative vote of a majority of the shares present in person or represented by proxy at the meeting and entitled to vote on the proposal. Accordingly, abstentions have the same effect as votes against the proposal, while broker non-votes will not be included in the vote count and will have no effect on the vote. If stockholders return a validly executed proxy solicited by the Board, the shares presented by the proxy will be voted on this proposal in the manner specified by the stockholder. If stockholders do not specify the manner in which their shares represented by a validly executed proxy solicited by the Board are to be voted on this proposal, such shares will be voted as an abstention.

If approved, the stockholder proposal would not automatically eliminate our classified board structure. In order to eliminate the classified board, a formal amendment to our bylaws would be required. In accordance with our certificate of incorporation, such amendment would need to be approved at a subsequent meeting of stockholders by holders of at least 80% of the outstanding shares of capital stock of the Company entitled to vote generally in the election of directors. Therefore, a vote in favor of the stockholder proposal would constitute a recommendation that the Board initiate this amendment process.

THE BOARD OF DIRECTORS MAKES NO VOTING RECOMMENDATION ON THIS PROPOSAL.

STOCKHOLDER PROPOSALS

Any proposals submitted by stockholders for inclusion in our proxy statement and proxy for our 20202022 annual meeting of stockholders in accordance with Rule 14a-8 under the Exchange Act must be received by the Company at its principal executive offices no later than November 30, 2019and26, 2021and must comply in all other respects with SEC rules relating to such inclusion.

In addition, in February 2021, the Board of Directors adopted a “proxy access” bylaw. The proxy access bylaw permits a stockholder or a group of up to 20 stockholders, owning 3% or more of the Company’s outstanding common stock continuously for at least three years, to nominate and include in the Company’s proxy materials director nominees constituting up to the greater of two directors or 20% of the Board, provided that the stockholder(s) and the nominee(s) satisfy the informational and other requirements specified in Article II, Section 2.2.2 of our bylaws. Pursuant to the proxy access bylaw, a stockholder wishing to nominate a director must provide notice to the Corporate Secretary at the principal executive offices of the Company not less than 120 days nor more than 150 days prior to the first anniversary of the date on which the Company’s definitive proxy statement was released to stockholders in connection with the prior year’s annual meeting. Accordingly, to be timely for inclusion in the proxy materials for the Company’s 2022 annual meeting, the Company must receive a stockholder’s notice to nominate a director using the Company’s proxy materials between October 27, 2021 and November 26, 2021, inclusive.

In connection with any proposal submitted by stockholders for consideration at the 20202022 annual meeting of stockholders, other than proposals submitted for inclusion in our proxy statement and proxy, the persons named in the enclosed form of proxy may exercise discretionary voting authority with respect to proxies solicited for that meeting, without including advice on the nature of the matter and how the persons intend to vote on the proposal, if appropriate notice of the stockholder’s proposal is not received by us at our principal executive offices by February 13, 2020.9, 2022.

OTHER MATTERS

The Board does not know of any other matters that may be presented at the Annual Meeting, but if other matters do properly come before the meeting or any postponements or adjournments thereof, it is intended that persons named in the proxy will vote on such matters as they deem appropriate.

Stockholders are requested to date, sign and return the enclosed proxy in the enclosed envelope, for which no postage is necessary if mailed in the United States or Canada. You may also vote by telephone by calling toll free1-800-PROXIES(776-9437) or via the internet atwww.voteproxy.com.

 

By Order of the Board of Directors,

JAMES J. LEYDEN,Daniel V. Logue

Corporate Vice President,

General Counsel & Secretary

ANNUAL MEETING OF STOCKHOLDERS OF

TELEFLEX INCORPORATED

May 3, 2019April 30, 2021

 

 

PROXY VOTING INSTRUCTIONS

 

 

INTERNET – Access “www.voteproxy.com” and follow theon-screen instructions or scan the QR code with your smartphone. Have your proxy card available when you access the web page. 

LOGOLOGO

 

  

TELEPHONE – Call toll-free1-800-PROXIES(1-800-776-9437) in the United States or1-718-921-8500 from foreign countries from any touch-tone telephone and follow the instructions. Have your proxy card available when you call.

 

COMPANY NUMBER

   

Vote online/phone until 11:59 PM EDT the day before the meeting.

 

 

ACCOUNT NUMBER

 

   

MAIL – Sign, date and mail your proxy card in the envelope provided as soon as possible.

     
IN PERSON – You may vote your shares in person by attending the Annual Meeting.   

 

 

NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS:The Notice of Meeting, Proxy Statement, 20182020

Annual Report and Proxy Card are available at www.teleflex.com/ProxyMaterials

 

Please detach along perforated line and mail in the envelope providedIF you are not voting via telephone or the internet.

 

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE ELECTION OF ALL DIRECTOR NOMINEES LISTED UNDER PROPOSAL 1, AND “FOR” PROPOSALS 2 AND 3.3 AND MAKES NO RECOMMENDATION WITH RESPECT TO PROPOSAL 4. PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE

FOR

  AGAINST  

  ABSTAIN  

Proposal 1. Election of Directors:
 
   FORAGAINSTABSTAIN

Proposal 1. Election of Directors:

Nominees:

   
 

    Nominees:

   

1a.   John C. Heinmiller

Candace H. Duncan

   
 
  

1b.  Andrew A. Krakauer

Stephen K. Klasko, M.D.

   
 
  

1c.   RichardStuart A. Packer

Randle

   
 

Proposal 2. Approval, on an advisory basis, of named executive officer compensation.

   
 

Proposal 3. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2019.

2021.
   
 

Proposal 4. Stockholder proposal, if properly presented at the Annual Meeting, to declassify our Board of Directors.
The shares represented by this proxy will be voted as directed by the Stockholder. If no direction is given when the duly executed proxy is returned, such shares will be voted “FOR” all nominees listed above, and “FOR” Proposals 2 and 3.3 and “ABSTAIN” for Proposal 4. In their discretion, the proxies are authorized to vote upon any other matter that may properly come before the meeting.

  PLEASE MARK, DATE AND SIGN AS YOUR NAME APPEARS AT LEFT AND RETURN IN THE ENCLOSED ENVELOPE.

To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.

  ☐      

Please check here if you plan to attend the meeting.  

 

Signature of Stockholder                  Date:          Signature of Stockholder            Date:         

Note:Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.


PROXY

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

TELEFLEX INCORPORATED

As an alternative to completing this form, you may enter your vote instruction by telephone at1-800-PROXIES, or via the internet at WWW.VOTEPROXY.COM, following the instructions provided. Use the Company Number and Account Number shown on your proxy card.

The undersigned hereby appoints JamesLiam J. LeydenKelly and Daniel V. Logue proxies, each with power to act without the other and with power of substitution, and hereby authorizes them to represent and vote, subject to any directions indicated on the other side of this proxy card, all the shares of stock of Teleflex Incorporated standing in the name of the undersigned with all powers that the undersigned would possess if present at the Annual Meeting of Stockholders of the Company to be held May 3, 2019April 30, 2021 or any adjournment thereof.

(Continued on the other side)